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Abstract 
 High-resolution magic angle spinning (HRMAS) NMR spectroscopy is used to study 
solid samples that are normally difficult to analyze due to broadening of peaks. Solid-phase 
peptide synthesis can bind peptides to an insoluble resin that can be analyzed with HRMAS 
NMR spectroscopy. A combination of HRMAS NMR and IRMPD spectroscopy, along with 
computational chemistry, was applied to analyze and evaluate the structure of resin-bound 
glutathione. Two-dimensional 
1
H-
1
H NMR experiments such as COSY, TOCSY, and ROESY 
were employed to assign and predict the structure of the resin-bound peptide. IRMPD results 
were used along with calculated protonated structures and spectra to evaluate the conformation 
of the peptide. The experimental spectrum was compared to the spectra and structures of the 
protonated species to hypothesize the most favoured structure. Molecular mechanics, molecular 
dynamics and DFT calculations were implemented to collect structures that best resembled the 
free and resin-bound glutathione peptide. The results from these methods were compared to 
determine the structure that is most probable for the glutathione peptide. A semi-folded 
conformation is the structure the resin-bound GSH most preferred as concluded from the NMR 
and DFT results. The IRMPD results were analyzed as separate from the resin-bound 
experiments and suggested protonated GSH had a folded conformation. 
 FK-13 was another peptide synthesized using the solid-phase peptide synthesis technique. 
The peptide was synthesized using a modified technique different from conventional 
methodology used in the past. The peptide was also analyzed using COSY, TOCSY, and 
ROESY to confirm that the synthesis was done correctly and hypothesize a structure. The low 
substitution of the peptide on the resin gave rise to minimal NOE interactions, but there was 
some evidence suggesting that the synthesis was successful and the peptide adopted a cyclic 
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conformation. These initial results are useful for future analyses and conformational studies of 
this resin-bound peptide. 
 Further work needs to be done for both peptides to explore the structures in more detail.  
The explicit model of solvation should be used to explore the effect of solvent molecules on the 
conformation of the glutathione peptide as opposed to the implicit model that PCM provides. 
FK-13 could be synthesized better so that a higher substitution is achieved and better NMR 
results are obtained. The IRMPD results obtained by the McMahon group can then be compared 
to the NMR results and computational calculations can be performed to obtain realistic structures 
of the peptide.  
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1.1 Peptide Structure and Analysis 
 Proteins are important cellular macromolecules consisting of one or more amino acid 
chains.  Chains consisting of 40 or fewer amino acids are designated as peptides. Peptides and 
proteins are key molecules due to their ability to perform a variety of cellular functions, 
including transport, enzymatic, and structural roles. Determining the structure of peptides and 
proteins can provide a better understanding of the overall function of these macromolecules. 
The fundamental building blocks of proteins are amino acids. There are 20 different 
standard amino acids each with a general chemical formula H3N
+
-CH(R)-COO
-, where ‘R’ is 
the side chain which varies for each amino acid – except for proline which has a cyclic R group 
connecting the amino group and α carbon. Amino acids can act as an acid or base at 
physiological pH due to their nature that the α amino and carboxyl group may be ionized. The 
state in which an amino acid α amino group bears a positive charge and the carboxyl group 
bears a negative charge is its zwitterionic form. The ‘R’ group of these amino acids are different 
for each of the standard 20 amino acids fall under three groups: nonpolar, uncharged polar and 
charged polar side chains. Individual amino acids can form a peptide bond, through a 
condensation reaction, between the amino group of one residue and the carboxyl group of 
another. With 20 different amino acids, an exponential variety of peptides can be formed 
depending on the number of residues in the chain.
1
  
 Peptide formation begins with the amino acids making up the primary structure, which is 
simply the sequence of the amino acids, by convention described numerically, from the N-
terminus to the C-terminus. The change in geometry of the backbone of the primary peptide 
sequence gives rise to the secondary structure of the peptide. The peptide bond that joins two 
amino acids tends to exhibit a planar structure that put the ‘R’ groups in a trans conformation 
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with respect to one another. Due to a variety of steric interactions between the ‘R’ groups, the 
peptide as a whole will not stay planar and the torsion angles between residues will be altered. 
Certain ‘R’ groups cannot have a staggered conformation with respect to one another; therefore 
they adopt an eclipsed conformation as well. In addition to the neighbouring steric effects 
between amino acids, a variety of intramolecular forces cause the linear peptide to adopt a 
secondary structure. Combinations of van der Waals interactions that arise from different 
electrostatic situations play a critical role in peptide formation and stability. The various dipole 
interactions (Figure 1.1.1 a i) assist in the folding of peptides, such as between two permanent 
dipoles, a permanent and induced dipole, or between two induced dipoles. Permanent dipoles, 
such as those induced by carbonyl groups, can interact with other permanent dipoles or induced 
dipoles (i.e. from methyl groups in the side chains). Peptides that have a low dielectric constant 
in the core tend to experience the effects of dipole-dipole interactions between functional groups 
more strongly, thereby greatly influencing the folding of the peptide. Interactions between two 
permanent dipoles can vary in their effects (Figure 1.1.1 a i); they may repel or attract one 
another depending on the functional group and its orientation. Interactions between a permanent 
dipole and an induced dipole will always result in an attraction between the groups (Figure 1.1.1 
a ii). The circulation and flow of electrons dictates whether there is an attraction or repulsion 
between induced dipoles. When the electrons of one functional group distort the electrons of 
another, an attractive force is felt, but if the group cannot induce a change in the electron flow, 
repulsion is experienced. The interactions between two induced dipoles (Figure 1.1.1 a iii) are 
very weak on their own, giving rise to London dispersion forces (such as two hydrogen atoms 
of the same methyl group interacting), which do not influence peptide folding very much in 
small numbers, but if the peptide has many of these London forces close together, they can 
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influence the peptide folding in some manner. London forces occur between two induced 
dipoles and create an attractive interaction between the two groups due to the instantaneous shift 
of electrons between two induced dipoles.
2
  
 
 
 
 
 
 
Figure 1.1.1: Amino acids that make up primary sequences can fold into secondary structures 
through a variety of stabilizing forces such as a) van der Waals forces and b) hydrogen bonds. A 
variety of dipole interactions can influence how peptide can fold a) i. Two permanent dipoles 
can influence one another to either cause an attraction or repulsion (in this case a repulsion is 
shown), ii. Interactions between a functional group with a permanent dipole can induce a dipole 
on a different group creating an attraction, iii. When two groups that do not have permanent 
dipoles are in close contact, the flow of electrons from those groups can create a London 
dispersion force, creating an attraction between the groups. B) Hydrogen bonding (dashed red 
lines) can occur between a hydrogen bond donor (in this case the amide proton of the backbone) 
with a hydrogen bond acceptor (a carbonyl group of a different segment of the peptide or 
different chain), and create a force that weakly stabilizes secondary structures, but in large 
numbers, hydrogen bonds play a key role in stabilizing secondary structure.   
b) a) 
i. 
i. 
iii. 
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 Another key interaction that dictates peptide folding is the interaction between a 
hydrogen donor and a hydrogen acceptor, commonly called hydrogen bonds (Figure 1.1.1 b). A 
hydrogen bond donor (such as from an –OH, -NH2, or even -CH3) creates an electrostatic 
interaction with a hydrogen bond acceptor (i.e. atoms that have a free lone pair of electrons 
contributed by carbonyls, alcohols, amines, etc…), forming strong interactions that are weaker 
than covalent bonds. In folded peptides and proteins, hydrogen bond donors are not exclusively 
restricted to interacting with one other hydrogen bond acceptor; in many cases the hydrogen 
will interact with multiple donors, such as the backbone carbonyl of an adjacent residue and 
another one that is several residues away. On the other hand, peptides in their unfolded state do 
not form as many hydrogen bonds with other residues and the hydrogen atoms will interact with 
the surrounding aqueous environment. As a result, hydrogen bonds in an unfolded peptide are 
very weak or do not exist, though in folded conformations, hydrogen bonds greatly influence 
the structure of the peptide. In the peptide’s folded state, hydrogen bonds that associate tend to 
occur in clusters along the sequence, meaning there will be sections of the folded peptide where 
many interactions give rise to certain structures, but other portions with no hydrogen bonding. 
For example, some larger peptides and especially proteins will contain multiple secondary 
structures (helices, sheets and turns), and in these sections there are many hydrogen bond 
interactions that lay the foundation for such structural features.
2
  
 Hydrophobic effects also dictate peptide folding based on the interactions of non-polar 
residues with aqueous environments. The driving force behind non-polar groups excluding polar 
groups (such as water) is largely enthalpic (i.e. it is more favourable for the non-polar group to 
dissociate in a non-polar solvent than an aqueous one) and also is entropically driven, whereas a 
non-polar medium is relocated to a non-polar environment. In the case of a single non-polar 
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residue, when it tries to disrupt the well-ordered matrix of an aqueous environment, the water 
molecules will reorient themselves around the non-polar chain as it cannot form any sort of 
hydrogen bond with the side-chain. This same example can also be applied to larger systems, 
such as peptides and proteins, where a large group of non-polar side chains will be surrounded 
by the water molecules creating a hydrophobic cavity. A large number of these hydrophobic 
interactions caused by the amino acid residues play a large role in dictating the folding of 
peptides and which side chains are localized within the protein to avoid the aqueous 
environments. One other specific interaction that contributes to peptide folding and stability is 
the disulphide bridge. With regards to peptides and proteins, these interactions only occur once 
the peptide has folded into its native state and only readily occur between the sulphur atoms of 
cysteine residues.
2
 
 Many types of secondary structures exist, but some of the most predominant structures 
are helices, β-sheets, coils and loops (Figure 1.2.1). As the peptide backbone begins to twist the 
α carbons in a uniform matter, it gives rise to a helical conformation. Depending on the 
residues, the conformation of the helix can vary in the number of amino acids per turn, the 
distance between each turn along the axis, and can turn to the left or right. The helix can only 
form if certain angles in each turn are sterically favourable, stable and can be held together, i.e. 
stabilized with hydrogen bonds. One secondary structure that is very stable in a helical form is 
the α-helix, a right-handed helix that is stabilized by hydrogen bonds with 3.6 amino acids per 
turn, and torsion angles of Φ = -57 ° and Ψ = -47°. The stabilizing force from the hydrogen 
bonding comes from the amide proton of residue n interacting with a carbonyl group of residue 
n-4. Along with hydrogen bonding, the R groups of each amino acid point out from the centre 
of the helix, in order to avoid steric complications, and the core is tightly packed so the atoms 
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are within van der Waals contact with one another. There are a variety of helices that make up 
this group of secondary structures, but the α-helix is the most stable of all the helices.2  
 
Figure 1.1.2: Various types of secondary structures that primary sequences tend to adopt –a) Φ 
and Ψ torsion angles in an α-helix b) α-helices, c) β-sheets, and d) β-turns are the most common 
types of secondary structures. These structures are stabilized by a variety of electrostatic forces, 
hydrogen bonds and hydrophobic effects. Smaller peptides will fold into a secondary structure 
and in larger proteins multiple secondary structures can comprise its entirety.  
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A second group of secondary structures is the β pleated sheet, which has Φ and Ψ angles 
that give the peptide a sheet-like structure. These structures are also stabilized by hydrogen 
bonds, but they usually occur between two monomers of the sequence as opposed to internally 
(as with the α-helix). These sheets can adopt two forms: parallel and anti-parallel. In a parallel 
formation, the two sheets run in the same direction (i.e. the C-termini for both chains are on the 
same side and run towards the N-termini) and the sheets are stabilized by hydrogen bonds 
across the chain. In the anti-parallel conformer, the direction of the C- to N-terminus is opposite 
for the two chains, but they are still stabilized by hydrogen bonds between the amide protons 
and carbonyl groups of the backbone. Many of these monomeric sheets can continuously form 
hydrogen bonds with one another to create an aggregate of β-sheets, and can occur between 
parallel or anti-parallel sheets. It has been seen that aggregates formed from parallel sheets are 
less stable when compared to sheets formed from anti-parallel peptides.
2
 In larger proteins, 
these β-sheets on the same chain can be connected through other peptide chains, such as helices 
or turns. Furthermore, sheets tend to have a natural right hand curve (similar to a helix turn) and 
this can cause the sheet to loop around and be stabilized through hydrogen bonding.
3
  
Helices and sheets make up approximately half of the secondary structures in fibrous 
proteins, and the remaining structures are non-repetitive structures such as coils, loops, and 
turns. These structures are just as organized as helices and sheets, but their conformations are 
more random. β-turns have four amino acids that comprise the turn and can be stabilized by 
hydrogen bonds between the backbone residues. Another common non-repetitive structure is the 
loop, which is usually 6 to 16 residues and almost always exists in larger proteins. Even though 
this group of structures is less common than the helices and turns, they usually are on the 
surface of proteins, meaning they play a large role in the overall biological function.
3
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Sequential and structural determination of peptides is a key step in the understanding of 
the function of the peptide and the structure of the protein it is a part of. Traditionally, peptide 
chain analysis was done by hydrolyzing the peptide bond between amino acids using an acid, 
base, or peptidase. The use of peptidases over acids and bases was preferred since different 
enzymes were more specific and would cleave a particular peptide bond between certain amino 
acids, whereas the acids or bases will attempt to break all the peptide bonds in the chain without 
any specificity. This method of analysis has been replaced with automated amino acid 
analyzers. The peptide can be broken down before analysis and observed with a combination of 
HPLC and UV spectrophotometry. When the amino acids are placed into the HPLC column 
they will elute at different rates; as they are broken down they can form a fluorescent adduct 
with 2-mercaptoethanol and o-Phthaladehyde, and will give a unique absorbance for each amino 
acid when measured by UV spectrophotometry. This breakdown does not give an exact 
indication of the structure of the protein as a whole, but by understanding the sequence of the 
peptide being analyzed, conclusions about the nature of the peptide can be drawn. For example, 
if many non-polar amino acids are observed in the peptide analysis, it suggests that this portion 
of the peptide may exist as part of the hydrophobic core of a protein. The methods outlined here 
can be used to analyze fragments and sequence of the peptides with the aid of HPLC and UV 
spectrophotometry.
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One of the first techniques used to establish a protein structure was X-ray 
crystallography. This method requires that the sample be crystallized, then a beam of X-rays 
bombards the crystal to produce a diffraction pattern. The resulting film (or digital image, in 
modern diffractometers) of the X-ray pattern shows the interactions between the X-ray and 
electrons producing dark spots on the film, which are indicative of areas where electron density 
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is concentrated, usually atomic centres. Traditionally complex mathematical functions were 
used to convert the diffraction pattern into a crystal structure of the sample, but this has been 
simplified with the aid of computers to generate the three-dimensional crystal structure. Proteins 
have been analyzed on numerous occasions using X-ray crystallography, but the technique is 
limited by the size and resolution of the crystal that is obtained for the sample. Protein crystals 
tend to be composed mostly of water which makes the overall crystal less ordered and the 
resulting diffraction pattern uninformative. Furthermore, the side chains of the individual 
residues are difficult to map since some of them cannot be differentiated as they have 
approximately the same size and shape, but fortunately the backbone of the protein can be 
visualized, allowing for the orientations of the side chains to be determined. Some of these 
issues can be overcome by knowing the sequence of the protein beforehand and, with the aid of 
mathematical functions, the crystal structure of the peptide can be accurately established. The 
accuracy of X-ray structures to the crystalline native structure of the protein is often a very good 
representation of that protein in solution. Most proteins normally exist in an aqueous 
environment inside cells and the protein crystal that is formed is mostly made up of water. Upon 
crystallization, these proteins tend to exist in their most native state just as in many enzymatic 
systems. The proteins will adopt the conformation that still makes them functional in the crystal, 
thereby making the X-ray pattern a good representation of what it looks like in a solution state.
3
  
Mass spectrometry (MS) has also evolved into an important tool in the analysis of 
peptides and proteins. An ionization source fragments the peptide into ions that are passed 
through a vacuum into a mass analyzer and then measured by the mass spectrometer. 
Traditional methods of ionization in MS include electron impact and chemical ionization, but 
these methods were poor as they were prone to completely destroying the peptide. Fast atom 
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bombardment (FAB) was introduced as a method, where the sample typically is bombarded 
with xenon or argon atoms. This method usually gives back a molecular weight of the sample, 
but works best below a 7 kDa limit. Electrospray ionization is another very common method 
used in the analysis of peptides by MS. The sample is introduced as a solution and after 
interacting with a nebulizing gas, it exits as an aerosol of charged droplets. Eventually, the 
droplets will evaporate, explode and release the ions into the vapour phase to be detected by the 
mass analyzer. Before passing into the detector, the ions generated must be separated so they 
can be read individually. Ion traps are just one of the many types of mass analyzers available for 
this technique; these in particular are very useful for peptide analysis and are used in the 
IRMPD technique (to be discussed later). Fragmented ions that make it into the ion trap are held 
until being ejected into the detector. These traps can be selective for ions of specific mass-to-
charge (m/z) by controlling the voltage so that one ion, or even many ions from the same parent 
molecule, can be detected. Tandem mass spectrometry (two mass spectrometers that work in 
series together) is another useful method of trapping ions for analyzing peptides. After 
fragmentation, a single ion of the parent molecule is isolated in the first mass spectrometer. This 
lone peptide fragment is isolated from other fragments of differing m/z ratios and contaminants. 
The fragment interacts with a collision cell where the fragment can break about any of its 
peptide bonds, and the individual fragments will be measured by the second mass spectrometer. 
As each ion is measured in the mass spectrometer, one can compare the sizes of each fragment 
and eventually deduce the sequence of the peptide.
5
 
 Infrared multiple photo dissociation (IRMPD) spectroscopy is a recently developed 
technique that has evolved into powerful tool for peptide structure determination. This 
technique works by irradiating a molecule with a laser at a specific frequency inducing 
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fragmentation of the peptide. If the molecule vibrates at the same frequency as the irradiating 
laser, the molecule will absorb as many photons as possible before it can no longer hold any 
more internal energy and dissociates. The fragment of the peptide is tracked as a change in the 
m/z ratio measured using a mass spectrometer. This technique also produces an IR spectrum 
showing the frequencies of the fragments produced after dissociation. IRMPD spectroscopy is a 
combination of mass spectrometry and IR spectroscopy; different sources of ionization can be 
employed to dissociate the peptides and a variety of ion traps can be used for differing times for 
laser and sample interactions. The different types of lasers that are available are, but not limited 
to, carbon monoxide, free electron (FEL) and optical parametric oscillator (OPO) lasers. 
Depending on the frequency range that is to be observed and the radiation power available, the 
choice of laser can vary from sample to sample. This technique has a mass spectrometer 
component to it, so different types of ion traps are available. The most common ion traps for 
analysis are Penning and Paul-type traps, each with its own pros and cons. The Penning trap 
allows for longer irradiation periods, producing more ions. The disadvantage to this type of trap 
is that the set-up of this apparatus focuses the laser on at certain point as opposed to irradiating 
the entire ion cloud. The Paul-type trap improves where the Penning trap falters in the sense that 
the entire ion cloud is irradiated by the laser. In a general sense, the Paul-type traps seem to be 
more efficient than the Penning traps. Unfortunately, the Paul-type trap is not as versatile as the 
Penning trap for many experiments. IRMPD spectroscopy is a newly established technique, but 
has great implication for the study of peptide structure.
6
  
 One of the most powerful tools in protein and peptide structure determination is nuclear 
magnetic resonance (NMR) spectroscopy. The theory of NMR spectroscopy is to be covered in 
detail in section 1.6, but here the application to structure determination of peptides and proteins 
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will be discussed briefly. By placing a sample into a magnetic field and irradiating it with a 
radio-frequency pulse, the magnetic nuclei will be excited and will generate a signal that is its 
own electromagnetic radiation. When an electronic cloud of a nucleus experiences a change 
from the applied magnetic field, it gives rise to differing internal magnetic fields and an overall 
change in the magnetic field. This difference from the applied magnetic field and the effects felt 
by the nuclei are tracked as a change in the chemical shift. The most common nuclear isotopes 
possessing magnetic moments that are analyzed include hydrogen-1 (proton), carbon-13, 
nitrogen-15, phosphorus-31, and fluorine-19 isotopes (just to name a few). With regards to 
peptides, 
1
H, 
13
C and 
15
Nare the most commonly observed nuclei as these elements occur 
frequently in peptides and proteins. By determining the frequency at which the protons resonate 
for a particular peptide sequence, the connectivity of the atoms can be determined within certain 
residues. Two-dimensional NMR experiments like COSY and TOCSY can establish the 
connectivity of protons within a peptide; the difference between the two is that COSY detects 
protons that are 3 bonds or less from one another, while TOCSY can detect interactions between 
protons that are within the same spin system. The COSY and TOCSY experiments usually 
identify the sequence of the peptide or protein being analyzed and can assign a frequency to all 
the protons in the system. Experiments that utilize NOE enhancement, such as NOESY or 
ROESY, can be used to determine the structure of the sample. These experiments establish 
through-space interactions between protons (usually restricted to 5 Å or less). By compiling a 
list of through-space interactions, the three-dimensional structure of the peptide or protein can 
be pieced together. In addition to proton-proton two-dimensional NMR experiments, 
heteronuclear experiments such as HMQC and HMBC are useful for assigning frequencies to 
heteroatoms and establishing structure. These experiments can be used to determine the 
14 
 
frequency at which a nucleus (not proton) resonates, and correlates it to a proton that is bound 
or nearby. For example, in an HMQC experiment, the magnetization of a heteronucleus, carbon 
or nitrogen being the most common, is exploited by using a proton that is directly bound to it 
and produces a signal for this interaction. This technique is especially useful for distinguishing 
between protons that may have the same chemical shift by correlating them to the different 
carbon or nitrogen atoms they are bound to. It may also resolve two protons that are chemical 
shift inequivalent that are bound to the same carbon. HMBC experiments use the through bond 
J-coupling between the heteronucleus and protons, i.e., protons that are usually three bonds or 
less away from a carbon will produce a signal. This technique is quite useful for establishing the 
structure of the peptide or protein since it may support some of the NOE interactions and 
eliminate any ambiguity in assignment. There are a variety of 2D NMR experiments that can be 
used to determine the three-dimensional structure of a peptide or protein, but analysis is not 
limited to 2D experiments as 3D and even 4D experiments are becoming increasingly more 
popular to aid in this determination.  These 3D and 4D experiments just add another nucleus to 
the experiment and the analysis involves looking at another axis on the spectrum. By combining 
the different homo- and heteronuclear NMR techniques, the NMR structure of a peptide can be 
hypothesized based on frequency of the nuclei, through-bond connectivity and through-space 
interactions.
7
 
 With all of these tools available to hypothesize a structure based on the evidence 
collected from these experiments, the final step would be to generate a visual representation of 
the peptide computationally. When creating a variety of structures that can represent the protein 
from the data that was acquired, structural constraints need to be applied so that the electronic 
structure does not violate any physical laws. Torsion angles need to be restricted so that when 
15 
 
sampling different structures, atoms do not rotate on top of other atoms or bring them too close 
in contact, which would be sterically or electrostatically unfavourable. These constraints also 
need to be applied when evaluating the hydrogen bond distances in these proteins. The next step 
to creating the input structure is to include all of the connectivity information and NOE 
interactions that were gathered from the various NMR experiments. These interactions will help 
provide an initial structure to work from as opposed to randomly sampling different structures 
from a straight chain. Once all the physical and NOE constraints are in place and an initial 
structure is generated, it can be optimized with the aid of a variety of molecular modelling 
programs. Each program that can be used for calculating protein structures is unique and uses 
different algorithms to approach one or multiple energetically and geometrically optimized 
structures. The results of calculations can be evaluated based on a multitude of criteria, namely 
root mean square deviation (RMSD) energy, and how well it complements the X-ray, MS, 
IRMPD and NMR data. If multiple ideal structures are generated, which is not uncommon for 
peptides as they can experience a variety of stable conformers, the most favourable one can be 
chosen by analyzing the aforementioned criteria. Calculated structures that tend to have the 
lowest RMSD value and energy of all the projected conformers will be the favourable 
structures, and those with the lowest values will most likely be the dominating native structure 
of the peptide or protein. These results can then be compared to the various spectroscopic 
results obtained to verify the most favourable structure. Molecular modelling of peptides and 
proteins is the final step in a long process of determining peptide structure from the initial step 
of the simple peptide sequence. All of these tools combine to better understand the structure of 
peptides and proteins and ultimately can be used to aid in the understanding of their functions in 
a larger biological system.   
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1.2 Solid-Phase Peptide Synthesis (SPPS)  
 Over 50 years ago, synthesis of short biologically active peptides was not a difficult 
task, but the approach used to make these short peptides did not lend itself well to the synthesis 
of longer peptides. Using theory based on pre-existing peptide synthesis techniques and 
chromatography theory, Robert Bruce Merrifield developed a technique in 1963 to synthesize 
and purify longer peptides in high yields. His method began by covalently linking an amino acid 
to an insoluble polymer resin matrix that contained a functionality to which the first amino acid 
could be linked. Merrifield’s choice of polymer was a chloromethylated copolymer mix of 
styrene and divinylbenzene, which had a mesh-like microporous structure that allowed reagents 
and solvents to pass through it. The attachment of the first of four amino acids in the 
tetrapeptide was done by adding a carbobenzoxy protected amino acid to the chloromethylated 
functional group in a dry solvent.
8
 His procedure then required that any of the unreacted sites 
were esterified using triethylammonium acetate. The cleavage of the carbobenzoxy protecting 
group on the first amino acid was carried out using 10% HBr in acetic acid to give a free amino 
terminus. The addition of the next amino acid for Merrifield’s synthesis utilized the N,N’-
dicyclohexylcarbodiimide method described by Sheehan
9
, which required an excess amount of 
the carbobenzoxy protected amino acid, DMF and diimide. Again, the amino acid was 
deprotected and all excess reagents were removed with acetic anhydride and triethylamine. This 
process of deprotecting and coupling a protected amino acid was one cycle of the process 
Merrifield described and was repeated three more times to complete the synthesis. The product 
was then cleaved from the resin, purified and isolated from incomplete chains using 
chromatographic methods. The next year, Merrifield demonstrated the ability of his technique in 
the synthesis of a nonapeptide, bradykinin, but used t-butyloxycarbonyl (Boc) protected amino 
17 
 
acids instead of the carbobenzoxy amino acids. This allowed for milder conditions for 
deprotection and purification throughout the synthesis. Using the method that he had developed 
previously, the nonapeptide was synthesized on resin and when cleaved displayed normal 
biological activity of the natural bradykinin peptide.
10
 Merrifield’s Boc method was a staple of 
peptide synthesis for about 8 years until Carpino introduced the possibility of using the 9-
fluorenylmethyloxycarbonyl (Fmoc) group to protect amino acids which required milder 
conditions to remove. Their study utilized methods that were used in Merrifield’s study, but 
instead employed the Fmoc protecting group on the amino acids to synthesize a dipeptide.
11
 The 
Fmoc protecting group only required that a secondary amine, such as piperidine, be used to 
cleave the group from the amino acid to create a dibenzoylfulvene adduct. As the field of 
peptide synthesis progressed, so did the understanding of the benefits of Fmoc peptide synthesis 
over Boc methods. A major leap forward in the field of peptide synthesis and Fmoc synthesis 
was the jump to automated peptide synthesis using Merrifield’s techniques and Carpino’s 
implementation of Fmoc chemistry. Traditionally, the synthesis was carried out manually using 
a Merrifield reaction vessel, shakers and valves to add or remove solutions. Manual synthesis 
was carried out using continuous flow set ups, where the reaction vessel would have the 
reagents of choice and solvents continuously pumped through the vessel and reacting with the 
resin. As the reagents react with the resin, it is continuously monitored by a UV 
spectrophotometer to determine the molecular substitution on the resin. The reagents have to be 
manually switched for specific steps in the synthesis, but the cycle of deprotecting, coupling and 
checking is done using these continuous flow setups.
12
 The concepts of continuous flow 
synthesis were then applied to semi-automatic and fully automated solid-phase peptide 
synthesis. Semi-automatic synthesis is very much like the continuous flow mechanics, but most 
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parts of the synthesis are done automatically or are computer controlled. The apparatus would 
pump in a selected reagent and solvent into the reaction vessel, will control the amounts that get 
circulated through the machine, and monitor the reaction progress and constantly recirculate 
reagents until a specific substitution is met. All of these processes are controlled by using a 
computer with the proper programming and commands to allow for the synthesis to occur. The 
only aspect of this method that is manual is that the user must switch the amino acid that is to be 
used for each step of the synthesis, as automations adds a single amino acid at a time. These 
semi-automatic methods tend to only be viable for single amino acid additions, so the jump to 
fully automated peptide synthesis was made possible by the ability to add all amino acids 
sequentially without changing any parts of the set-up in a fully automatic synthesizer. These 
machines follow the same cycle of adding DMF then the amino acid, mixing, adding piperidine, 
washing and checking reaction progress until the peptide is fully synthesized. All of the amino 
acids that are to be used in the synthesis are housed within the machine and all of the processes 
that the control the flow of the reagents is done through a computer.
13
  
 Another major leap forward for the field of peptide synthesis was the introduction of on-
resin cyclic peptide synthesis. The synthetic procedure follows the same concepts outlined by 
Merrifield in order to cyclize a peptide on resin using a “head-to-tail” method. Early reports of 
cyclic synthesis were not able to keep the peptide bound to the resin for cyclization, but upon 
cleavage from the resin, lactamization of the carboxyl terminus and amino terminus created the 
cyclic peptide. Fridkin demonstrated this by the synthesis of polyglycine and polyalanine cyclic 
peptides with the aid of polyalcohol carriers to ensure that the cyclic product is favoured and 
formed, preventing other intermolecular interactions or secondary structure formations. This 
method worked well upon liberation of the peptide sequence from the carrier; the yield of the 
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cyclic peptide was moderately high with some contamination from oligopeptides.
14
 Other 
methods for the formation of cyclic peptides involved the bond formation between the side 
chains of specific amino acid residues. One instance of this type of cyclization was shown by 
Lebl through the formation of cysteine disulphide bridges across the peptide chain. While this 
method is very different from the “head-to-tail” methodology done by Fridkin, the cyclized 
peptide was formed on resin before being liberated from the resin.
15
 Side-chain to side-chain 
cyclization has also been done on some occasions with Schiller performing the cyclization 
between the ε amino group and the β carboxyl group.16 This synthesis more closely resembles 
the “head-to-tail” synthesis in which the terminal amino and carboxyl ends are joined, but this 
was done through the side chains as opposed to the backbone of the peptide. “Head-to-tail” 
synthesis of a peptide through the backbone functionalities while being bound to a resin was 
described by Sklyova through their synthesis of the glycine analog gramicidin S. By affixing a 
pre-synthesized tetrapeptide to a polymer, they were able to avoid inter- and intra-chain 
acylation that would give unwanted side products. The tetrapeptide (which contained a single 
unusual amino acid) of L-ornithine-L-leucine-D-phenylalanine-L-glycine was bound to the 
resin through the 5 amino group of L-ornithine. With the tetrapeptide bound to the resin, 
unwanted side reactions would be limited and the extension of the peptide could be carried out 
to complete the decapeptide sequence. The peptide was then cyclized on the resin to complete 
the synthesis of gramicidin S before being cleaved.
17
 Another study in which the N-terminus 
and C-terminus of a peptide were cyclized on resin before cleavage was also conducted by 
Isied, where the hexapeptide (Gly-His)3 was synthesized on resin. A 2,4-dinitrophenyl (Dnp) 
protected His residue was used to anchor the hexapeptide to a resin while Boc and OBzl were 
protecting the N- and C-terminus, respectively. Upon cleavage of the Boc and OBzl groups, the 
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peptide sequence was cyclized while remaining bound to the resin, but still had all of the Dnp 
protecting groups on the His residues.
18
 These two examples of cyclic peptide synthesis are the 
“head-to-tail” type of synthesis being performed on resin that are very different from 
conventional linear solid-phase peptide syntheses.  
 The synthesis of a peptide using Merrifield’s method begins with the choice of a resin. 
The resin bead is not an entirely solid bead in which a reaction occurs, but rather it is a porous 
bead that allows for reagents to pass through the insides of the mesh. The common term “solid-
support” simply refers to the insolubility of the resin bead in solution. The resin that is used 
must be: a stable support that can be easily filtered off from any solvent that is used during the 
synthesis, must not react with any of the solvents or reagents that are used in the synthesis, 
should be able to swell in the solvent of choice so that upon expansion the reagents can access 
all of the available reaction sites on the resin, and should have an anchor to allow for the 
attachment of the first reagent or amino acid. A variety of resin types exist such as gel type 
resins, which generally are a polymer of different compounds, surface supports, composite gels 
and brush polymers. The connecting branch between the first amino acid and the resin is the 
anchoring support or a linker. A linker provides space between the resin and the peptide that is 
being synthesized; it also contains a functional group to allow the first amino acid to be 
coupled. The functional group can vary depending on the goals of the synthesis and the first 
amino acid – it can be an amino group, hydroxyl or even a halogen for some reactions. There 
are even some linkers that are specialized for syntheses of cyclic peptides that may involve 
linkage through a side chain.
12
 
 The coupling of the first amino acid to the linker has changed vastly over the years as 
the understanding of SPPS has evolved. In Merrifield’s first described synthesis, an amino acid, 
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triethylamine and ethyl acetate were used to activate the reaction mixture so that linkage could 
occur.
8
 In older methods, pre-activated acyl derivatives were prepared to form an ester bond 
between the linker and the first amino acid, such as acyl halides
19
, esters
20
, and anhydrides
21
. 
Methods for in situ activation involved N,N’-dicyclohexylcarbodiimide (DCC) which had been 
a cornerstone of solid-phase synthesis for quite some time. Other reagents for in situ activation 
that are more commonly used in the modern era are 2,6-dichlorobenzoyl chloride
22
 and 1-(2-
Mesitylenesulfonyl)-3-nitro-1H-1,2,4-triazole with 1-methyl-imidazole
23
. In some scenarios, 
during pre-activation, side reactions can occur between the free carboxyl group of the amino 
acid and the activation reagent to form an O-acylurea side product. These side reactions can be 
avoided through the use of benzotriazole derivatives and phosphonium or aminium salts, such 
as HOBt and HBTU/HATU.
24,25
 The mixtures of these reagents along with the activating 
reagent are the requirements that are needed in order to couple the first amino acid to the linker 
successfully. After the first amino acid is bound to the resin, more amino acids can be coupled 
to elongate the chain until completion, but first the protecting group on the α amino group must 
be removed to form a new peptide bond to a second amino acid. Most techniques use Fmoc as a 
protecting group for the amino end of the residue, which is a very common protecting group 
because it only requires mild basic conditions to be cleaved. This allows for protecting groups 
on amino acid side chains to be acid-labile or more strongly basic labile. Cleavage of the Fmoc 
protecting group is carried out with treatment of the residue with 20% piperidine in DMF 
(Figure 1.2.1) creating a dibenzylfulvene-piperidine adduct that can be observed using UV 
spectrophotometry to analyze the resin substitution level.  
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Figure 1.2.1: Reaction mechanism for the cleavage of a 9-fluorenylmethoxycarbonyl (Fmoc) 
protecting group from an amino acid. The ‘R’ group at the end of the chain represents the amino 
acid residue in which the Fmoc protecting group is bound to. Cleavage is initiated by treatment 
of piperidine (I) to create the carbanion (II). Upon elimination of the amino acid, 
dibenzylfulvene (III) is formed which then creates a dibenzylfulvene-piperidine adduct (IV) that 
can be measured using UV spectrophotometry to determine the substitution level of the amino 
acid coupling.  
 Analysis of the peptide and the coupling efficiency can be accomplished by measuring 
the absorbance of the dibenzylfulvene-piperidine adducts since it has an absorption maximum 
of 301 nm (with a ε of 7800 M-1 cm-1). With a UV spectrophotometer, the absorbance of this 
cleaved product can be measured using the following equation
12
: 
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Measuring the absorbance of the resin bound peptide is a very good quantitative check 
for the degree of substitution, along with other methods such as an elemental analysis and 
reverse-phase HPLC. Qualitative methods such as the ninhydrin test
26
 and bromophenol blue 
test
27
 give an idea of the coupling success based on a visual test.  
 After the check for the substitution level for the first amino acid and the cleavage of the 
Fmoc protecting group, the second amino acid can be attached to continue chain elongation. 
Traditionally, a mix of N,N’-diisopropylcarboiimide (DCC), HOBt, and the Fmoc protected 
amino acid were used as coupling reagents in DCM or DMF yielded good coupling results. 
Unfortunately anhydrous crystals of HOBt have been classified as an explosive and cannot be 
transported by sea or air.
28
 Newer methods of peptide elongation use aminium or phosphonium 
salts, such as HBTU, HATU, HCTU, PyBOP, PyAOP and TBTU, to activate the reaction along 
with DIPEA to create the peptide linkage between the first and second amino acid. Reaction of 
the Fmoc protected amino acid with these aminium or phosphonium salts creates an ester 
product that can be easily coupled to the free amino end of the first residue. When the second 
amino acid is coupled, the quantitative and qualitative checks can be performed on the resin to 
determine the degree of substitution then washed through with DMF. The sample is then 
subjected to treatment with 20% piperidine in DMF to remove the Fmoc protecting group on the 
second amino acid and the third amino acid can be added. The cycle of deprotecting, adding the 
amino acid, checking and washing is done continuously until the chain has fully be elongated to 
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complete the peptide chain (Figure 1.2.2). The same methods can be utilized when synthesizing 
a cyclic peptide, but the final step is cyclization of the peptide by joining the N-terminus with 
the C-terminus by using aminium or phosphonium salts to activate the reaction.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.2: General schematic of the solid-phase peptide synthesis as proposed by Merrifield 
adapted from Kates and Albericio.
12
 The resin, orange circle denoted “R”, has an anchoring 
linker attached to it, green rectangle labelled “Linker”, which contains a functional group in 
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which the first amino acid can be coupled to. The dashed box is the legend and shows what the 
blue circle, purple triangle and red diamond represent in the flow chart.  
 Merrifield’s solid-phase peptide synthesis has evolved into a powerful tool in the field of 
peptide chemistry since it was first introduced back in 1963. His work to synthesize peptides on 
resin have given chemists a powerful tool to assemble segments of larger proteins that may not 
have been viable in solution state or that had extensive sequences. Because of his effort, 
Merrifield was awarded a Nobel Prize in Chemistry in 1984 for his discovery of solid-phase 
peptide synthesis. Even to this day, the foundation of his work is still being exploited in the 
synthesis of peptides in manual and automated manners.  
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1.3 Solid-Phase Peptide Synthesis Procedure 
 All of the amino acids needed for the synthesis of all peptides in this project were 
purchased from EMD Millipore Chemicals
®
 and all solvents used were supplied by Sigma-
Aldrich
®
 and EMD Millipore Chemicals
®
. All reactions required for synthesis were carried out 
in a custom designed glass vessel known as a Merrifield vessel (Figure 1.3.1), which is 10 cm 
long, has a fritted disk at the bottom and can have a 2 mm glass stopcock inserted at the top.  
 
Figure 1.3.1: Manual solid-phase peptide synthesis is carried out in a Merrifield vessel inserted 
into a filter flask so that the removal of excess solvent and reagents can be collected easily.  
 The synthesis began by reacting 5 molar equivalents of a Fmoc-protected amino acid 
with 3.3 molar equivalents of DCBC and pyridine to couple the amino acid to the resin. The 
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vessel was allowed to shake on a Burrell Wrist-Action Shaker for a minimum of 18 hours for 
the reaction to take place. After the coupling attempt was complete, the resin was washed 4-5 
times with DMF to remove any excess DCBC, pyridine and unreacted amino acid. At this point 
a very small portion of the resin-bound amino acid was removed and allowed to dry in a fume 
hood for approximately 45 minutes. Approximately 2-3 mg of the dry resin was weighed into an 
Eppendorf tube and 1 mL of 20% piperidine in DMF was added to cleave the Fmoc from the 
amino acid. The tube was then shaken for approximately 30 minutes to prepare the sample for a 
substitution check. After 30 minutes passed, the contents of the tube were passed through a 
glass pipette with glass wool to isolate fulvene adduct from the resin. Knowing the amount of 
fulvene in solution indirectly determined the molar substitution of the amino acid to the resin. A 
Beckman Coulter DU 640B Spectrophotometer set to read at 301 nm was used to determine the 
amount of fulvene. The solution was diluted 1:10 with DMF to make a 2% piperidine solution 
then placed in the spectrophotometer to determine the degree of substitution using Equation 
1.2.1.  
Measuring the degree of substitution needed to be performed after every coupling step 
with the goal of achieving a substitution of 80% or greater of the previously available sites. If 
the coupling was less than 80%, the reaction needed to be redone until at least the minimum 
requirement was met or if the coupling does not change after multiple attempts. If the 
substitution was equal to or greater than 80% the next amino acid coupling could be done.  
 After the first amino acid had been coupled, all of the unreacted sites needed to be 
capped to ensure that chain elongation properly occurred and no truncated chains were 
synthesized. The capping was done by treating the resin with 5 molar equivalents of acetic 
anhydride and DIPEA and allowed to shake for 20 minutes. The excess reagents were washed 
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out with DMF 4-5 times, a small portion of the resin was removed, dried and the substitution 
was measured to ensure nothing had changed since the capping reaction began. The next step 
was to cleave Fmoc from the amino acid to leave a free amino terminus so that the next amino 
acid could be coupled. Fmoc cleavage was carried out by treating the resin with 20% piperidine 
in DMF and allowing it to shake for a minimum of 30 minutes. The resin was then washed with 
DMF 4-5 times to remove all the fulvene that had been cleaved, then a small amount of the 
resin was removed, dried and a substitution check was performed to ensure all of the Fmoc had 
been removed from the amino acid. An indication for when all of the Fmoc had been cleaved 
from the amino acid was when the absorbance for the substitution check is negative or zero.  
 Chain elongation continued by reacting 4 molar equivalents of an Fmoc protected amino 
acid, HBTU and HOBt, 1.5 molar equivalents of DIPEA and the resin bound amino and 
allowing the mixture to shake for a minimum of 18 hours. Immediately following the reaction 
time, the resin was washed 4-5 times with DMF to remove any excess reagents and amino acid 
that may not have reacted. At this point a small amount of the resin-bound peptide was removed 
and allowed to dry in a fume hood for approximately 45 minutes. A substitution check was 
performed next to determine the success of coupling of the amino acid to the previous one. The 
procedure to do this utilized the same method for checking the first amino acid coupling and 
Equation 1.2.1 as well. The coupling reactions were done numerous times until the coupling of 
the previously available sites was 80% or greater, or until the percentage did not improve with 
multiple attempts. When the coupling of the amino acid to the previous one was deemed 
sufficient, the Fmoc protecting group could be cleaved and the next amino acid was added. This 
continuous cycle of deprotecting an amino acid, coupling the next one, checking the 
substitution, and deprotecting again was done until the peptide had been fully synthesized. 
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 After chain elongation was complete, any protecting groups that remained on the peptide 
were removed. There were a wide variety of protecting groups for each amino acid and each 
required different conditions to be cleaved. The Fmoc protecting group was simply removed 
with 20% piperidine in DMF, but other protecting groups required mild to harsh acidic or basic 
conditions depending on the reactivity. Once all the protecting groups were removed and 
washed out, the peptide was fully synthesized free from the effects of protecting groups.  
An alternate method was also used to synthesize the FK-13 peptide. An HMBA-AM 
resin was used instead of the Wang resin, which allowed for the amino acids to possess strongly 
acidic labile protecting groups. The HMBA-AM resin is a base-labile resin, which requires a 
strong base to cleave the peptide from the resin. Thereofre at the end of the synthesis, the 
protecting groups can be treated with a strong acid while the peptide remains bound to the 
resin.
21
 Instead of using a combination of HBTU and HOBt, just HCTU was substituted in place 
of both of these reagents. In addition to this, the amount of molar equivalents needed to do each 
coupling attempt was increased to 5 molar equivalents for the Fmoc-protected amino acid and 
HCTU and 10 molar equivalents for DIPEA. Also, the time needed to shake the vessel was 
greatly reduced from 18 hours to just 2. Coupling of the first amino acid and substitution checks 
all remained the same for this slightly modified procedure.  
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1.4 Nuclear Magnetic Resonance Spectroscopy 
 1.4.1 Basic Principles 
 One of the most powerful tools for chemical analysis of organic and inorganic 
compounds is nuclear magnetic resonance (NMR) spectroscopy. NMR spectroscopy analyzes 
the response of magnetic dipoles of atomic nuclei to an external applied magnetic field. For 
nuclei to possess a nuclear magnetic moment, μ, the nuclear spin angular momentum, I, must be 
greater than zero. Common nuclear isotopes that have an I = ½ are 
1
H, 
13
C, 
15
N, 
19
F and 
31
P, 
while nuclei that have an I = 0 are said to be NMR inactive. In the absence of a magnetic field, 
all orientations of the magnetic moments are energetically equivalent, but in the presence of an 
applied external magnetic field, B, the energy can be defined by: 
 Emag = -μ∙B  (1.4.1) 
If this external field is applied, the z component of the I vector has 2I+1 possible orientations of 
the magnetic moment. Also with spin and magnetism proportional to one another, the magnetic 
moment can be defined by: 
 μ = -γ∙I  (1.4.2) 
In equation 1.4.2, γ is the magnetogyric ratio, which is unique for every nuclear isotope. In an 
applied magnetic field, there are two states which a magnetic moment can adopt: α and β state 
(Figure 1.4.1). These different energy states are known as Zeeman levels and can be described 
as: 
 ΔE =  (hγ ÷ 2π) B0  (1.4.3) 
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Figure 1.4.1: For a spin ½ nucleus, two different states can be occupied by the spins (α and β). 
The energy it takes for a spin to move from the α state to the β state is defined by the ΔE and 
this energy different is unique for every nucleus.  
While the magnetic field remains off, the spin polarization axes point in a variety of directions 
(not just up or down), but once the field is turned on the spin polarization begins to spin around 
the field at a constant angle between the field and the spin magnetic moment. This movement of 
spinning is called precession and is analogous to a top spinning. If the top is spinning upright it 
will be stable, but as soon as the top becomes tilted, it begins to topple to the ground. If the top 
on an angle is spinning fast enough though, it will circle around trying to keep all the 
momentum it has and not topple over. The frequency of precession is proportional to the 
magnetic field and is commonly known as the Larmor frequency (given in rad s
-1
).
29
  
 ω0 = -γ∙B0 
 (1.4.4) 
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Many nuclei have a positive γ which gives the Larmor frequency a negative value, meaning the 
nuclei will precess in a counter-clockwise manner. On the other hand, when the γ has a negative 
value, the Larmor frequency will be positive and precession will be in the clockwise direction. 
While the magnetic field is on, the spins will fluctuate at different magnitudes and directions in 
tiny amounts. Even though these fluctuations are minuscule, they are needed in the long term to 
observe the difference in magnetism. Eventually when the spins stop precessing, they return to a 
thermal equilibrium where the distribution of spin polarizations is stable. There will still be 
slight precession occurring in the nuclei and the net distribution of spins will likely be in the 
same orientation as the magnetic field.
29
  
 As soon as the magnetic field is turned on, the macroscopic nuclear magnetization 
gradually builds up due to the random wandering of the spin polarizations. This exponential 
build up occurs exponentially (a first-order process) over a time described by T1, is known as 
the spin-lattice relaxation time constant or the longitudinal relaxation time constant. When the 
polarizations are rotated by a π/2 pulse along the x-axis, the net spin polarizations that occur 
along the z-axis would rotate into the –y-axis. Over time though, these spins will want to return 
to the thermal equilibrium populations and the precessing nuclear magnetizations will begin to 
decay. This decay of the macroscopic nuclear magnetizations is characterized by another first-
order time constant called T2, also known as spin-spin relaxation time constant or the transverse 
relaxation time constant.
29
 
 The electronic cloud of a nucleus responding to change due to an applied magnetic field 
is known as chemical shift. The applied magnetic field induces the circulation of electrons 
within the nucleus which gives rise to magnetic fields surrounding the nucleus as well. Since 
these electrons produce their own magnetic field, the Larmor frequency also changes depending 
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on the environment of the nucleus and the presence of other magnetic nuclei that may be 
interacting with the electrons. Chemical shift, δ, can be calculated by measuring the Larmor 
frequency of a specific nucleus and comparing it to a reference compound (such as 
trimethylsilane), and is normally measured in Hz or ppm: 
  δ = 
       
 
    
    (1.4.5) 
Chemical shielding, σ, is the influence of the electric current on a nucleus, and is driven by the 
magnetically-induced circulation of electrons. It is measured with respect to the “bare” nucleus 
of an atom and is composed of diamagnetic (σd) and paramagnetic (σp) terms: 
  σ = σd + σp (1.4.6) 
Orientation of the molecule in the field plays a role in how the chemical shift and chemical 
shielding are affected. This orientation dependence can be best described using the chemical 
shielding tensor, which is a 3x3 matrix that relates the orientation of the molecule to how the 
electric currents are being induced: 
 
  σ = (
σ    
 σ   
  σ  
) (1.4.7) 
The principal components of the principal axis system are the eigenvalues σ11, σ22, and σ33. 
Larmor frequency is dependent on the chemical shielding tensor and can be related back to 
Equation 1.4.4: 
  ω0 = γ(1-σiso)∙B
0 
(1.4.8) 
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σiso is the average of the principal components: σ11, σ22, and σ33. The chemical shielding tensors 
can be used to hypothesize the structure and orientation of the molecule within the magnetic 
field.
29
  
 In many cases, there will be multiple nuclei in a molecule to be analyzed. Indirect spin-
spin coupling, more commonly known as J-coupling, is a mechanism in which nuclear spins are 
able to communicate with one another through chemical bonds. The term “coupling” is used in 
multiple scenarios throughout this thesis, in solid-phase synthesis, and for J-coupling. 
Therefore, in this thesis, the term coupling will refer to synthetic reactions during peptide 
synthesis and J-couplings will be referred to as interactions. These interactions depend on the 
orientation and structure of the molecule being analyzed, but are independent of the external 
magnetic field. Since J-coupling is electron mediated, it can be used to establish the 
connectivity between different nuclei. The J-coupling is reported in Hz and usually is 
designated as 
X
JAB where X is the number of bonds between nuclei A and B. The interaction 
between nuclei gives rise to the splitting in NMR spectra that describes the association of one 
nucleus with other nuclei that it may be interacting with. Theoretically, J-coupling can be 
described as the sum of four individual terms: 
  JTotal = Jorbital + Jspin-dipolar + JFermi-contact + Jspin-dipolar-FC (1.4.9) 
Jorbital is the product of nuclear spin angular momentum coupling and electronic orbital 
momentum, and has diamagnetic and paramagnetic terms. Jspin-dipolar are interactions between 
nuclear and electron spins that are not near the nucleus. JFermi-contact is dictated by the density of 
electrons at the nucleus, and usually only describes s-character bonding orbitals. Jspin-dipolar-FC is 
a cross term between spin-dipolar and Fermi-contact interactions.
29
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 Dipolar coupling is dependent on the through-space interactions between two magnetic 
nuclear spins. Energetically, this is equivalent to: 
  E = (
    
  
  
            
  
) (
  
  
) (1.4.10) 
Equation 1.4.10 is the classic description of nucleus A interacting with nucleus B, where r is the 
distance between the two nuclei, but the quantum mechanical equivalent is: 
  ĤDD = γXγYħ
2
 (
    
  
  
            
  
) (
  
  
) (1.4.11) 
With the use of spherical polar coordinates, equation 1.4.11 can be converted to: 
  ĤDD = 
     
 
  
[A+B+C+D+E+F] (
  
  
) (1.4.11) 
The term in the front, before the six different terms (Equation 1.4.12), is usually represented as 
R (in Hz) and is the dipolar coupling constant. 
  A = ÎXz ∙ÎYz (3cosΘ-1) (1.4.12) 
  B = 
 
 
 (ÎX+ ∙ÎY- + ÎX- ∙ÎY+)(3cosΘ-1) 
  C =  
 
 
 (ÎXz ∙ÎY+ + ÎX+ ∙ÎYz)sinΘcosΘ     
  D =  
 
 
 (ÎXz ∙ÎY- + ÎX- ∙ÎYz)sinΘcosΘ     
  E =   
 
 
 ÎX+ ∙ÎY+
 
sin
2Θ      
  F =  
 
 
 ÎX- ∙ÎY-
 
sin
2Θ      
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In a rapidly tumbling solution, the six terms (A to F) are orientation-dependent and average out 
to zero. On the other hand, solids that are locked in space do not average out to zero in the terms 
A to F.
29
  
 1.4.2 High-Resolution Magic Angle Spinning (HRMAS) 
 The NMR of solids is very different from solutions. Due to the lack of free tumbling 
motion, dipolar coupling is the dominant mechanism (as opposed to J-coupling) and the 
resonance frequency depends on the orientation of the nuclei in the magnetic field. In addition 
to these differences, solids are difficult to work with as they have longer T1 times, are 
insensitive, exhibit line broadening due to dipolar coupling, and possess anisotropic line shapes. 
Luckily, there are many techniques to improve solid-state NMR spectroscopy, one being high-
resolution magic angle spinning (HRMAS). HRMAS (and other techniques used to improve 
solid-state NMR) is beneficial in the sense that solubility (and usually volatility) is not a 
problem, the data collected can be compared to X-ray results, Fourier-transform NMR is not 
limited by freezing or boiling point of solvents, and just a powder is needed (not entire crystals). 
Since solid-state NMR is orientation-dependent, the chemical shift anisotropy term is affected 
by these solids and causes broadening in spectra. Factors such as the magnetic field strength, 
flux and solvent-polymer interactions also add a magnetic susceptibility broadening factor. Each 
of these issues that cause spectral broadening can be addressed by spinning the sample at the 
magic angle of 54.74° with respect to the magnetic field (Figure 1.4.2). This angle is a product 
of the orientation-dependent term P2(cosΘ) equalling zero
30
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  P2(cosΘ) = (3cos
2Θ-1)/2 = 0 (1.4.13) 
  Where cos
2Θ = 1/3 
  Θ = cos-1(1√3) = 54.74° 
 
Figure 1.4.2: Magic angle spinning is an orientation dependent technique that spins the sample 
at Θ = 54.74° with respect to the magnetic field. Line broadening is common amongst solid-
samples, but by spinning the sample at the magic angle narrow lines can be obtained. 
The result is a reduction of line broadening, yielding narrow lines at the isotropic frequency if 
the spinning rate is sufficiently high compared to the breadth of the interactions being averaged. 
If the spinning rate is less than the total breadth of the interaction, then spinning side bands 
(which look like narrow peaks) will also occur at multiples of the spinning rate from the 
isotropic peak.  
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1.4.3 Pulse Sequences 
 The nuclear spin polarizations must be excited in order for a signal to be produced. This 
is executed by initially exciting the nuclear spins with a radiofrequency (r.f.) pulse. In the 
simplest case, the pulse excites the nuclear spins, and as they return to thermal equilibrium, the 
weak r.f. signals radiated by the nuclei are amplified and detected. An r.f. pulse is used to excite 
the sample, which then reacts by released transverse nuclear magnetization. Once the r.f. pulse 
is turned off, the nuclear spins give off their own r.f. NMR signal (free induction decay, FID), 
but they are very weak and need to be amplified before they can be processed. The signal is then 
digitized and can be converted from a function of time to a function of frequency with a 
mathematical operation known as Fourier transformation. The result is an NMR spectrum that is 
displayed on the computer.
29
 
 
Figure 1.4.3: Block diagram of a single pulse NMR experiment, where the black rectangle with 
a phase that is a multiple of π/2 and the signal acquisition follows (wave line).  
The pulses used are in phases that are multiples of π/2 (or sometimes 90°).  For a single pulse 
experiment, such as the one in Figure 1.4.3, the nuclear spins are excited once and then 
detected, but by adding a second r.f. pulse, more spectral information can be obtained. After the 
first r.f. pulse is used, a delay time, t1, is initiated before the second pulse is released and then 
detection occurs. Figure 1.4.4 shows a two pulse sequence, but multiple pulses per sequence are 
not uncommon. 
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Figure 1.4.4: In a multiple pulse sequence, two different pulses (black rectangles) are used with 
a time delay in between pulses (τ). Acquisition occurs after the second pulse. Two pulses can be 
used to irradiate nuclei on two separate occasions to achieve different goals (depending on the 
pulse phases used). 
 Until now, the examples given were for a single channel experiment where only one 
nucleus was being irradiated and observed. In many cases, this type of experiment is not 
sufficient and a second channel is added. This second channel is commonly a different nucleus 
than in the first channel, i.e. an atom such as 
13
C or 
15
N.  These types of experiments involve 
multiple pulses on both channels, multiple time delays, often decoupling and the acquisition can 
occur on either channel. Figure 1.4.5 shows an example of one of these two channel 
experiments (INEPT). After acquiring the signal from these two channel experiments, two-
dimensional spectra are normally produced, but by adding more channels, extra dimensions can 
be added into the spectrum. It is not uncommon to add a third dimension to obtain 3D NMR and 
there was an instance where a 7D NMR spectrum was obtained.
31
 Adding more channels and 
dimensions to a spectrum allows for more information about the sample being analyzed to be 
revealed, depending on the pulse sequences used. 
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Figure 1.4.5: Block diagram of the INEPT pulse sequence is an example where second channel 
is added to observe another nucleus. In this case the second channel is 
13
C and data acquisition 
occurs on this channel as opposed to on the 
1
H channel. 
 1.4.4 COSY, TOCSY and ROESY 
 There are many different pulse experiments available, but the three focussed on in this 
thesis are COSY, TOCSY, and ROESY. These are all single channel experiments that observe 
1
H signals. COSY, or correlated spectroscopy, establishes connections between nuclei that are 
J-coupled. The block diagram from this pulse sequence is shown in Figure 1.4.6; the pulse 
begins with a π/2 pulse, followed by a variable t1 delay time. Next, a second π/2 pulse is used 
and the signal is collected during a time t2. The FID is collected for both time delays and 
Fourier transformed in both dimensions. The result is frequencies that will align with one 
another to create “cross-peaks” in the spectrum. The signals in a COSY spectrum only represent 
nuclei that are connected by J-coupling. In the simplest case, COSY will detect 
1
H atoms that 
are three bonds or less away from one another. This experiment is especially useful for 
determining connectivity between nuclei in molecules.
32
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Figure 1.4.6: Block diagram of the COSY pulse sequence. A π/2 pulse along the x-axis is 
applied, then a time delay occurs followed by another π/2 pulse along the x-axis. The COSY 
technique allows for nuclei that are J-coupled to be observed.  
 Total correlated spectroscopy (TOCSY) is a technique that mixes all of the 
magnetization for a set of coupled nuclei. Nuclei that are within the same spin system will be 
observed interacting with one another. The method to this approach is that a π/2 pulse is applied 
and then allowed to evolve during t1. Another π/2 pulse is then applied and right after, a mixing 
time begins. This mixing time is a period when the magnetization is transferred throughout the 
spin system of the molecule. Instead of being restricted by J-couplings (as COSY is), all of the 
spins that are within the system that are interacting with one another will be observed as cross-
peaks in the spectrum. However, magnetization does not travel across carbonyl, ethers and other 
heteroatoms, but this can be beneficial as it can be used to identify individual residues within 
larger peptides. After the mixing time, another π/2 pulse is applied and the signal is acquired. In 
the case of larger proteins and peptides, this technique can prove to be more beneficial than 
COSY since it can identify all the spins within individual residues.
32
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Figure 1.4.7: Block diagram of the TOCSY pulse sequence. A π/2 pulse along the x-axis is 
applied, followed by t1 delay and then another π/2 pulse. The mixing of the magnetization 
throughout the spin systems then occurs during the “mixing time”. Nuclear magnetization is 
transferred from nuclei to nuclei allowing for all of the spins in an entire spin system to be 
observed.  
 Rotating-frame nuclear Overhauser effect correlation spectroscopy (ROESY) is a 
technique that provides information concerning distances between nuclei. This technique is 
based on dipolar interactions between nuclei (NOEs) in the rotating-frame. The rotating frame is 
a coordinate system that rotates with the field to make the r.f. field look static. The rate of 
change for the net magnetization, with an applied magnetic field (B1), in the rotating frame can 
be represented as: 
  
     
  
        (   
 
 
   )  (1.4.14) 
This results in M(t), being independent of time. While in the rotating frame, the magnetization 
will not experience any precession if it is in an applied field. Relaxation in the rotating frame 
will be achieved by B1 decaying with a time, T1ρ, or the spin-lattice relaxation time in the 
rotating frame.
29
 Initially a π/2 pulse along the x-axis is applied then a time t1 occurs. Following 
the t1 time, there is a spin-lock along the y-axis. This spin-lock, keeps the nuclear polarization 
spinning along the axis the entire duration of this event. Once the spin-lock is complete, signal 
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acquisition occurs. If the pulse for the spin-lock is too strong then magnetization is able to 
transfer to J-coupled spins, which would be give the same information as COSY and 
subsequently reduce the dipolar interactions in the molecule. The NOEs that are produced from 
ROESY all have a positive sign, but those interactions that come from shared magnetization 
through J-coupling also have the same sign which makes interpreting the data more difficult. 
ROESY is beneficial when analyzing intermediate sized molecules (1000 to 3000 MW) but 
NOE enhancement is not as effective for large or very small molecules. In small peptides, 
ROESY is useful and can be used to establish the three-dimensional structure by analyzing and 
evaluating the different NOE interactions that are seen in the spectra.
32
  
 
Figure 1.4.8: The ROESY pulse sequence begins with a π/2 pulse along the x-axis and then a 
time delay, t1. While the bulk magnetization is along the y-axis, a “spin-lock” is applied on that 
same axis to keep the magnetization along that axis. This allows for through-space NOEs 
(dipolar interactions) to evolve and be observed once the data is acquired.  
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In the following sections of this thesis, the results of the work done on glutathione and FK-13 
will be presented. Chapter 2 contains an introduction to the GSH peptide followed by the 
results. The results of the solid-phase synthesis, NMR, IRMPD and structure calculations on the 
GSH peptide are presented first, followed by a discussion summarizing all of the results and 
drawing conclusions about the work. Chapter 3 begins with an introduction to the LL-37 
peptide and FK-13 which is then followed by the results. The results of the FK-13 peptide 
consist of the solid-phase synthesis and NMR data. Following these results, a discussion about 
the results and concluding statements are given. Finally, a conclusions chapter, Chapter 4, will 
provide statements about the work done in this thesis. These conclusions include a summary of 
the work done on both peptides, the value of the work accomplished, and the future directions 
of the work.  
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2.0 Glutathione 
 2.1 Introduction 
 2.2 Experimental Procedures 
 2.3 Results 
 2.4 Discussion  
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2.1 Introduction 
Glutathione (GSH) is an essential peptide in the protection against reactive oxygen 
species and free radicals through its role in certain enzymes. The structure of GSH has been 
studied with a variety of methods including NMR, molecular dynamic calculations, mass 
spectrometry and IRMPD spectroscopy. However, this peptide is still being studied in a variety 
of manners and new aspects of the tripeptide are being discovered. It is a simple peptide that can 
be analyzed using a variety of techniques and still has great implication in the field of peptide 
chemistry. 
 Glutathione (GSH) is a tripeptide that with the amino acid sequence γ-glutamic acid-
cysteine-glycine (ECG), but there is an unusual peptide linkage between the γ-carboxyl group of 
glutamic acid and the α-amino group of cysteine (Figure 2.1.1). This peptide primarily acts as 
an antioxidant and antitoxic agent.  
 
Figure 2.1.1: Skeletal structure of neutral glutathione with the α carbons labelled. A 
conventional peptide bond between amino acids would be between the α-carboxyl group of one 
amino acid and the α-amino group of the next amino acid. In GSH, the γ-carboxyl group of 
glutamic acid (Glu) forms a bond with the α-amino group of cysteine (Cys).  
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Glutathione is a biosynthetic peptide synthesized primarily by two enzymes: γ-
glutamylcysteine synthase (γ-GCS) and glutathione synthase (GS). In the synthesis of GSH, γ-
GCS synthesizes γ-glutamylcysteine via an ATP-mediated condensation reaction between 
glutamate and cysteine. This formation of γ-glutamylcysteine is the rate-determining step in the 
biosynthesis of GSH, and is limited by the amount of cysteine available in the cell. The next 
step is to create GSH by adding glycine to the C-terminal end of the dipeptide. GS is the 
enzyme responsible for this step in the synthesis and is also an ATP driven reaction.
33
 
 One role of GSH is to act as an antioxidant by scavenging free radicals or reducing 
harmful peroxides, but this produces a potentially harmful dimer, GSSG (oxidized GSH). The 
antioxidant ability of GSH is due in large part to the peptide’s thiol group that can donate a H+ 
and electron for these reactions. The dimer can then be converted back to GSH with the help of 
glutathione reductase, which is an NADPH dependent enzyme. GSH is also a co-factor for 
GSH-peroxidases (GPx), which are another important class of enzymes that protect the cell 
against oxidants. These enzymes function by reducing hydrogen peroxide and other peroxides 
to water, an alcohol and GSSG. Glutathione S-transferases (GST) are another major class of 
enzymes that relieve the oxidative stress on cells from xenobiotics. They act against α,β-
unsaturated carbonyls, epoxides and peroxides that are introduced into the cell. By reducing 
these harmful agents, GSTs prevent them from reacting with other important macromolecules 
such as proteins and nucleic acids.
34
 The antitoxic function of GSH is very similar to its 
antioxidant role. GSH has nucleophilic and reducing properties so it can interact with 
electrophiles and oxidizing agents to prevent harm to the cell. Most of the detoxifying roles that 
GSH possesses work in tandem with GS-S-transferases to reduce the effect that electrophilic 
xenobiotics have in the cell.
35
 These GSTs have also been shown to provide defense against 
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carcinogens and affect antineoplastic drugs.
36
 GSH is an important cofactor for the function of a 
variety of enzymes that help in the defense against oxidizing agents and potentially harmful 
toxic compounds.  
 The structure of glutathione is one that has been studied in the past by NMR and other 
computational methods. The first experiment to determine the structure of GSH was performed 
by Fujiwara by analyzing a fully ionized sample with the aid of 
1
H NMR spectroscopy. 
Analysis of 1D 
1
H NMR spectra and the J-coupling of the peaks suggested that the most stable 
conformer of the tripeptide was when the CO2
-
 and NH3
+
 of glutamate are fully extended away 
from the rest of the chain.
37
 A later study done by York was performed to analyze GSH in 
solution again, but 
13
C NMR was used along with 
1
H NMR to determine the structure of the 
peptide. The J-coupling in the 
1
H NMR spectra was used along with the spin-lattice relaxation 
times in the 
13
C NMR to hypothesize a structure of the tripeptide. Their studies revealed that at 
physiological pH, the glutamate and cysteine ends are hindered in their motions, but the glycine 
end is very mobile and can rotate freely. They also observed an interaction between the 
1
H of 
the glutamate amino group and the carbonyl of the peptide backbone. This observation 
contradicts the results that Fujiwara had obtained because York’s results suggest that the CO2
-
 
and NH3
+
  are not extended away and folded in towards the rest of the backbone.
38
 Additional 
studies have shown that GSH has the flexibility to coordinate itself with metal ions such as Cd, 
Zn, Pb and Hg with high specificity as proven with 
13
C NMR.
39
 GSH acid-base chemistry has 
also been monitored using NMR spectroscopy while the peptide was coordinated to 
methylmercury.
40
 High-resolution magic angle spinning (HRMAS) NMR spectroscopy 
combined with computational calculations were used to predict the chemical shifts and 
hypothesize a structure. 
1
H, 
13
C and 
15
N NMR experiments were performed on crystals of GSH 
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to determine the experimental shifts for the individual nuclei. The experimental results were 
then compared to calculated 
1
H and 
13
C shifts, and suggested there were similarities between the 
two methods to validate the structure of GSH.
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Further analysis of the GSH structure was done with the aid of molecular dynamics 
experiments. GSH and 16 different charge states were analyzed by Lampela using molecular 
dynamics simulations and NMR spectroscopy to determine if the peptide favoured a 
conformation at varying pH. The results of this study revealed that the NMR results did not 
fully agree with the MD simulations, as the side chains of the Cys and Glu residues preferred a 
staggered conformation in the NMR data, and the simulations suggested that it preferred a 
gauche orientation. Additionally at physiological pH, the simulations revealed that the molecule 
did not prefer any state due to the flexibility of the chain. The study also looked at the proximity 
in which the thiol group of Cys comes with the Glu Cα-H bond. The most favoured structure for 
this thiol and hydrogen contact is when the contact is minimal and the Glu has NH3
+
 and COO
- 
groups, the thiol is uncharged, and the Gly carboxyl is COO
-
.
42
 Zhang also used molecular 
dynamic and NMR experiments to study the conformation and hydrogen bonding properties of 
GSH in water. NMR spectroscopy was used to determine the shift of the 
1H’s that were 
responsible for taking part in the hydrogen bonding with water. The varying differences in 
frequency determine whether a bond was strong or weak, and could be compared to the 
molecular dynamic calculations. The simulations suggested that GSH has three common 
conformations: extended, semi-folded and folded (Figure 2.1.2). The extended form is the most 
favourable of all the states and can interchange with the folded state, but that rarely occurs. The 
hydrogen bond that was strongest in the simulations was between the amide proton of glycine 
and the water residues, but other water residues will coordinate to the cysteine amide proton to 
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form stable clusters.
43
 Other molecular dynamics simulations with GSH at varying pH showed 
that at pH 7.0 (close to physiological conditions), the tripeptide had no favourable conformation 
and can exhibit a wide variety of structures similar to Lampela’s work.44 
 
 
 
Figure 2.1.2: GSH predominantly exists in one of three states: a) folded, b) and d) extended and 
c) semi-folded. Zhang et al. conducted NMR and molecular dynamic experiments to observe 
the coordination of water molecules to the various hydrogen bond acceptors in GSH to observe 
which conformation is most favoured.
43
  
Mass spectrometry and IRMPD spectroscopy have also been used to analyze the 
structure of GSH on multiple occasions. Electrospray ionization (ESI) mass spectrometry was 
used to obtain spectra of a protonated GSH and GSH dimer. A mixture of GSH and various 
amino acids was then observed with ESI-MS to evaluate the interaction between the tripeptide 
and the amino acids. GSH was able to form complexes with eight common amino acids which 
had implications for GSH and amino acid interactions in human blood.
45
 Collision induced 
dissociation (CID-MS) was also used to generate GSH cations using two different chemicals. 
The two different methods of ionization provided spectra that were very similar to one another. 
Computational calculations were also done to show the capability of the radical to move around 
in the tripeptide, and the energy barriers associated with the radical migration.
46
 IRMPD is a 
quickly evolving technique that is now being applied to investigating the structure of protonated 
peptides. Two residues of GSH (Cys and Gly) were studied using IRMPD spectroscopy in the 
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CysGly and GlyCys conformation by Osburn. Migration of the radical between the two 
dipeptides was studied by obtaining the IR spectra of the samples and comparing them to 
calculated IR spectra. The migration of the hydrogen atom from the sulphur atom to the α-
carbon is not favoured for the Cys-Gly conformer, but does occur for the Gly-Cys conformer as 
supported by the IR spectra and DFT calculations. These results could then lend themselves 
well to the full GSH peptide when trying to understand the radical movement.
47
 Recently, the 
reactivity and migration of the radical in the full GSH tripeptide was studied by Osburn as well. 
The results of the protonated tripeptide radical migration were inconclusive as the absorption 
region being analyzed contained too many overlapping broad peaks. The spectrum for the Glu-
Cys dipeptide did show migration of the sulphur radical to the α-carbon of the Glu residue, 
which was expected based on their previous study. The region of 2800-3700 cm
-1
 in the 
spectrum for the tripeptide suggested that the radical does migrate from the sulphur atom to the 
α-carbon as hypothesized from their previous study.48  
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2.2 Glutathione (GSH) Experimental Procedures 
 2.2.1 Synthesis of Glutathione 
 Synthesis of the tripeptide glutathione was carried out using methods outlined and 
adapted from Kates and Albericio
12
 and Chan and White
13
. The amino acids that were used in 
this synthesis were: Fmoc-Glu(ODmab)-OH, Fmoc-Cys(Mmt)-OH and Fmoc-Gly-OH, and the 
coupling reagents were HBTU and HOBt. Synthesis was carried out in a custom designed glass 
vessel, known as a Merrifield vessel, which is 10 cm long, has a fritted disk at the bottom and a 
2 mm glass stopcock in the top.  
 Synthesis began by weighing 0.5022g of Wang-OH resin (200-400 mesh, 0.6-1.0 
mmol/g substitution) into the Merrifield vessel and was shaken for one hour in DCM. The 
average molar substitution of the resin was used to determine the amounts of each reagent 
needed for the coupling of Fmoc-Gly-OH. This first coupling step required, 0.5973 g of Fmoc-
Gly-OH, 287.8 μL of DCBC, 267.7 μL of pyridine and 10 mL of DCM. These reagents were 
added directly into the vessel and allowed to shake for a minimum of 18 hours. After this 
attempt, the resin was washed and the coupling success was measured (using methods outlined 
in section 1.3 and for each substitution check in this synthesis), but the substitution was only 
0.6126 mmol/g (76.5% of the previously available sites). This coupling was less than ideal, so a 
solvent change was implemented and DMF was used instead of DCM. After 4 more attempts of 
using DMF with the same amounts of reagents, the final coupling for Fmoc-Gly-OH (G3) was 
measured to be 0.6802 mmol/g (85.0% of the previously available sites). The coupling of this 
amino acid was successful and allowed for the addition of the next amino acid, Fmoc-
Cys(Mmt)-OH (C2), to be carried out. The resin-bound amino acid was treated with 
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approximately 10 mL of 20% piperidine in DMF to cleave the Fmoc protecting group. After a 
few cleavage attempts, the substitution check for Fmoc removal showed a negative value for the 
absorbance, and the chain elongation could proceed with the next amino acid.  
 For this synthesis, 4 molar equivalents of the amino acid (C2), HBTU and HOBt were 
used, along with 1.5 molar equivalents of DIPEA for each coupling. The amounts of reagents 
needed for the second amino acid coupling were based off the molar substitution of the previous 
amino acid, hence 0.8413 g of Fmoc-Cys(Mmt)-OH, 0.5183 g of HBTU, 0.2092 g HOBt and 
89.7 μL of DIPEA were required. These reagents were weighed into a round bottom flask and 
dissolved in approximately 15 mL of DMF, then agitated for 5 minutes to dissolve the contents 
and pre-activate the mixture. The mixture in the round bottom flask was added to the Merrifield 
vessel that contained the glycine bound amino acid and a very minimal amount of solvent. The 
mixture of reagents was then allowed to react for a minimum of 18 hours. After this 18 hour 
period, the resin was washed 5 times with DMF to remove excess reagents. Next, a small 
amount of the resin was removed and dried in a fume hood for 45 minutes. The substitution 
check was then done to determine the degree of coupling of C2 to G3; after 5 attempts, the 
coupling of Fmoc-Cys(Mmt)-OH was sufficient to continue the synthesis of glutathione. The 
substitution of C2 to G3 was calculated to be 0.4891 mmol/g (71.9% of the previously available 
sites). Even with multiple attempts to couple C2 to G3, the ideal substitution of 80% was not 
met, but all previous attempts up to the fifth coupling attempt did not show much change in the 
substitution. At this point, the Fmoc protecting group on C2 was cleaved with 20% piperidine in 
DMF. 
 The coupling of the final amino acid, Fmoc-Glu(ODmab)-OH (E1), was done using 
0.6688 g of the Fmoc protected amino acid, 0.3726 g of HBTU, 0.1504 g HOBt, and 64.5 μL 
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DIPEA. These reagents were weighed into a round bottom flask, dissolved in approximately 15 
mL of DMF, and agitated for approximately 5 minutes to pre-activate the mixture. This solution 
was then added to the Merrifield vessel and was allowed to shake for a minimum of 18 hours. 
After 18 hours, the resin was washed 5 times with DMF to remove any excess or unreacted 
material. A small amount of resin was removed and dried to determine the coupling success of 
E1 to the previous amino acid C2. This coupling took three attempts to get the final substitution 
of 0.3987 mmol g
-1
 and marked the end of the chain elongation of glutathione.  
 Even though the tripeptide was completely synthesized, the protecting groups on C2 and 
E1 had to be removed. The first protecting group that needed to be cleaved was the Fmoc 
protecting group on the α amino group of E1. This was done by treating the resin with 20% 
piperidine in DMF and shaking the vessel for 30 minutes. After 30 minutes, the resin was 
washed 5 times with DMF to remove dibenzylfulvene adduct in solution. A small portion of the 
resin was removed and dried in a fume hood to determine if every Fmoc protecting group was 
cleaved. The sample was then diluted and checked in the UV spectrophotometer, and when a 
negative absorbance was observed, it was assumed the Fmoc was completely removed. 
Cleavage of the ODmab protecting group from E1 was done by treating the resin-bound peptide 
with 2% hydrazine in DMF 10 times. Each time the resin was treated with the hydrazine mix, 
the vessel was shaken for approximately two minutes and then washed through with DMF 4-5 
times. Following this cleavage, the α carboxyl group of E1 was free from the effects of the 
protecting group. The protecting group on C2, Mmt, had to be cleaved using a 1:5:94 mix of 
TFA:TIS:DCM. This solvent mixture was added to the vessel and agitated for 30 minutes. 
Following the shaking, the resin-bound peptide was washed 5 times with DMF to remove the 
Mmt protecting group. The resin was washed through with DMF 4 more times to ensure that no 
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free protecting groups, unreacted reagents or other impurities remained in the vessel. The final 
product obtained was resin-bound glutathione free from the effects of protecting groups. The 
product was removed from the vessel and placed in a fume hood until it was completely dry and 
subsequently stored in a vial that was put into a desiccator. 
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Figure 2.2.1: Flow chart for the synthesis of the resin-bound peptide glutathione. Methods used 
in this synthesis were adapted from Kates and Alberts
12
 and Chan and White
13. ‘R’ represents 
the Wang resin in which the peptide was synthesized on. 
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2.2.2 NMR Experiments Conducted on Glutathione 
 All NMR experiments conducted on glutathione were done at the University of 
Waterloo using a Bruker Avance 500 MHz NMR spectrometer equipped with a Doty Scientific 
triple-tuned DSI-XC4 HRMAS probe at ambient temperature (~295 K). The probe was 
equipped with a 
13
C-
2
H LF Trap Wand, 
13
C-
2
H MF Tune/Voltage Division Wand, 
13
C-
2
H LF 
Tune/Voltage Division Wand and a 
13
C-
1
H capacitor. A small amount of the dry resin-bound 
peptide was loaded into a XC4 40 μL Kel-f sealing cell, which filled approximately half the 
volume of the cell. The rest of the cell was filled with DMF-d7 and a XC4 nominal Teflon plug 
was used to cap it. The cell could only be used reliably for spectroscopy if there were no air 
bubbles in it, so care was necessary in preparing the samples. The sealing cell was then loaded 
into a Doty Scientific XC4 4-mm silicon nitride thin wall rotor and capped with Torlon short 
turbine caps. The rotor was then placed into probe and spun at a speed of 4.5-4.6 kHz at the 
magic angle of 54.74°. 
 One-dimensional 
1
H NMR spectra, plotted as spectral intensity versus frequency, were 
obtained using a simple one-pulse sequence. The spectrum was collected after 1024 transients, 
with an acquisition time of 0.62 seconds and a spectral width of 6613 Hz. A 90° 
1
H pulse length 
of 7.75 μs at low power (0.00 dB) was used to obtain the spectrum. The resulting 8k data points 
were zero-filled to 16k data points for Fourier Transform and apodized using the exponential 
windowing function with a Lorentzian broadening constant of 0.30 Hz, sine bell shift of 0 and a 
Gaussian broadening factor of 0. The spectrum was referenced internally to the chemical shifts 
of the DMF solvent and applied to all other 1D and 2D 
1
H experiments. All spectra were 
processed using the Bruker XWIN-NMR 3.5 pl6 software. 
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 Two-dimensional 
1
H-
1
H COSY experiments used the cosyqf90 pulse sequence and 
collected a set of 256 x 1024 data points in the t1 and t2 dimensions, respectively. Each 
increment consisted of 128 transients with 4 dummy scans over a spectral width of 6009 Hz in 
both dimensions. A 90° pulse length of 7.55 μs was applied at a power level of 0.00 dB with an 
acquisition time of 0.085 seconds. Delay increments (IN0) of 0.166 ms, a dwell time of 83.2 μs 
and a relaxation delay of 2 seconds were also applied in the pulse sequence. After acquisition 
and Fourier transform was applied, the data sets underwent apodization using the SINE 
multiplication function with a Lorentzian broadening constant of 0.30 and 1.00 Hz in the t1 and 
t2 dimensions, respectively. In both dimensions, the sine bell shift was set to 0 and the Gaussian 
broadening factor was set to 0.1 in the t1 dimension and 0 in the t2 dimension. The COSY 
spectrum was calibrated using the value obtained from the 1D 
1
H experiment for both the t1 and 
t2 dimensions. The spectrum was processed using the Bruker XWIN-NMR 3.5 pl6 software.  
 Two-dimensional 
1
H-
1
H TOCSY experiments used the DIPSI-2 pulse sequence and 
were collected in a set of 512 x 4096 data points in the t1 and t2 dimensions, respectively. A 
total of 56 transients and 16 dummy scans were used per increment over a spectral width of 
5000 Hz in both dimensions. A 90° pulse length of 8.00 μs was used at a power level of 0.00 dB 
and 90° pulse at low power of 70 μsec was accompanied by a 19.12 dB power level for the 
TOCSY-spin lock. A TOCSY mixing time of 35 ms and an acquisition time of 0.40965 seconds 
were used in the pulse sequence as well. Delay increments of 0.199 ms, a dwell time of 100 μs, 
and a relaxation delay of 2 seconds were also used for this experiment. Upon Fourier transform, 
the data sets were apodized using the QSINE multiplication function with a Lorentzian 
broadening factor of 0.30 and 1.00 Hz in the t1 and t2 dimensions, respectively. In both 
dimensions, a sine bell shift of 2 was applied and the Gaussian broadening factor was set to 0.1 
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in the t1 dimension and 0 in the t2 dimension. The TOCSY spectrum was referenced using the 
value obtained from the 1D 
1
H experiments on this sample. The spectrum was processed using 
Bruker XWIN-NMR 3.5 pl6 software.  
 Two-dimension 
1
H-
1
H ROESY experiments utilized the roesyph pulse sequence and 
collected a set of 512 x 2048 data points in the t1 and t2 dimensions respectively. A total of 64 
transients and 16 dummy scans per increment were used over a spectral width of 5000 Hz in 
both dimensions. A 90° pulse length of 8.00 μs at a power level of 0.00 dB along with a 50 ms 
pulse for the ROESY spin-lock at a power level of 28.02 dB. Each pulse had an acquisition time 
of 0.2049 seconds and a 20 μs power switching delay. Upon Fourier transform, the data sets 
were apodized using the QSINE multiplication function with a Lorentzian broadening factor of 
0.30 and 2.00 Hz in the t1 and t2 dimensions, respectively. A sine bell shift of 2 was applied in 
both dimensions and a Gaussian broadening factor of 0.1 in the t1 and 0.05 was used in t2 
dimension. The spectrum was referenced to the same solvent reference as the 1D 
1
H 
experiments for this sample. Processing of the ROESY experiments was done using the Bruker 
XWIN-NMR 3.5 pl6 software.  
 2.2.3 Infrared Multiple Photon Dissociation Acquisition of Glutathione 
 Reduced L-Glutathione was purchased from Sigma-Aldrich for use in the IRMPD 
experiments. All IRMPD experiments were performed at the Centre de Laser Infrarouge 
d’Orsay (CLIO) in Orsay, France by members of the McMahon group. The free electron laser 
(FEL) was used for the experiments and was produced using a 10-50 MeV electron beam. The 
FEL beam was guided into a Bruker FT MS APEX-Qe 9.4T FT-ICR mass spectrometer which 
was coupled to the apparatus.  
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 The experiment was scanned continuously over the range of 900-2000 cm
-1
. The FEL 
output consisted of 8 μs macropulses composed of 500 micropulses with a repetition rate of 25 
Hz. An average IR power of 500 mW had macro- and micropulse powers of approximately 20 
mJ and 40 μJ, respectively. The spectrum was reported as frequency versus IRMPD efficiency. 
The spectrum was calibrated using phosphotyrosine as a reference compound.
49
 The calculated 
protonated structures of GSH were created by adding a proton to each of the heteroatoms and 
then performing a DFT calculation using the DFT/B3LYP method with a 6-31g+(d,p) basis set. 
This was done for each site of protonation and with different orientations of the proton around 
each site. The calculations resulted in a calculated structure of protonated glutathione and a 
calculated spectrum. The calculated spectra were adjusted using scaling factor of 0.965 for 
B3LYP/6-31g level of theory.
6
 
 2.2.4 Computational Calculations of Glutathione 
Initially glutathione and DMF structures were created in GaussView 5.0 and DFT 
calculations were performed to optimize the structures with the aid of the Gaussian 09W 
program. The dielectric constant of DMF needed to be determined to be applied as a solvent 
box around glutathione in its calculation. Using the DFT/B3LYP method with a 6-31g+(d,p) 
basis set, DMF was optimized and the value for the dielectric constant that was obtained was 
used as a constant to surround the GSH molecules in further calculations. Another DFT/B3LYP 
method calculation with a 6-31g+(d,p) basis set and the PCM model for solvation was 
performed on the straight chain conformer of GSH. A single structure was obtained from the 
DFT calculation and used to explore the different conformations of GSH. A large number of 
unique structures needed to be generated from the initial conformer to create a large sample size 
of candidate structures. The approach used would generate a large number of structures that 
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when optimized, would provide the different possible conformations in which GSH may be 
found in.  
To do this, the first step was to generate the AMBER force field for the GSH molecule. 
This required that the partial charges of each atom in the GSH molecule be determined so they 
could be applied to the molecular mechanic calculations in the next steps. A fitting algorithm 
known as ChelpG in Gaussian 09W was used to aid in this determination. Since specific bond 
lengths, angles and torsion angles are already known for particular atom combinations, the 
partial charges calculated would be the only other variables needed to create the AMBER force 
field.  
Next, the large sample size of structures needed to be generated, and this required the 
DFT GSH structure to be physically altered in some systematic way. For instance, the bond 
lengths between atoms were altered by 1 Å or the torsion angle between four different atoms 
was changed by 10°. Using the molecular mechanics method and the custom AMBER force 
field, the altered structure was subjected to a geometry minimization along with a frequency 
calculation. In total, a set of 7 000 structures was generated and the accompanying MM 
calculation was performed to give a large collection of GSH molecular conformations. The 
output files of these MM calculations contained optimized structures of the GSH molecule 
along with the energies (in Hartrees) of these optimizations. All calculations were done using 
the Gaussian 09W program.  
Further calculations needed to be done on GSH to simulate the effect that the linker 
would have on the conformation of the peptide. Molecular dynamic experiments were 
conducted to calculate the best angles for the peptide and the linker. The AMBER parameters 
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and partial charges that were generated for the molecular mechanics portions of this study had 
to be used for the molecular dynamic experiments as well. Some of the AMBER atom types that 
were in the linker were not found when the calculations were performed and atom types had to 
be created, based on existing atom types in the AMBER library. With the help of the Roy group, 
a python script was written to run these simulations using Python 2.7.5 and MMTK (molecular 
modelling tool kit). The script was run with a temperature of 298.15 K, 1 fs timesteps, 100000 
equilibration steps, 10000000 production steps and outputting information every 100 steps. 
Once the simulation was complete, a text file with all the dihedral angles of the peptide was 
generated and converted into a histogram.  
Using the free GSH molecule generated from the DFT calculation, a linker was added to 
acquire a structure that would be optimized to best represent the resin-bound peptide. The 
calculation was done with the DFT level of theory calculation using the RB3LYP method with a 
6-31g+(d,p) basis set and the PCM model for solvation. This calculation was done using the 
Gaussian 09W program. 
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2.3 Glutathione Results 
 2.3.1 Results of Synthesis 
The results of the synthesis of the tripeptide are summarized in Table 2.3.1. Coupling of 
the Fmoc-Gly-OH (G3) amino acid to the Wang resin was initially done using the DCBC 
method with pyridine and DCM as the solvent. The results from this step were not close to ideal 
with only a 0.6126 mmol/g coupling (76.5% of the previously available sites). A change in 
solvent was implemented and DMF was the solvent to be used for all subsequent couplings. 
After a few more attempts, the first amino acid coupling was measured to be 0.6802 mmol/g 
(85.0% of the previously available sites). After a third and fourth attempt, not much change was 
seen in the molar substitution of G3, therefore it was considered the end point of the first 
coupling. The resin-bound amino acid was then treated with acetic anhydride to cap any 
unreacted sites on the resin before the Fmoc protecting group was removed. Removal of the 
Fmoc protecting group was done with 20% piperidine in DMF and when the sample was 
measured in the UV spectrophotometer the absorbance showed a negative value.  
Coupling of the second amino acid, Fmoc-Cys(Mmt)-OH (C2), was done using HBTU, 
HOBt and DIPEA as coupling reagents. The first three attempts for coupling this amino acid in 
DMF were very poor, approximately 0.4 mmol/g (58.8% of the previously available sites). A 
change from 15 mL of DMF to 10 mL was implemented to create a more concentrated mixture. 
The results of the next two attempts had greatly improved the results, increasing the substitution 
to 0.4891 mmol/g (71.9% coupling of the previously available sites). All of the Fmoc-
Cys(Mmt)-OH that was purchased was used in the five coupling attempts, so no further 
attempts to try to achieve the 80% benchmark were done. Fmoc was cleaved using 20% 
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piperidine in DMF and when the sample was tested in the UV spectrophotometer the 
absorbance was negative.  
Table 2.3.1: The coupling conditions and substitution needed for each attempt in the 
solid-phase peptide synthesis of the tripeptide, glutathione. The percentage of the total available 
sites was based off the initial molar substitution of 0.80 mmol/g. 
Amino Acid Coupling 
Method 
Solvent # of 
Coupling 
Attempts 
Resin 
Substitution 
(mmol/g) 
% Subs 
of 
Previous 
Available 
Sites 
% Subs 
of Total 
Available 
Sites 
1
st
: Gly DCBC DCM 1 0.6126 76.5% 76.5% 
DMF 4 0.6802 85.0% 85.0% 
2
nd
: 
Cys(Mmt) 
HBTU/HOBt DMF 5 0.4891 71.9% 61.1% 
3
rd
: 
Glu(ODmab) 
HBTU/HOBt DMF 3 0.3987 81.5% 49.8% 
 
Coupling of the final amino acid Fmoc-Glu(ODmab)-OH (E1) was done only three 
times with HBTU, HOBt and DIPEA to achieve a final substitution of 0.3987 mmol/g (81.5% 
of the previously available sites). The tripeptide glutathione had been fully synthesized, but the 
protecting groups on E1 and C2 had to be removed. Before removal of the protecting groups, a 
portion of the resin was taken out from the Merrifield vessel and allowed to dry in a fume hood 
for a minimum of 24 hours. Cleavage of the protecting groups began with the ODmab group on 
E1 using 2% hydrazine in DMF, then the Mmt group on C2 with a mix of TFA:TIS:DCM (in a 
1:5:94 ratio). The peptide substitution was checked again to ensure that nothing had changed 
when the protecting group cleavage was done. Finally the Fmoc protecting group on E1 was 
cleaved with 20% piperidine in DMF and checked in the UV spectrophotometer to have a zero 
or negative absorbance. The final product obtained was a resin-bound glutathione free from the 
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effects of protecting groups. The fully synthesized deprotected resin-bound tripeptide was 
removed from the Merrifield vessel and allowed to dry for a minimum of 24 hours before 
analysis.  
2.3.2 NMR Analysis of Glutathione 
Proton assignment of the tripeptide was carried out with the aid of 1D 
1
H and 
1
H-
1
H 2D 
experiments. The use of COSY allows for interactions between protons that are J-coupled three 
bonds or less from one another to produce a signal known as a “cross-peak” in the 2D spectrum. 
TOCSY also shows interactions between protons that are within the same spin system, but not 
restricted to the three bond limitation, which is one of the drawbacks of the COSY experiment. 
These assignments are summarized in Table 2.3.2 and are consistent with the 1D 
1
H spectrum. 
Using the COSY and TOCSY spectrum (shown in Figure 2.3.2), three different spin systems 
were identified; all three had an amide proton interacting with an α proton, two systems had an 
α interacting with a β, but only one system had interactions with γ protons. One shift that was 
not seen in the COSY or TOCSY and was assigned using the 1D spectrum was the proton on 
the α carboxyl group of E1 (Figure 2.3.1). This peak was first thought to be a spinning side 
band, but after conducting the 1D experiment at different spinning speeds the peak was 
determined to be that of the α carboxyl proton of E1. The first experiment was done by spinning 
the sample at 4.6 kHz and acquiring a 1D spectrum of the sample and the second experiment 
was spun at 3.9 kHz. In both cases, a small peak suspected to be the proton on the carboxyl 
group was seen at 10.28 ppm. If the peak was not at 10.28 ppm for both spinning speeds, the 
peak would be considered a spinning side-band, but this was not the case so the peak was real. 
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Figure 2.3.1: Comparison of 1D spectra for confirmation of the α carboxyl proton of E1 tested 
at two different spinning speeds. A chemical structure of the E1 residue portion is provided in 
the first spectrum and the proton bolded in red is the carboxyl proton of interest for both spectra. 
The inset in both spectra provides an expansion of the region between 10.6 ppm and 10.0 ppm 
to show the peak for the carboxyl proton: a) the sample was spun at 4.6 kHz, b) sample was 
68 
 
spun at 3.9 kHz, much lower than the first experiment to test if the peak in question was a real 
peak or a spinning side band.  
Table 2.3.2: 
1
H NMR chemical shift assignments of the resin-bound GSH peptide referenced 
internally to the solvent peaks of DMF-d7 
Amino 
Acid 
NH Hα Hβ Hγ Other 
E1 8.47 4.75 2.72 
2.86 
2.98 
3.09 
10.28 (α 
carboxyl) 
C2 8.50 4.48 2.61 
2.67 
- - 
G3 8.31 3.93 - - - 
 
Assignment of these spin systems to the individual amino acids was very simple, since G3 has 
no β protons and C2 has no γ protons. Therefore, the one system that had only an amide and α 
alpha interaction belonged to G3 and the system that had an amide, α and β belonged to C2. The 
α protons of glycine normally exhibit a chemical shift near 4.0 ppm, which is seen in the COSY 
and TOCSY spectra. There was a strong correlation between the amide proton of G1 
(approximately 8.3 ppm) and the α proton (approximately 3.9 ppm). These were the only 
interactions between protons with chemical shifts at these values. It was concluded that this 
interaction between amide and α proton belonged to G1. A single spin system had an α proton 
correlating to a β proton, but no other γ protons was determined to belong to protons of C2. The 
amide and α protons show a strong interaction at approximately 8.5 ppm and 4.5 ppm. An 
interaction between the C2 α proton and two β protons was also seen in the “α region” of the 
COSY and TOCSY spectra. This α proton interaction with two β protons is not uncommon and 
is a result of the β protons of the β-methylene group being chemically inequivalent to one 
another. With this chemical inequivalency, these β protons have individually interacted with the 
α proton each producing their own cross-peak in the spectra. Another interaction seen in the 
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“amide region” of the TOCSY is one between the backbone amide proton of C2 and one of the 
β protons in the side chain. This interaction is greater than the COSY three-bond limitation 
between protons and was only observed in the TOCSY spectrum and provides additional proof 
that these set of cross-peaks belongs to the C2 system. The final amide and α proton interaction, 
along with all other protons in this system, belonged to the E1 residue. This spin system showed 
a strong correlation between an amide proton and an α proton at approximately 8.4 ppm and 4.8 
ppm. The α proton then showed an interaction between 4 different signals in the “α region” 
representing the β and γ protons. The four signals that were seen interacting with the α proton 
were at 2.7, 2.9, 3.0 and 3.1 ppm. The two signals that are the most upfield were determined to 
belong to the β protons of C2 and the more downfield protons belonged to the γ protons. The 
environment of the γ protons causes them to appear more downfield; this is due to the carbonyl 
group that is adjacent to these protons and its proximity to the backbone C2 amide functionality. 
The circulation of the electrons within the carbonyl group creates a deshielding effect that is felt 
by the γ protons of E1. Also, these protons appear inequivalent to one another even though they 
are on the same carbon, giving rise to the two peaks interacting with this α proton. The β 
protons are not as deshielded as the γ protons since they are further from the carbonyl group, but 
they do experience chemical shift inequivalency due to the two different signals interacting with 
the α proton. The protons at approximately 3.0 and 3.1 ppm belong to the γ protons of E1 and 
the remaining two peaks (2.7 and 2.9 ppm) belong to the β protons of E1. Using COSY and 
TOCSY, the three different spin systems of GSH were identified and the individual protons for 
each system were able to be assigned to their respective chemical shifts.  
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A set of secondary shifts was also seen for this tripeptide (Table 2.3.3), but were not as 
informative as the primary shifts (labelled with a (2) in Figure 2.3.2). During the synthesis, the 
peptide may have adopted a structure different that the most predominant conformer that is 
seen. A secondary shift was seen for G3, where an amide and α proton were interacting near 8.6 
ppm and 4.0 ppm. This α shift is very characteristic of glycine residues and is very distinct from 
the first G3 interaction. This α proton also shows no interactions with any other protons, so it 
was confirmed that it was indeed a secondary shift for the G3 residue. There was also a 
secondary set of peaks for the C2 residue for each of the protons. There were some weak 
intensity peaks for the amide and α protons interacting with one another, and that α proton was 
interacting with two β protons again. These β protons did not have as high an intensity as the 
protons for the other conformer, but they were present in the “α region”. These α and β protons 
also showed no interactions with any other protons, such as a γ proton, therefore it was assumed 
that these peaks belonged to a secondary C2 spin system. The E1 spin system also exhibited a 
secondary set of peaks as well, but some of the interactions were more intense than expected. 
The amide and α protons show a weak interaction more upfield than the previous conformer and 
this α proton again interacts with four different protons. These four protons represent the β and γ 
protons, and they are seen interacting with the alternate α proton of E1. Using the same methods 
of deduction as the primary conformer, the signals that appeared further downfield belong to the 
γ protons and the remaining signals are for the β protons. Just as with the first conformer, a set 
of three different spin systems and the individual protons were assigned to each of the three 
amino acids using the COSY and TOCSY spectra.  
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Table 2.3.3: 
1
H NMR chemical shift assignments for a secondary conformer of the resin-bound 
peptide GSH referenced internally to the solvent peaks of DMF-d7 
Secondary NH Hα Hβ Hγ Other 
E1 8.26 4.27 2.29 
2.34 
2.63 
2.70 
- 
C2 8.43 4.62 2.88 - - 
G3 8.58 4.01 - - - 
 
 Assignment of the protons in the individual spins systems was complete and the next 
step was to use these shifts and examine the ROESY spectrum to determine the structure of the 
peptide. The use of the ROESY spectrum not only provides insight to the structure, but it also 
assists in determining if the synthesis of glutathione was done correctly. The ROESY spectrum 
(Figure 2.3.3) produced 20 interactions between protons through-space. These interactions 
shown in Table 2.3.4, are broken down into 14 that are within the same spin system and six 
which are between different amino acids. Of these interactions, two were used to establish the 
secondary structure of GSH.  
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Table 2.3.4: Tabulated list of NOE interactions for the resin-bound peptide GSH. The 
interactions listed in bold red are those between different amino acids. The ROESY spectrum 
was referenced internally to the solvent peaks of DMF-d7. 
Interaction 
# 
Chemical 
Shift F1 
(ppm) 
Chemical 
Shift F2 
(ppm) 
Amino Acid 
1 
Amino Acid 
2 
1 8.57 4.75 G3 NH (2) E1 Hα 
2 8.55 4.63 G3 NH (2) C2 Hα (2) 
3 8.31 4.50 G3 NH C2 Hα 
4 8.50 4.50 C2 NH C2 Hα 
5 8.45 4.74 E1 NH E1 Hα 
6 8.31 3.94 G3 NH G3 Hα 
7 8.57 4.02 G3 NH (2) G3 Hα (2) 
8 8.45 2.98 E1 NH E1 Hγ 
9 8.45 2.71 E1 NH E1 Hβ 
10 8.31 2.62 G3 NH C2 Hβ 
11 8.50 2.64 C2 NH C2 Hβ 
12 4.74 2.99 E1 Hα E1 Hγ 
13 4.62 2.88 C2 Hα (2) C2 Hβ (2) 
14 4.71 2.84 E1 Hα E1 Hβ 
15 4.75 2.79 E1 Hα E1 Hβ 
16 4.75 2.74 E1 Hα E1 Hβ 
17 4.74 2.69 E1 Hα C2 Hβ 
18 4.49 2.67 C2 Hα C2 Hβ 
19 4.51 2.59 C2 Hα C2 Hβ 
20 4.74 2.58 E1 Hα C2 Hβ 
 
The 14 interactions that are within the same spin system were already seen in the previous 
COSY and TOCSY experiments and do not provide any additional information beyond what is 
already known. Each of the amide protons and α protons of the three peptides were seen 
interacting within their respective spin systems, C2 had interactions between the α and β 
protons, and E1 had many interactions within the residue as well between the α, β and γ protons. 
Interactions between sequential amino acids will help confirm that the synthesis was done 
correctly. Interactions 3 and 10 confirm that the synthesis between the first two amino acids 
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were successful. Interaction 3 is between the amide proton of G3 and the α proton of C2 and 
interaction 10 is between the G3 amide proton and the C2 β proton. The distance between these 
protons interacting is very minimal and is not surprising to see in the ROESY spectrum. These 
interactions provide good evidence that the first two amino acids were coupled correctly. 
Interactions 17 and 20 are between the E1 and C2 residues, but both are between the E1 α 
proton and the C2 β proton. If E1 and C2 we joined through the α amino and carboxyl group 
(such as the case for C2 and G3), these two protons interacting with one another would not be 
unusual, but because the linkage is between the γ carboxyl group of E1 and the α amino group 
of C2, interactions 17 and 20 become quite far in space. This interaction does suggest that the 
synthesis was done correctly, but it is an interaction for this specific linkage that is greater than 
the normal acceptable distance for ROESY interactions.  Having this interaction present 
suggests that the E1 end of the peptide must be much closer in space than if it were in an 
extended state. Based on the through-space couplings from the ROESY spectrum, the secondary 
conformer of the peptide must have some sort of folding motif that allows the E1 α end to be 
closer to the middle of the peptide.  
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By combining all of the ROESY interactions, a three-dimensional structure of GSH can be 
proposed. Interactions between the α proton of E1 and the β protons of C2 suggest that this end 
of the tripeptide is folded in towards the middle. The G3 and C2 interaction just suggests that 
the two residues are close to one another and potentially exist in a linear state. The ROESY 
results with the two key interactions do suggest that there is some folding involved with the 
structure of the peptide. The lack of a G3-E1 interaction could suggest the peptide is in a semi-
folded state, but it’s possible that interaction was not seen in the ROESY. A folded or semi-
folded state is consistent with what Zhang et al. suggested in their NMR and computational 
study.
43
 The effect of the linker and DMF solvent play a role in the folding of this peptide that 
makes it differ from the solution results. A combination of computational calculations (DFT and 
molecular dynamics) can give insight into the structure that would be formed while the 
tripeptide is on the linker.  
There were also three interactions that were between protons for the secondary 
conformer; interactions 2, 7 and 13. Interactions 7 and 13 are within the same spin system, 
where 7 was between the amide and α protons of G3 and 13 was between the α and β protons of 
C2. Interaction 2 was between sequential amino acids for this secondary conformer, G3 amide 
interacting with the C2 α. This single interaction does not give any insight into a possible 
secondary conformer of this tripeptide, it merely suggests that there first two amino acids are in 
the proper order. It is impossible to propose a structure for this GSH conformer without more 
interactions. An unusual interaction between a proton in the secondary set of shifts and the main 
set was observed. It is labelled as interaction 1 and is between the secondary amide shift of G3 
and the α proton of E1 in the main set of shifts. It is odd such an interaction would arise, but this 
still would not give insight into the conformation of the secondary conformer or even the first. 
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2.3.3 Infrared Multiple Photo Dissociation Analysis of Glutathione 
 Upon acquiring the IRMPD spectrum of protonated GSH, a large number of protonated 
isomers were created at the various numbered positions as listed in Figure 2.3.4. The initial 
structure and all isomers were calculated using the B3LYP/6-31g(d) level of theory.  
 
Figure 2.3.4: Optimized structure of gas-phase GSH using B3LYP/6-31g(d) level of theory. 
The possible sites of protonation are numbered and are referred in the interpretation and 
analysis of spectra. The carbon, oxygen, nitrogen, sulphur and hydrogen atoms are coloured in 
grey, red, blue, yellow and white, respectively.  
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Of all the calculated structures, five isomers had relatively similar calculated spectra that 
matched the experimental spectrum (Figure 2.3.5). The calculated spectra compared to the 
experimental spectrum can be seen in the Appendix. There were only three different sites of 
protonation for these isomers, but for three of the sites the orientation of the proton differed 
between isomers (Figure 2.3.6). The corresponding calculated energies are a sum of the 
electronic and thermal free energies and are shown along with the relative energies in Table 
2.3.5.  
 
Figure 2.3.5: Experimental IRMPD spectrum of protonated glutathione. The intensities are 
reported as IRMPD efficiency versus the frequency of the fragment (in cm
-
1).  
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Figure 2.3.6: Five possible pronated species (labelled 1-5) of GSH that have calculated spectra 
that most resemble the experimental spectrum. The candidates were chosen based on the 
similarity between the calculated spectra and the experimental spectrum. Comparative studies 
are done to determine which protonated species would best represent the experimental 
spectrum. The hydrogen, carbon, oxygen, nitrogen and sulphur atoms are represented in white, 
grey, red, blue and yellow respectively. The extra proton that is added for each isomer is 
coloured green for easier visualization. 
Table 2.3.5: Calculated free energies (kJ mol
-1
) and relative free energies of the different 
isomer candidates for the GSH molecule. All structures were calculated using the B3LYP/6-
31g(d) level of theory. 
Structure Number Σ Electronic and Thermal 
Free Energies (kJ mol
-1
) 
Relative Free Energies 
(kJ mol
-1
) 
4 -3690131 0 
5 -3690128 +3 
3 -3690090 +41 
1 -3690027 +104 
2 -3690005 +126 
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These five isomers were chosen based on the similarities between the experimental spectrum 
and the calculated spectra. The carbonyl frequencies of the experimental and calculated spectra 
are listed in Table 2.3.6.  The frequencies that best match the experimental spectrum come from 
isomers 1, 2, and 5. The protonation on isomer 1 was on atom 6, for isomer 2 it was on atom 2 
and for isomer 5 it was on atom 4. The mode of vibration for isomers 1 and 2 are the E1 γ 
carbonyl stretch and for isomer 5it is the C2 α carbonyl stretch. When comparing the differences 
in carbonyl frequencies to the experimental, isomers 1, 2, and 5 are only slightly red-shifted. 
The bond lengths between the carbon and the oxygen for these C2 carbonyls are fairly typical of 
carbonyl groups (1.22 Å); therefore a large discrepancy in the shifts is not expected. The 
vibrational mode for isomers 3 and 4 are a C2 carbonyl stretch and G3 carbonyl stretch, 
respectively. Protonation for isomers 3 and 4 both occurred on atom 4. The differences in 
frequencies for these two isomers compared to the experimental are very blue-shifted. A 
possible explanation for this large blue-shift is that the bond lengths between these atoms are 
slightly shorter than normal, which requires more energy to stretch. Therefore the frequency in 
which these modes occurred is going to appear higher than expected. From the carbonyl 
frequencies, isomers 1, 2, and 5 are the best matches to the experimental spectrum so far, but 
examination of the amide region and low frequency region will provide additional support to 
determine which isomer is the best fit for the experimental spectrum. 
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Table 2.3.6: Calculated carbonyl frequencies for the five possible isomers and the deviation 
from the experimental shift.  
Isomer Number Carbonyl Stretching 
Frequency (cm
-1
) 
Vibrational Mode Δ in Frequency from 
Experimental 
Experimental 1726 - - 
1 1723 E1 γ Carbonyl -3 
2 1723 E1 γ Carbonyl -3 
3 1740 C2 α Carbonyl +14 
4 1752  G3 α Carbonyl +26 
5 1723  C2 α Carbonyl -3 
 
The carbonyl peaks in the calculated and experimental spectra were used to pick the most likely 
candidates for the protonated structure, but the set of peaks between 1800 cm
-1
 and 1700 cm
-1
 
were used to provide additional evidence to identify the fitting isomer. Shifts for the peaks in 
the vicinity of 1700 cm
-1
 are reported in Table 2.3.7.  For each of the isomers, the calculated 
spectra had at least one peak that matched very well to the experimental spectrum. Isomer 1 had 
two different vibrational modes for the two frequencies that matched best which were a C2 
amide and G3 amide bend. Isomer 2 also had a C2 amide bend that matched exactly with the 
experimental spectrum, but the frequency at 1488 cm
-1
 was unusual. This mode was a concerted 
bend of the G3 and C2 amide groups, E1 α carboxyl, and protonated carbonyl group. This peak 
at 1488 cm
-1
 was red-shifted by a small amount, but it was the largest difference between 
frequencies for all the peaks that had matched well. Isomers 3, 4, and 5 all exhibited a G3 amide 
bend. Isomers 3 and 4 both had frequencies that matched very well with the experimental 
spectrum, but isomer 5 was slightly blue-shifted from the experimental. A possible explanation 
for this isomer to having a slightly blue-shifted peak could be a result of the slightly longer 
bond length between the G3 amide and C2carbonyl causes the energy required to stretch the 
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bond to be increased. Many of the frequencies in this region of the calculated spectra for all 
isomers matched well with the experimental spectrum, therefore eliminating certain structures 
from being the potential experimental protonated structure is difficult at this point. Analysis of 
the low frequency region of the different spectra can be used to narrow down the search for the 
best structure. 
Table 2.3.7: Calculated amide/amino frequencies for the five possible isomers and the deviation 
from the experimental shift. There were multiple peaks in the amide and amino range, therefore 
the peak that was closest for the calculated spectra dictate the difference from the experimental.  
Isomer Number Amide/Amine  
Frequency (cm
-1
) 
Vibrational Mode Δ in Frequency from 
Experimental 
Experimental 1474 
1495 
1506 
- 
- 
- 
- 
- 
- 
1 1471 
1497 
C2 NH Bend 
G3 NH Bend 
-3 
+2 
2 1488 
1506 
Various Bends 
C2 NH Bend 
-7 
0 
3 1497 G3 NH Bend +2 
4 1505 G3 NH Bend -1 
5 1480 G3 NH Bend +6 
 
The final set of experimental peaks, that will help characterize the which isomer is the potential 
best fit, are in the range of approximately 1100 cm
-1
 to 1200 cm
-1
. This range shows C-O 
stretching and bending motions, along with C-C stretch and bend, but in these calculated 
peptides two modes were found: C-OH bend and C-H twist. The data for this area in the 
calculated spectra are summarized in Table 2.3.8. Each of the isomers was either 5 or 6 cm
-1
 
blue-shifted from the respective experimental peaks. Isomers 1 and 3 experienced a concerted 
twisting motion of the E1 side chain. This motion caused the β and γ carbons to twist along with 
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the C2 residue and α groups of E1. These shifts were only blue-shifted by 5 cm-1 and were very 
close to the experimental value. Isomers 4 and 5 had a vibrational mode that represented a G3 
carboxyl bend. Both of these shifts were only blue-shifted by 6 cm
-1
, which also was very 
similar to the experimental spectrum. Isomer 2 experienced a different vibrational motion at 
1141 cm
-1
 than isomers 1 and 3. The motion was a COH bend of the E1 α carboxyl group for 
the OH group and the protonated carbonyl. As opposed to being the E1 side chain twisting that 
was seen at this frequency for other isomers, the protonated carbonyl and carboxyl group are 
both bending at the same time at this frequency. Isomer 2 also experienced the G3 amide bend 
at 1158 cm
-1
 just as isomers 4 and 5 did as well. There were no peaks that were deviated from 
the experimental spectrum by a large amount for this region either, so determination of which 
isomer would be represent the protonated GSH could come from the analysis of the calculated 
structures and energies.  
Table 2.3.8: Calculated vibrational modes for experimental and calculated GSH species in the 
1100 cm
-1
 to 1200 cm
-1
 range. All modes may not match up equally, therefore the deviation is 
calculated based on the peak it closest resembles.  
Isomer Number Frequency (cm
-1
) Vibrational Mode Δ in Frequency from 
Experimental 
Experimental 1136 - - 
1152 - - 
1 1141 E1 Twisting +5 
2 1141 
1158 
E1 COH Bend x2 
G3 COH Bend 
+5 
+6 
3 1141 E1 Twisting +5 
4 1158 G3 COH Bend +6 
5 1158 G3 COH Bend +6 
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Comparison of the relative energies of the different isomers was given in Table 2.3.5. 
Isomer 4 has the lowest energy of all the structures and was used to calculate the relative 
energies. Multiple intramolecular hydrogen bonds within isomer 4 helped stabilize the 
calculated structure, namely in the E1 residue. Protonation on the E1 γ carbonyl has allowed it 
to form a hydrogen bond with the E1 α carboxyl group, bringing the α and γ ends closer in 
space. There is also a hydrogen bond across the chain between the β proton of E1 and the G3 
carbonyl. A β proton is very weakly acidic compared to an α proton, but this interaction seems 
to be occurring in the peptide chain and could provide a small stability factor for the peptide. 
Isomer 5 is the second most stable in terms of relative energy, but there is a major difference in 
structure between 4 and 5 even though the sites of protonation are the same. The E1 residue still 
forms a hydrogen bond within itself, but the other end of the chain does not form the hydrogen 
bond as seen in isomer 4. The G3 end of the peptide is in an extended conformation and is 
facing away from the E1 residue. This major change in the calculated structure may be 
responsible for the higher relative energy of this conformer. A large gap in the relative energies 
occurs between isomers 5 and 3. Isomer 3 is the third most stable of all the conformers. This 
isomer does not contain any clear intramolecular hydrogen bonds that distort the structure in the 
same manner that isomers 4 or 5 did. This peptide appears to be in a semi-folded state, where 
the G3 end of the chain is almost linear, but then the C2 α carbon the chain takes a turn before 
extending off again. In each of the ends, the atoms appear to be in a staggered conformation, 
thus lowering the overall energy, but not enough to be one of the lowest. Isomer 1has the 
protonation occurring on atom 6, but again this proton does not seem to form any intramolcular 
hydrogen bonds. It also appears to have a semi-folded conformation like isomer 3, but the E1 
side chain is more linear for isomer 3. The group of atoms from the C2 amide to the E1 β 
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carbon has a dihedral angle that is closer to 180°. Since there are not many hydrogen bonds 
stabilizing this structure and is not as folded, the energy of this peptide is much higher than that 
of isomer 3. The relative energy of isomer 2 was +126 kJ mol
-1
, which was the highest of all 
five candidates. This isomer also has no intramolecular hydrogen bonds that would add extra 
stability for this protonated structure. The structure is also in a semi-folded conformation and is 
even more linear in the E1 side chain than isomer 1. The isomer also has been protonated on 
atom 2, which does remove some of the stability of a regular carboxyl group. When compared 
to a neutral carboxyl group, there is resonance between the carbonyl and hydroxyl group, but 
due to the added proton at on the carbonyl for this isomer, the resonance structures are the same 
for both oxygen atoms. This increases the energy of the overall system and makes this isomer 
very unstable when compared to isomer 4.   
Based on the similarities in spectra, stability and energy of the structure, certain isomers 
can be removed as the possible protonated species. Isomer 5 is the best candidate of the five 
structures. The differences between the experimental spectrum and calculated spectrum are 
minimal for all three regions of the spectrum. The structure of this protonated species has an 
intramolecular hydrogen bond stabilizing the E1 end of the peptide, which makes the calculated 
energy of this isomer the second lowest of all five. Isomer 4 is also a very good candidate to 
represent the experimental spectrum. The amide and low frequency regions of the spectra match 
well with one another, but the calculated carbonyl frequency is blue-shifted compared to the 
experimental. Even though there are some slight discrepancies in the shifts for the spectra, the 
energy of the protonated peptide is the lowest of all five, making it the most stable. The 
structure of this protonated species is very stable due to a variety of intramolecular hydrogen 
bonds that are being formed within the entire peptide, giving it a folded structure. Since both of 
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these isomers have the same site of protonation, it is possible that both of these isomers exist as 
the experimental protonated species. Evidence of this is comes from the experimental spectrum; 
there are two peaks at 1726 and 1742 cm
-1
. Isomer 5 had a calculated frequency very close to 
1726 cm
-1
 and isomer 4 had a calculated frequency very close to 1742 cm
-1
. These two 
calculated peaks combined could be the cause for the experimental spectrum having two peaks 
such as this. This would suggest that there could be a statistical mixture of the two isomers for 
this protonated sample of GSH. Isomer 5 is probably the strongest candidate of these five 
isomers that would represent the protonated GSH molecule and isomer 4 is also a good structure 
to represent the molecule, but there is a strong possibility that both of these structures exist in a 
mixture of species. 
2.3.4 Computational Modelling of Glutathione 
 The result of the DFT calculation of GSH in DMF resulted in the structure shown in 
Figure 2.3.7. The structure of the GSH was calculated without the influence of the polymer 
resin, but still gives a good representation of the peptide’s monomeric conformation in DMF.  
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Figure 2.3.7: Optimized structure of GSH using B3LYP/6-31g(d) level of theory. The PCM 
model of solvation was used to simulate a DMF environment around the GSH molecule. The 
carbon, oxygen, nitrogen, sulphur and hydrogen atoms are coloured in grey, red, blue, yellow 
and white, respectively. 
Starting with the structure in Figure 2.3.7, a variety of GSH conformers can be explored. 
An AMBER force field for the GSH molecule needed to be generated before the different 
structures of the initial product could be created. Using Gaussian 09W with the ChelpG 
algorithm, the partial charges for the individual atoms in the molecule were determined (see 
Appendix). Combining the AMBER library of known values between atoms and the calculated 
partial charges, the AMBER force field for the specific GSH molecule was created to observe 
the different conformations. Simple molecular mechanics calculations were performed using the 
AMBER force field and in total, 20 000 structures were generated from the MM calculations. 
The output files of each individual calculation contained a geometrically optimized structure 
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and an energy in Hartrees. The collection of 20 000 structures were then tabulated based on 
their output number and the energy that accompanies that structure (Figure 2.3.8). 
 
Figure 2.3.8: Plot depicting the energy of the individually calculated structures with respect to 
the output number of the GSH molecule.  
The next step was organizing the calculated structures from lowest in energy to highest (Figure 
2.3.9). The lowest energy structure in this case is the most stable of all the structures, but it is 
not a good assumption that the lowest energy structure after the MM calculations will be the 
same as the DFT structure. The reasoning behind this is that MM calculations are less precise 
than the DFT calculations and will sometimes give deviations between structures. The change in 
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energy with the change in structure can be observed graphically by looking at the change in the 
slope of the graph. The points on the graph where the slope changes dramatically is indicative 
of a large change in geometry and a large change in energy. The front end of the graph has a 
large slope for the low energy conformations representing some changes in the more stable 
structures. As the plot progresses, not much change in the energy or the structures are seen 
through the middle of the set of structures, but towards the end large changes are seen by the 
sharp spike for the high energy conformations. The points on the graph where the slope changes 
the most (red squares in Figure 2.3.9) are the structures that are the most interesting to observe 
since they will be unique to one another due to the large changes in geometry. The points in the 
middle of the graph where the slope does not change as much are still important. This plot was 
not specifically used to determine which structures should be observed, but was used to 
generate the next plot which ultimately decided which specific structures were chosen to 
analyze. 
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Figure 2.3.9: The GSH molecules after they were optimized individually were reorganized 
based on their energies (in Hartrees) from lowest to highest. The red squares indicate the areas 
of the plot with the biggest change that would possess the most unique structures to analyze.  
Choosing the structures that are unique and to be further optimized was done by creating a 
“threshold” graph (Figure 2.3.10). The threshold graph is a derivative plot of Figure 2.3.9 and 
by setting a limit that requires a change in energy of 1.00
-5
 Hartrees between successive 
structures, the most unique structures can be chosen. A change in energy less than 1.00
-5
 
between successive structures was marked a zero when tabulated and suggests there was not a 
major difference between conformers. Structures were chosen by finding the largest changes in 
the points of the derivative plot. Each line in Figure 2.3.10 represents a single structure and 
large energy changes between structures are noted by a drop from one line to another. If there is 
very little change in energy (i.e. the threshold of 1.00
-5
 was not met) there will be a gap in the 
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plot and the structure before the gap is the most unique structure for that region. The plot shows 
a great degree of change at the extremes indicating that the structures at these points are the 
most interesting to analyze.  
 
Figure 2.3.10: Threshold plot depicting the difference in energies between structures. If the 
threshold of 1.00 x 10
-5
 in energy difference between structures was not met, a value of zero 
was input indicating little to no change in structure conformation.  
Using the threshold plot, 19 structures were chosen that were considered unique and 
important in the understanding of the different conformations of GSH. Some of the structures 
that were chosen were the lowest and highest energy conformer, along with some more 
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structures at the extremes of the plot. A few conformers from the middle of the plot were chosen 
as well to cover most of that region. The lowest energy structure (Figure 2.3.11) has a folded 
conformation, where the E1 end is close in space to the G3 end and the C2 system is the middle 
point of the folded tripeptide. The folding of the tripeptide in this conformation is favoured due 
to the hydrogen bonding between the α carbonyl of E1 and the proton on the carboxyl group of 
G3. Also an interaction between the amide proton of G3 and the carboxyl backbone of E1 
causes the structure to be slightly folded in as well. This peptide is also very flexible at the C- 
and N-terminus which does not make the tripeptide planar. Even though this calculated structure 
was done at a relatively low level of theory, it does show some similarities to the results 
obtained from the ROESY spectrum. The sequential amino acid interactions are seen in this 
peptide with an intramolecular distance of less than 6 Å for each interaction. One of the most 
important interactions that gave the most information about structure between the α proton of 
E1 and β proton of C2 is very close in space for this conformer. Again, since the structure was 
calculated using molecular mechanics, the structures obtained should be viewed as rough 
estimations and not considered as entirely accurate when compared to the higher levels 
structures obtained by DFT calculations. There are large differences in the structure between the 
lowest energy MM structure and the DFT structure, since the MM structure is very folded and 
the DFT structure seems to be only semi-folded. Also, comparisons to the ROESY NMR should 
be viewed with caution as the structure provided from the MM might not be the one seen in the 
NMR experiments. 
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Figure 2.3.11: Lowest energy conformation of a free GSH calculated using molecular 
mechanics and a custom AMBER force field viewed from various angles. Carbon, hydrogen, 
oxygen, nitrogen and sulphur atoms are shown in grey, white, red, blue and yellow, 
respectively. Parts a) and b) show the folded shape of the tripeptide and an overhead view of 
some of the hydrogen bond interactions bringing the chain close together; c) depicts the flexible 
ends of the GSH molecule.  
On the other hand, the structure with the highest energy (Figure 2.3.12) after the MM 
calculations does not have the same conformation at all. The G3 end in this conformation points 
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away from the E1 end, but the E1 amino group is oriented so that it is pointing towards the G3 
end. The E1 end is forced into this position due a hydrogen bonding interaction between the α 
amino group of E1 and the γ carboxyl group of E1. The G3 end of the peptide does not have any 
interactions with any other part of the peptide chain, which leads to that portion to be extending 
away from the rest of the peptide chain. This peptide has a semi-folded conformation, much like 
one of the forms it has been known to take from Zhang’s NMR and computational studies.43 
Using the low level of theory calculations, a group of structures of glutathione have been 
generated and can be used for more complex calculations to establish an idea of the different 
conformations this peptide can adopt. 
 
 
 
 
 
Figure 2.3.12:  Highest energy conformation of the tripepetide GSH shown in the semi-folded 
conformation. Carbon, hydrogen, oxygen, nitrogen and sulphur atoms are shown in grey, white, 
red, blue and yellow, respectively. The E1 end of the peptide is folded in towards the middle of 
the peptide, whereas the G3 end is extending away from the middle.   
The next step was to attach the lowest energy conformers to a linker and then subject 
this linker-bound GSH to different molecular dynamics simulations and higher level 
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calculations (DFT level of theory). The linker-bound peptide calculations should provide a 
better interpretation of how the peptide folds while being bound to the resin.  
The molecular dynamics simulations provided the probabilities for each of the different 
dihedral angles that could be present. Figure 2.3.13 shows the results of the simulation and 
values that each dihedral angle is most likely to adopt. Each curve represents a group of 
sequential atoms and the most populated dihedral angle it adopted in the simulation. For 
example, the dihedral angle between E1 carbonyl oxygen/E1 carbonyl carbon/E1 Cα/E1 Cβ 
(denoted as O-C-CT-CT in the histogram) is most likely to have a dihedral angle of -79°. Table 
2.3.9 summarizes the angles in which all of the angles the peptide favours the most.  
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Figure 2.3.13: Histogram of the most favoured angles in the glutathione peptide while bound to 
the linker. The data for this chart was collected using MMTK to simulate and predict the 
peptide’s most favoured conformations at 298.15K. Each coloured line represents a different 
dihedral angle in the GSH peptide. The data from this figure is summarized in Table 2.3.9.  
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Table 2.3.9: From Figure 2.3.12, the most populated angles for each of the dihedral angles is 
presented in the second column. C=O is representative of the carbonyl carbon and O represents 
the oxygen atom in the carbonyl group participating in the dihedral angle. 
Angle Dihedral Group Angle (°) 2
nd
 Most 
Populated Angle 
(°) 
1 E1 O/E1 C=O/E1 Cα/E1 Cβ -79 -89 
2 E1 O/E1 C=O/E1 Cα/E1 NH2
 
50 60 
3 E1 C=O/E1 Cα/E1 Cβ/E1 Cγ 70 - 
4 E1 Cα/E1 Cβ/E1 Cγ/E1 γ C=O -109 -99 
5 E1 Cβ/E1 Cγ/E1 γ C=O/E1 γ O -89 -79 
6 E1 Cβ/E1 Cγ/E1 γ C=O/C2 NH 100 110 
7 E1 Cγ/E1 γ C=O/C2 NH/C2 Cα 180 - 
8 E1 γ C=O/C2 NH/C2 Cα/C2 Cβ -89 -99 
9 E1 γ C=O/C2 NH/C2 Cα/C2 C=O 150 - 
10 C2 NH/C2 Cα/C2 Cβ/C2 SH 170 - 
11 C2 NH/C2 Cα/C2 C=O/C2 O 170 160 
12 C2 NH/C2 Cα/C2 C=O/G3 NH -19 -29 
13 C2 Cα/C2 C=O/G3 NH/G3 Cα 180 - 
14 C2 C=O/G3 NH/G3 Cα/G3 C=O 180 - 
15 G3 NH/G3 Cα/G3 C=O/G3 O -69 -59 
 
These simulations are very much like the molecular mechanics calculations and are only 
approximations. While the most populated angles are being reported, some of the other angles 
are populated as well, but not to the same extent as the preferred angle. In some cases, the 
difference in population was only less than 3000 structures, of the possible 100000. This 
secondary angle is shown in the fourth column of Table 2.3.8 and was only used if the 
difference between the primary and secondary angle population was less than 3000. With these 
results, the methods of molecular dynamics can be compared to the DFT structure. 
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The free GSH peptide from Figure 2.3.7 was used to do a further calculation using the 
DFT level of theory. The peptide was coupled to a linker and then subjected to the higher level 
calculation to determine the structure of the peptide and evidence of the effects (if any) 
introduced by the linker. The resulting structure is shown in Figure 2.3.14.  Assuming the 
structure exists in a semi-folded state, this structure fits fairly well with the NMR predictions 
based on the proximity of the E1 α proton to the C2 β proton. The structure is slightly folded, 
but the linkage between the G3 residue and the linker influence the secondary structure 
formation of this peptide. The linker almost keeps the G3 and C2 residues linear, but then the 
semi-folded structure begins at the C2 α group. The dihedral angles of the backbone between 
G3 α-G3 NH-C2 C=O-C2 α is approximately -179°, but the G3 NH-C2 C=O-C2 α-C2 NH 
dihedral is about 1.5°. The structure quickly goes from being almost a sheet structure to having 
some sort of bend or fold. The rest of the backbone after this fold has almost a sheet structure as 
well. This slight bend in the peptide chain brings the E1 end closer to the C2 portion of the 
peptide allowing for the key NOE interaction to be observed. There are only slight differences 
between the DFT structure of the free GSH and the linker bound structure, but those are minor 
differences in the angles. It is clear that, there are many similarities in the structures between the 
two peptides. This suggests that the linker does not affect the structure of the peptide very much 
for small peptides such as GSH. This comparison also supports the notion that the linker-resin 
still allows the peptide to adopt the native conformation that the peptide prefers.   
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Figure 2.3.14: DFT calculated structure of GSH while bound to the resin via a linker group. 
The peptide that was calculated matches the NMR spectra fairly well. The semi-folded structure 
brings the E1 α proton close enough to the C2 β proton to see that key interaction, consistent 
with what was observed in the ROESY spectrum. The differences between this structure and 
Figure 2.3.7 are minimal suggesting that the linker does not affect the native secondary structure 
of the peptide on a large scale. Small differences in the torsion angles and bond angles were 
observed, but nothing drastic. The carbon, oxygen, nitrogen, hydrogen, and sulphur atoms are 
coloured in grey, red, blue, white and yellow, respectively.  
 By combining all of the results from the different methods there are many similarities in 
the results. The NMR results suggest that the structure has some sort of folded structure, semi-
folded or folded, from interactions 17 and 20 between the E1 Hα and C2 Hβ protons. These 
interactions suggest that the peptide must be folded or semi-folded to bring the E1 end closer to 
the middle part of the peptide. From the IRMPD, the two possible best candidates that best fit 
the experimental spectrum were isomers 4 and 5 in Figure 2.3.6. Isomer 5 had a structure that 
was folded at one end of the peptide stabilized by an intramolecular hydrogen bond. The isomer 
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matched well in all regions of the spectra and had the second lowest energy of all five isomers. 
Isomer 4 had a spectrum that matched fairly well to the experimental and the energy was the 
lowest for all five structures and also had a folded structure stabilized by a variety of hydrogen 
bonds. These structures are protonated, which is different from the resin-bound peptide, so the 
behaviour of the protonated peptide may be different than the neutral structure. Therefore, 
analyzing the IRMPD structures on their own, separate from the NMR and structure 
calculations was done and not used to draw upon the final structure of the resin-bound GSH. 
The molecular mechanics and dynamics simulations suggest that the peptide is in more of a 
folded state, but the DFT calculation on the GSH-linker structure suggest a semi-folded state.  
Both the molecular mechanics and dynamics experiments are very rough approximations and 
cannot be considered entirely accurate on their own. Information from the NMR and DFT 
structures has more value as experimental observations. The combination of NMR and DFT 
calculations suggest a semi-folded conformation when GSH is bound to the linker. However, to 
simulate the full effect of the linker and solvent, the molecule should be treated using the 
explicit model of solvation where GSH interacts with molecules of DMF as opposed to being in 
a box simulating the dielectric constant of DMF.  
Using a variety of spectroscopic and computational methods, it is likely that the peptide 
has adopted a semi-folded state. The molecular mechanics and dynamics experiments are only 
approximations and cannot be interpreted as fully accurate and were not used to draw 
conclusions about the GSH structure. The lack of an E1-G3 interaction in the ROESY spectrum 
eliminates the possibility of a folded conformation for the resin-bound peptide. The DFT 
calculations also suggest that the peptide has adopted a semi-folded conformation while bound 
to the resin further eliminating the possibility of a folded structure. The IRMPD results were 
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analyzed separately and did not factor into the analysis of the resin-bound peptide conformation 
since the protonated species would behave differently than the synthesized peptide. The 
protonated species likely has a folded conformation, where protonation of the E1 γ carbonyl 
allows for the peptide to form many intramolecular hydrogen bonds to create a stable structure.  
The computational calculations at all levels could be improved by adding more complex 
situations. These situations could be using different basis sets, creating a larger set of structures 
for the peptide and linker and using the explicit model of solvation. NMR results can be 
improved by attaining a sample that has higher molecular substitution and a ROESY with more 
sensitivity. These results on the study of glutathione, suggest that the peptide has a semi-folded 
conformation due to the agreement between the NMR and DFT results. 
  
102 
 
2.4  Discussion 
 Synthesis of the tripeptide, glutathione, was done successfully achieving a final 
substitution of 0.3987 mmol/g (49.8% substitution of the total available sites). The synthesis 
was performed using standard solid-phase peptide synthesis methods. A Wang resin was used to 
anchor the peptide, and the protecting groups on the residues required mild conditions to be 
cleaved. The C2 residue had a Mmt protecting group that was removed with 2% hydrazine in 
DMF and the E1 residue had an ODmab group that was removed with 1% TFA in DCM. 
Coupling of the individual amino acids was successful for G3 and E1, but with C2 there was 
some difficulty coupling the residue. The methods that were used are “old-fashioned” and have 
been replaced by modern methods that do not require as many materials, and techniques that are 
more efficient. The initial coupling, even though an 85% coupling was achieved, could have 
been improved with the use of DMAP or MSNT. These two starting materials are more 
effective than DCBC as they allow for multiple attempts without capping the reaction sites. 
They do, however, require more materials and take longer, but the outcome of multiple attempts 
could yield better results than DCBC.
12
 The HBTU/HOBt method is also out-dated as HOBt has 
been classified as an explosive and cannot be transported.
27
 Newer methods simply use HCTU 
as a coupling reagent and only need a two hour reaction time per attempt. By replacing these 
two flaws in the original synthesis, the substitution could be increased for this tripeptide so that 
more than 50% of the total sites could be occupied. 
 Both 1D and 2D HRMAS NMR experiments were used to analyze the resin-bound 
sample of glutathione. Using COSY and TOCSY, the three different amino acid spin systems 
were identified along with their respective R-groups. The E1 residue showed a signal at 10.28 
ppm which was not seen in the COSY and TOCSY spectrum, but was seen in the 1D spectrum. 
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Each of the residues also gave rise to a set of secondary shifts, but the degree of detail was not 
as high as the first set of peaks. This secondary set of shifts could be the result of a secondary 
conformer formed by the peptide. With the spin systems defined, ROESY was performed to 
analyze the through-space interactions of the peptide, and these were used in an attempt to 
hypothesize a structure. In total, 20 different interactions were observed where six were 
through-space. The key interactions from this experiment were between the E1 α proton and 
each of the two C2 β protons. Having these protons in close proximity suggests that the peptide 
does adopt somewhat of a semi-folded conformation. The peptide is not completely folded 
because there were no E1 and G3 interactions observed, and the peptide is not fully extended 
based on interactions noted above, which would not be seen by ROESY in the extended state. 
The secondary set of shifts also saw few interactions, but not enough to hypothesize a structure 
since those interactions were just within the same spin system or on sequential backbone 
residues. The semi-folded conformation is a form that Zhang et al. had proposed in their 
computational and NMR study
43
, so it is not surprising that this peptide adopted one 
conformation from this study.  
 IRMPD studies on this peptide were also done with the aid of Dr. Terry McMahon and 
Dr. Rick Marta. An IRMPD spectrum was obtained from a sample of GSH and was compared 
to five different calculated spectra of protonated species. The regions that were used to 
characterize and compare the spectra were the carbonyl region, amide region and low frequency 
region. The protonated species that had the calculated spectrum that matched the best to the 
experimental was protonated isomer 5. Even though it was not an exact match, the small 
differences in the frequencies gave isomer 5 the closest match in terms of peak positioning. This 
structure had the second lowest energy of all five structures and had an intramolcular hydrogen 
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bond forming between the protonated carbonyl and the E1 residue. Isomer 4 had the lowest 
electronic and thermal free energies of the five possible candidates. There was only one peak 
that was very blue-shifted for the calculated spectrum, but the peaks in the other regions 
matched very well. The structure of this isomer was in a folded state, where a variety of 
hydrogen bonds brought the two ends of the chain together in close proximity and stabilized this 
structure.  Taking the comparison of the calculated and experimental spectra, free energies, and 
conformation of the calculated structures into account, isomers 4 and 5 are both possible 
candidates that fit the experimental spectrum the best and it is possible that a mixture of these 
species exists.  
 Computational studies on GSH were also conducted at the AMBER and DFT levels of 
theory to predict the most favourable conformation of the peptide. Initially free GSH was drawn 
into Gaussian 09W and then optimized using DFT level of theory with the 6-31g+(d,p) basis set 
in DMF using the PCM model of solvation. Using the DFT structure as a starting point, the 
structure was modified to create thousands of new structures and subjected to molecular 
mechanic calculations using a custom AMBER force field. The results were organized and the 
most favourable conformation of GSH was extracted and used in further studies. GSH was then 
attached to a linker and molecular dynamic experiments were done to predict the most 
favourable dihedral angles for the peptide. Another GSH-linker peptide was put into Gaussian 
and calculated at the DFT level of theory to produce a realistic interpretation of the GSH 
peptide while bound to the linker in DMF. This structure best represents the peptide that was 
synthesized and the results of the calculations share similarities to the NMR results. The 
molecular dynamics results did not agree though, as this technique is not as accurate and only 
provides rough approximations. Therefore, the structure from the computer based calculations is 
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a semi-folded conformation and shares similarities to the NMR results for this resin-bound 
peptide.  
 Using SPPS, a sample of GSH was bound to a resin and analyzed by HRMAS NMR 
spectroscopy. An IRMPD spectrum of GSH was also obtained and different protonated 
structures and their corresponding spectra, were generated to draw comparisons. Computational 
calculations were done with free GSH and the linker to generate a structure that best resembles 
the peptide while bound to the resin. All of these methods were then compared to one another 
and similarities in the findings were reported. The structure seems to favour a semi-folded 
conformation. These initial studies are similar to Zhang’s recent work43 where the peptide exists 
in a semi-folded state, but further work needs to be done. The synthesis of GSH can be 
improved to achieve a higher substitution on the resin in a number of ways. The HMBA-AM 
resin used for the FK-13 synthesis (see next chapter) can be used along with a different first 
amino acid coupling method (not DCBC). Also, Fmoc-Glu-O-2-PhiPr and Fmoc-Cys(Trt)-OH 
would be better amino acids to be used in conjunction with the HMBA-AM resin. These two 
protecting groups are acid labile and would not affect the removal of the peptide from the 
resin.
13, 50
 The computational calculations on GSH can be further improved by using an explicit 
model of solvation as opposed to the implicit model to understand the way the peptide interacts 
with the DMF molecules. Also the structures that were chosen after the random sampling could 
be all subjected to more complex calculations, which were not done due to time constraints in 
this study. There are a lot of areas for improvement and future work for these peptides, but the 
work done in this thesis can easily be built upon for further exploration and understanding. 
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3.0 FK-13 
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 3.2 Experimental Procedures 
 3.3 Results 
 3.4 Discussion  
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3.1 Introduction 
FK-13 is a part of the larger LL-37 peptide, which plays a vital role in the first line of 
defense against bacterial infections. It has also been shown to have anti-cancerous and anti-HIV 
properties, but these characteristics specifically come from the FK-13 region of the peptide. 
Some of the first experiments to determine the structure of this peptide were done using circular 
dichroism methods, but now NMR has been manipulated to determine its structure, function and 
mechanism. Understanding the structure and role of this peptide is key has many biological and 
biochemical implications to the prevention of infections and other harmful agents.  
 The peptide LL-37, a portion of a larger protein hCAP-18, has been identified as part of 
the cathelicidin family of proteins and also possess antibacterial properties.
51
 The gene encoding 
this peptide is highly expressed in bone marrow and the testes, organs that are usually free from 
infectious bacteria. The structure of the LL-37 peptide is an α-helix, which plays a large role in 
the antibacterial function and enhanced capabilities of this peptide.
52
 Solid phase synthesis and 
subsequent analysis by circular dichroism provides evidence that the LL-37 peptide favours an 
α-helical conformation, where a plane across the centre of the helix separates the hydrophobic 
and hydrophilic residues.
53
 Furthermore, by placing the LL-37 peptide in an aqueous 
environment, the α-helix formation was induced more favourably and was seen to have 
enhanced activity against E. coli. An aqueous salt environment was also used to test the 
formation of the peptide, and suggested that this medium also favoured helix formation.
53
 A 
variety of factors in the environment dictates how much α-helix formation occurs with this 
sequence. Helix formation could be dependent on salt, pH, and concentration of the peptide 
sequence. Increased concentrations of the peptide and salt ions favour the formation of the 
helix, and environments that have neutral pH will favour the formation of the helix over low 
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pH.
52
 The helix conformation is not only the preferred conformer of this peptide, but is a 
necessity for antibacterial activity. The helical structures displayed greater activity against E. 
coli than conformers that were random structures.
52
  
 The process in which the LL-37 peptide functions is believed to bein a manner where 
oligomers of the peptide attack and disrupt the bacterial membrane. When the oligomers bind to 
the outer bacterial membrane they will begin to disturb its order and are able to enter the inner 
membrane. Once inside, the oligomers dissociate into monomers and cover the inner membrane 
of the bacteria. Finally, after a certain concentration of LL-37 has been reached inside the 
bacterial membrane, the peptide begins to breakdown the inner membrane, killing the bacterium 
in the process.
53
 Oren and his group hypothesized that this was the mechanism of LL-37 to fight 
against bacterial infections. 
15
N and 
31
P NMR studies also have been conducted to determine the 
mechanism in which LL-37 penetrates and disrupts bacterial membranes. 
15
N solid-phase NMR 
studies revealed that the action of LL-37 was similar to what Oren’s group had hypothesized, 
but the 
31
P results of this study disagreed with this model. The 
31
P NMR and differential 
scanning calorimetry results suggested that the LL-37 peptide induces a positive curvature 
strain. Bacterial membranes normally have a negative curve in their structure, but the presence 
of LL-37 warps this negative conformation and strain the lipid bilayer to curve to a positive one. 
With larger concentrations of LL-37, the strain in the membrane allows for penetration and the 
leakage of ions and molecules.
54
 LL-37 possess unique properties for a helical antimicrobial 
peptide, which make it stand apart from other helical peptides. The LL-37 peptide easily 
oligomerizes in solution, protecting it from enzymatic degradation compared to native peptides 
that are susceptible to this degradation. The LL-37 peptide can bind effectively to zwitterionic 
or negatively charged phospholipid vesicles, whereas native peptides can only bind to 
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negatively charged vesicles. When the peptide is bound to these vesicles, it is highly resistant to 
proteolytic degradation whether the vesicle is zwitterionic or negatively charged. This peptide is 
also able to self-associate when bound to zwitterionic phospholipid vesicles, but will dissociate 
when bound to negative vesicles.
53
 These properties of LL-37 make it a powerful molecule to 
fight bacterial infections. LL-37 also has properties that fight against cystic fibrosis
56
, sepsis in 
rats
57
, and anti-HIV and anti-cancerous properties
58
.  
 The portion of the LL-37 peptide that is responsible for the anti-HIV properties is FK-
13. FK-13, called that for the first two residues and the number of residues that make up this 
portion of the entire LL-37, has the sequence Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-
Leu-Arg (FKRIVQRIKDFLR).
51,53
 This section of the peptide is the shortest the LL-37 can be 
cleaved to and still retain antimicrobial properties. Li had tested the shortest length that the LL-
37 peptide could be cleaved to and still possess antimicrobial and anticancer activity. The 
process was to cleave amino acids from the C- and N-termini and evaluate peptide’s activity; 
the results revealed that residues 17-29 were the minimal portion of the α-helical peptide to 
maintain its antimicrobial and anticancer properties.
59
 Further studies revealed that the F17 
residue was essential for the anti-HIV activity. Upon deletion of this residue, the peptide (KR-
12) lost all anti-HIV activity, indicating that the function of the peptide was dependent on the 
FK-13 segment being intact and F17 being present in the sequence.
58
 
 The three-dimensional structures of native LL-37 and FK-13 have been predicted with 
the use of NMR. Solution NMR studies on the hCAP-18 protein have been conducted in the 
past to determine the structure of this protein. Using 
1
H-
1
H TOCSY experiments, the backbone 
of the peptide was able to be assigned and with NOESY experiments, the conformation of the 
peptide was hypothesized. Using the NOE interactions and calculating the best possible 
110 
 
structures (with the proper restraints in place), the protein was determined to have an α-helical 
structure.
60
  
 
Figure 3.1.1: The native structure of FK-13, which is a part of the LL-37 peptide, is an α-helix. 
The α-helical structure plays a large role in the peptide’s antibacterial function and mechanism 
of this peptide to fight against bacterial infections. Adapted from Li et al.
59
 
Solid-state NMR was used by Henzler to investigate the structure and mechanism in 
which LL-37 operates. In one of their first studies, the structure was determined using 
13
C 
CPMAS NMR of a powder sample of the LL-37 peptide. The carbonyl peaks were used to 
establish the structure of the peptide based on characteristic shifts for secondary structures. The 
frequencies at which the carbonyls in the peptide resonated were indicative of an α-helix. 15N 
and 
31
P NMR experiments were used in the same study to determine the mechanism of the 
peptide and the way it orients itself to disturb bacterial membranes.
55
 Further studies done by 
Henzler utilized solid-state 
2
H NMR to further understand where and how the LL-37 peptide 
inserts itself into lipid membranes. Their results examined the method by which the LL-37 
peptide penetrates hydrophobic/hydrophilic bilayers. They hypothesized that the hydrophobic 
half of the helix inserts itself approximately 5-6 Å into the hydrophobic portion of the bilayer. 
They observed this phenomena by using de-Paked 
2
H NMR experiments, and noticed a decrease 
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in quadrupolar splitting in the spectra, which indicated that there was some disorder in the lipid 
bilayer.
61
 Two-dimensional heteronuclear experiments also played a critical role in the analysis 
of the LL-37 peptide. 
15
N-
1
H NMR experiments were used to justify that a sample of LL-37 was 
successfully cloned and purified for further examination. The conclusion was made based on 
characteristic Asn and Gln cross-peaks in the HSQC spectrum that were consistent with the 
peptide sequence. Although this study did not fully explore the structure of the peptide, it 
demonstrated the versatility of two-dimensional heteronuclear NMR in characterizing LL-37.
62
 
A study that uses both solid-state and solution-state NMR to investigate the structure of LL-37 
was done by Porcelli. First, the resonances for the individual residues were established using 
two-dimensional 
1
H-
1
H TOCSY and NOESY experiments. By using all the NOE interactions, 
H/D exchange results, and computational simulations, the peptide was determined to have an α-
helix-break-helix conformation. NOESY was used again to determine the structure of the 
peptide when it interacts with micelles. The results showed that the hydrophobic residues will 
point towards the centre of the micelle and the hydrophilic residues will be facing the solvent.
63
 
The structure of the peptide in micelles again was studied by Wang, but they used a different 
detergent in the micelles, and three-dimensional NMR. An isotopically enriched (
15
N and 
13
C) 
sample of LL-37 was analyzed using triple-resonance experiments that were 
1
H-
1
H-X (where X 
is either 
15
N or 
13
C). The results of this study revealed that there were some differences in the 
manner in which LL-37 interacts with micelles compared to Porcelli’s study. They found that 
the peptide was not mobile at the N-terminus, but flexible at the C-terminus, the structure was a 
helix throughout (rather than helix-break-helix), and that the starting and ending residues are 
different between the different micelles.
51
 Wang also attempted 
13
C natural abundance 
experiments on this peptide and used 
1
H-
13
C  and 
1
H-
15
N HSQC experiments to look at the 
112 
 
interactions between the peptide and micelles again. The heteronuclear experiments were used 
to establish dihedral angles of the peptide for better structure calculations, 
13
C results revealed 
what portions of the peptide were more structured and the use of HSQC was used to determine 
specific residues interacting with the micelle.
64
 Aside from the many studies that look at micelle 
and LL-37 interactions using NMR, some have proceeded to understand how the structure plays 
a role in cancer treatment.
65,66
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3.2  FK-13 Experimental 
 3.2.1 Synthesis of FK-13 
Synthesis of the 13-residue cyclic peptide, FK-13, was done using methods outlined and 
adapted from Kates and Albericio
12
 and Chan and White
13
. The amino acids used in this 
synthesis were: Fmoc-Asp-O-2-PhiPr-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ile-OH, Fmoc-Arg(Pbf)-
OH, Fmoc-Gln(Trt)-OH, Fmoc-Val-OH, Fmoc-Phe-OH and Fmoc-Leu-OH. All of the amino 
acids that were used in this experiment are considered to be part of the “standard 20 amino 
acids” (with the exception of Fmoc-Asp-O-2-PhiPr-OH) due to the strong acidic cleavage 
conditions all of the protecting groups share. In this synthesis, HOBt and HBTU were not used 
together as coupling reagents- instead HCTU replaced both these reagents. Synthesis was 
performed in a Merrifield vessel connected to a 250 mL filter flask for easy removal of excess 
reagents and solvents. 
Another change implemented for this synthesis from that of glutathione was the use of 
an HMBA-AM resin (Figure 3.2.1). The HMBA-AM resin contains a free hydroxyl group for 
attachment of the first amino acid, much like the Wang OH resin, but this type of resin is base 
labile requiring strongly basic conditions to cleave the peptide from the resin.
21
 Initially, 0.5153 
g of HMBA-AM resin (copoly(styrene-1% DVB), 200-400 mesh, 0.70 – 1.20 mmol/g 
substitution) was weighed into the Merrifield vessel and was allowed to swell for 30 minutes in 
distilled DCM and then 30 minutes in DMF. The initial molar substitution of 0.88 mmol/g was 
used, as indicated on the bottle, to determine the weight of the first amino acid and volume of 
pyridine and DCBC needed for the first coupling.  
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Figure 3.2.1: Two different resin-linker combinations used in solid-phase peptide synthesis: a) 
HMBA-AM resin, contains a free hydroxyl group and is base labile- the peptide can be cleaved 
from the resin using strong basic conditions;
21
 b) Wang resin with a hydroxyl functionality 
cleavage of peptides from this resin can be accomplished using strong acidic conditions.  
 The coupling of Fmoc-Asp-O-2-PhiPr-OH (D10), required 1.074 g of the Fmoc 
protected amino acid, 302 μL of pyridine, 325 μL of DCBC, and approximately 10 mL of DMF. 
These reagents were added directly to the vessel and allowed to shake for a minimum of 18 
hours per attempt. After each attempt, the resin was washed 5 times with DMF, and a small 
portion of the resin was removed and dried in a fume hood for the substitution check. Multiple 
attempts were needed to couple the D10 residue to the resin, but after 5 attempts, the molar 
substitution (measured using methods outlined in section 1.5 and used for all other substitution 
checks done for this synthesis) was 0.5605 mmol/g (63.9% substitution of the previously 
available sites).  Even though this is below the benchmark set earlier in the experiment, the 3
rd
, 
4
th
 and 5
th
 substitution checks did not show any change in the substitution and the synthesis of 
the peptide was continued. Based on this substitution, 397 μL of DIPEA and 214 μL of acetic 
anhydride was added to the vessel and shaken for an hour to cap all of the remaining unreacted 
sites of the resin. A substitution check was done after this capping process, and no change in the 
molar substitution was observed. The resin-bound amino acid was treated with approximately 
10 mL of 20% piperidine in DMF to cleave the Fmoc protecting group. After numerous 
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piperidine treatments, the substitution check for Fmoc removal gave a negative value, which 
indicated that no Fmoc remained, allowing the next amino acid to be added to the chain.  
 In addition to the change of resin being employed, the HOBt and HBTU method has 
been replaced with simply HCTU. Using a single reagent instead of two is a cleaner and quicker 
process and has the same function as the HOBt/HBTU method. The coupling of the second 
amino acid, Fmoc-Lys(Boc)-OH (K9) required 0.6767 g of the Fmoc protected amino acid, 
0.5975 g of HCTU and 506 μL of DIPEA. These reagents were weighed and then added directly 
into the Merrifield vessel along with approximately 10 mL of DMF to dissolve the reagents. 
The reaction mixture only required 2 hours of shaking per coupling attempt which allowed for 
more attempts each day. Following every attempt, the resin was washed 5 times with DMF and 
then a small portion of the resin was removed for the substitution check. In total, 7 attempts to 
couple the K9 were needed to give a molar substitution of 0.4512 mmol/g (80.5% substitution 
of the previously available sites). After the substitution was deemed sufficient for the coupling, 
the Fmoc protecting group was cleaved off K9 with 20% piperidine in DMF allowing the next 
amino acid to be added to the chain.  
 Synthesis of the peptide continued with the addition of Fmoc-Ile-OH (I8) to elongate the 
chain further. This step required 0.4108 g of I8, 0.4809 g of HCTU and 407 μL of DIPEA for 
the reaction. The reagents were added into the Merrifield vessel with approximately 10 mL of 
DMF and allowed to shake for a minimum of 2 hours per attempt. After each attempt, the resin 
was washed 5 times with DMF, and a small amount of the resin was removed to do a 
substitution check. After 7 attempts, the coupling showed great success with a molar 
substitution of 0.4368 mmol/g (96.8% substitution of the previously available sites). After a 
sufficient coupling for this amino acid, the peptide was treated with 20% piperidine in DMF to 
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cleave the protecting group. Once a negative value was obtained for the absorbance reading, the 
next amino acid was added to the chain. 
 The Fmoc-Arg(Pbf)-OH (R7) residue was the next amino acid to be added to elongate 
the chain. This step in the synthesis required 0.7301 g of R7, 0.4656 g of HCTU and 394 μL of 
DIPEA which was all added to 10 mL of DMF in the Merrifield vessel. The vessel was allowed 
to shake for a minimum of 2 hours per attempt and after each attempt, the resin was washed 
through 5 times with DMF. A small amount of resin was taken out of the vessel and dried for a 
substitution check. The coupling showed quite good success after 9 attempts, achieving a molar 
substitution of 0.3631 mmol/g (83.1% substitution of the previously available sites). The 
substitution level was sufficient for the next amino acid to be added, so the Fmoc protecting 
group was cleaved with 20% piperidine in DMF allowing for the next amino acid to be coupled. 
 Chain elongation continued with the addition of Fmoc-Gln(Trt)-OH (Q6) to the peptide. 
The addition of this residue required 0.5713 g of the Fmoc protected amino acid, 0.3870 g of 
HCTU and 328 μL of DIPEA for the reaction. All of these reagents were added into the 
Merrifield vessel along with approximately 10 mL of DMF as the reaction solvent. The vessel 
then was shaken for at least 2 hours in each attempt and followed by washing with DMF 5 
times. A small amount of the resin was removed for substitution checks after each attempt, and 
after 9 attempts, the molar substitution was measured to be 0.2917 mmol/g (80.3% substitution 
of the previously available sites). This was sufficient for the next amino acid addition, so the 
resin was treated with 20% piperidine in DMF to remove the Fmoc protecting group. Fmoc-
Val-OH (V5) was the next amino acid in the sequence of the peptide being synthesized. This 
step required 0.2551 g of V5, 0.3109 g of HCTU and 263 μL of DIPEA - all dissolved in 10 mL 
of DMF which was placed directly into the Merrifield vessel. All of these reagents required a 
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mixing time of at least 2 hours for each coupling, and after each shaking period, the resin was 
washed 5 times with DMF, and then a small amount of the resin was removed to dry for a 
substitution check. This amino acid coupling took 4 attempts to achieve a molar substitution of 
0.2745 mmol/g (94.1% substitution of the previously available sites). This substitution level 
was more than acceptable and the next step was cleaving the Fmoc group from the V5 residue 
so that the next amino acid could be coupled.  
 The next amino acid that was to be added was another Fmoc-Ile-OH (I4) residue. This 
step in the synthesis required 0.2500 g of I4, 0.2926 g of HCTU and 248 μL of DIPEA and all 
reagents were added directly into the Merrifield vessel with 10 mL of DMF. The reagents in the 
Merrifield vessel were shaken for a minimum of 2 hours for each attempt and were washed 5 
times with DMF after each reaction period. A small amount of resin was then removed from the 
vessel and dried in a fume hood for a substitution check. This coupling attempt took only 3 tries 
to reach a molar substitution of 0.2677 mmol/g (97.5% substitution of the previously available 
sites). This substitution was enough to proceed with the cleavage of the Fmoc protecting group 
(using 20% piperidine in DMF) and the addition of the next amino acid. 
 Another Fmoc-Arg(Pbf)-OH (R3) residue was added and was the 8
th
 amino acid to be 
added to the sequence. This step in the synthesis needed 0.4475 g of R3, 0.2853 g of HCTU and 
242 μL of DIPEA all placed into the Merrifield vessel along with 10 mL of DMF. The reaction 
vessel was then shaken for a minimum of 2 hours and followed by washing with DMF 5 times. 
Each substitution check required a small amount of the resin to be removed and dried after the  
DMF washings. The coupling of the R3 residue took 7 tries to obtain a molar substitution of 
0.2352 mmol/g (87.8% substitution of the previously available sites). The coupling was 
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sufficient for this step and the resin was treated with 20% piperidine in DMF to remove the 
Fmoc protecting group, allowing the next amino acid to be coupled. 
 The next amino acid in the sequence was another Fmoc-Lys(Boc)-OH (K2) residue. For 
this coupling, 0.2839 g of K2, 0.2507 g of HCTU and 212 μL of DIPEA were added into the 
Merrifield vessel containing the resin-bound peptide and 10 mL of DMF. Again, a minimum of 
2 hours for each reaction was needed to allow the reagents to react and after each 2 hour time 
period, the resin was washed with DMF 5 times. After each set of washings, a small amount of 
resin was removed from the vessel and dried for a substitution check. After 5 attempts, the 
degree of substitution was measured to be 0.2041 mmol/g (86.7% substitution of the previously 
available sites). This substitution was good and the resin-bound peptide was subjected to 20% 
piperidine in DMF to remove the Fmoc protecting group to allow the next amino acid to be 
coupled. 
 The 10
th
 amino acid added in this synthesis was Fmoc-Phe-OH (F1) and required 0.2307 
g of the Fmoc protected amino acid, 0.2175 g HCTU and 184 μL of DIPEA. All of these 
reagents were weighed out and then added into the Merrifield vessel along with 10 mL of DMF. 
The vessel was then shaken for at least 2 hours for each coupling attempt and subsequently 
washed 5 times with DMF. After the washings, a small portion of the resin was removed from 
the vessel and dried in a fume hood for the coupling check. The coupling of F1 took 5 tries to 
get a molar substitution of 0.1904 mmol/g (93.3% of the previously available sites). This 
substitution level was enough for the next amino acid to be coupled so the peptide was treated 
with 20% piperidine in DMF to remove the Fmoc protecting group. 
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 The next amino acid in the sequence was another Fmoc-Arg(Pbf)-OH (R13) residue. 
This amino acid needed 0.3138 g of R13, 0.2029 g HCTU and 172 μL of DIPEA per coupling 
to proceed. With each attempt, the reaction vessel was shaken for 2 hours and then washed with 
DMF 5 times after the reaction. A small portion of the resin was then removed from the vessel 
to dry in a fume hood for the substitution check. After 8 couplings, the R13 residue coupled 
with a molar substitution of 0.1711 mmol/g (89.9% substitution of the previously available 
sites). With a molar substitution of this level, the Fmoc group on R13 could be cleaved, using 
20% piperidine in DMF, and then the next amino acid could be added. 
The 12
th
 amino acid to be added in this peptide was Fmoc-Leu-OH (L12). This synthesis 
step required 0.1558 g of L12, 0.1824 g of HCTU and 154 μL of DIPEA. All of the reagents 
were weighed out before being added into the Merrifield vessel containing the resin-bound 
peptide and approximately 10 mL of DMF. Each coupling attempt required a 2 hour shaking 
period and was followed by washing with DMF 5 times. Next, a small portion of the resin was 
removed, dried and used in a substitution check. Five coupling attempts were needed for the 
L12 coupling to achieve a 0.1592 mmol/g molar substitution (92.4% substitution of the 
previously available sites). This substitution was good and so the resin was then treated with 
20% piperidine in DMF to cleave the Fmoc protecting group from the L12 residue allowing for 
the final amino acid to be added.  
The final amino acid to be added for this peptide sequence was another Fmoc-Phe-OH 
(F11) residue. Each coupling attempt required 0.1579 g of the Fmoc protected amino acid, 
0.1686 g of HCTU, and 143 μL of DIPEA. With each attempt, a 2 hour shaking period was 
needed for the reaction to proceed. After the shaking time, the resin was washed 5 times with 
DMF and a small portion of the resin was removed after each attempt to perform a substitution 
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check. In total 6 coupling attempts were done to reach a final molar substitution of 0.1471 
mmol/g (93.0% substitution of the previously available sites). With this amino acid being 
coupled, all of the residues in the sequence had been added to the peptide chain while still 
bound to the resin. 
The next step was to cyclize the peptide connecting the F11 α amino group to the D10 α 
carboxyl group. The first amino acid in this sequence, D10, had the O-2-PhiPr protecting group 
on it, which needed to be removed first. Cleavage of the O-2-PhiPr protecting group was carried 
out by treating the resin-bound peptide with 1% TFA in DCM. Approximately 5 mL of this 
mixture was placed into the Merrifield vessel and allowed to shake for 2 minutes. After the 
shaking, the resin was washed 3 times with DMF to remove any excess solvent, reagents, and 
any of the O-2-PhiPr that may have been cleaved off. This cleavage of the O-2-PhiPr protecting 
group was done 10 times to leave a free α carboxyl group. The Fmoc protecting group on F11 
was the next to be cleaved; this required approximately 8 mL of 20% piperidine in DMF. The 
reaction vessel was shaken for approximately 30 minutes to remove all the Fmoc protecting 
group from the peptide. After a few attempts, the Fmoc check showed a negative absorbance for 
the UV measurement, indicating no Fmoc remained on the peptide. With a free α amino and α 
carboxyl group on the peptide, the “head-to-tail” cyclization of the peptide could be carried out. 
Based on the final substitution on the F11 residue, the amounts of HCTU and DIPEA for the 
cyclization were determined to be 0.1568 g and 133 μL, respectively. This cyclization process 
was treated in the same manner as the coupling of an amino acid, so the after the reagents were 
added into the vessel, it was shaken for 2 hours and then washed 5 times with DMF. There was 
no way to check the substitution of the peptide, so the reaction was carried out 4 times to 
attempt to complete the cyclization of the peptide. 
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After assuming the peptide was cyclized, the final step was to cleave all of the protecting 
groups from all the remaining residues. The remaining protecting groups (Pbf, Boc and Trt) all 
required strongly acidic conditions to be cleaved. To remove these protecting groups, the resin 
was treated once with a mixture of 95:5 TFA:TIS. The vessel was allowed to shake for 30 
minutes and was then washed 3 times with TFA, then DCM, followed by 10% DIPEA in DCM, 
and finally DCM again. The resin was then swollen in DMF for 24 hours, filtered and then 
allowed to dry in a fume hood until it was completely dry. The final product was the 13 amino 
acid cyclic peptide FK-13 free from the effects of protecting groups. The dry product was then 
transferred to a vial and placed in a desiccator.  
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Figure 3.2.2: Flow chart for the synthesis of the cyclic peptide FK-13, using methods adapted 
from Kates and Alberts
12
 and Chan and White
13
. HCTU replaced HOBt and HCTU as the 
coupling reagents, and each coupling time period only required 2 hours of mixing. In the end, 
the linear sequence was cyclized on resin free from the effects of protecting groups. 
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3.2.2 NMR of FK-13 
 All NMR experiments conducted on the FK-13 samples were done using a Bruker 
Avance 500 MHz NMR spectrometer at the University of Waterloo’s NMR facility. The magnet 
was equipped with a Doty Scientific triple-tuned DSI-XC4 HRMAS probe equipped with a 
13
C-
2
H LF Trap Wand, 
13
C-
2
H MF Tune/Voltage Division Wand, 
13
C-
2
H LF Tune/Voltage Division 
Wand and a 
13
C-
1
H capacitor. All experiments were conducted at ambient temperature (~295 
K). A small amount of the dry resin-bound FK-13 was loaded into a XC4 40 μL Kel-f sealing 
cell and filled to approximately to half the volume; the remaining volume was filled with DMF-
d7 and was capped with a XC4 Teflon plug. The sample needed to have no air bubbles in the 
cell; if there was air present, it would have to be reopened and filled again until no bubbles 
remained. The cell was loaded into a Doty Scientific XC4 4-mm silicon nitride thin wall rotor 
and capped with Torlon short turbine caps, which was then placed into the probe and spun at a 
speed of 4.4-4.7 kHz at the magic angle of 54.7°. 
 One-dimensional 
1
H NMR spectra, plotted as spectral intensity versus frequency, were 
obtained using the dipsi21D pulse sequence. The spectrum was collected after 1024 transients, 
with an acquisition time of 0.62 seconds and a spectral width of 6614 Hz. A 90° 
1
H pulse length 
of 7.81 μs was used at low power (0.00 dB). The resulting 8k data points were zero-filled to 16k 
data points for Fourier Transformation and apodized using the exponential multiplication 
window function with a Lorentzian broadening constant of 0.30 Hz, sine bell shift of 0, and a 
Gaussian broadening factor of 0. The spectrum was referenced internally to the chemical shifts 
of the deuterated DMF solvent, and applied to all other 1D and 2D 
1
H experiments. All spectra 
were processed using the Bruker XWIN-NMR 3.5 pl6 software.  
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 Two-dimensional 
1
H-
1
H COSY experiments used the cosyqf90 pulse sequence and 
collected a set of 256 x 1024 data points in the t1 and t2 dimensions, respectively. Each 
increment consisted of 136 transients with 4 dummy scans over a spectral width of 5000 Hz in 
both dimensions. A 90° 
1
H pulse length of 7.81 μs was applied at a power level of 0.00 dB with 
an acquisition time of 0.1025 seconds. A relaxation delay of 2 seconds with delay increments of 
0.166 ms and a dwell time of 83.2 μs were used in the pulse sequence as well. After acquisition 
and Fourier transform was applied, the data sets underwent apodization using the SINE 
multiplication function with a Lorentzian broadening constant of 0.30 and 1.00 Hz in the t1 and 
t2 dimensions, respectively. A sine bell shift of 0 was used in both dimensions and a Gaussian 
broadening factor of 0.1 was used in the t1 dimension, and 0 in the t2 dimension. The spectrum 
was calibrated using the solvent reference value obtained from the 1D 
1
H experiments and 
applied to both dimensions. The spectrum was processed using the Bruker XWIN-NMR 3.5 pl6 
software.  
 Two-dimensional 
1
H-
1
H TOCSY experiments utilized the DIPSI-2 pulse sequence and 
collected a set of 256 x 1024 data points in the t1 and t2 dimensions, respectively. A total of 128 
transients and 16 dummy scans per increment were used over a spectral width of 5500 Hz in 
both dimensions. A 90° 
1H pulse length of 7.69 μsec was used at low power (0.00 dB) and a low 
power 90° pulse of 60 μs was used at a power level of 18.41 dB for the TOCSY-spin lock. A 
TOCSY mixing time of 35 msec and an acquisition time of 0.09353 seconds were used in the 
experiments. Delay increments of 0.18177 ms, a dwell time of 91.2 μs and a relaxation delay of 
5 seconds were also implemented in the pulse sequence. Upon completion of acquisition, the 
data sets were Fourier transformed and apodized using the QSINE multiplication function with 
a Lorentzian broadening factor of 0.30 and 1.00 Hz in the t1 and t2 dimensions, respectively. In 
125 
 
both dimensions a sine bell shift of 2 was applied and Gaussian broadening factor was set to 0.1 
in the t1 dimension and 0 in the t2 dimension. The TOCSY spectrum was referenced to the value 
obtained from the 1D 
1
H experiments conducted before this experiment. The spectrum was 
processed using the Bruker XWIN-NMR 3.5 pl6 software. 
 Two-dimensional 
1
H-
1
H ROESY experiments used the roesyph pulse sequence and 
collected a set of 256 x 1024 data points in the t1 and t2 dimensions respectively. A total of 128 
transients and 16 dummy scans per increment were used over a spectral width of 5500 Hz in 
both dimensions. A 90° 
1H pulse length of 7.69 μs was used at a power level of 0.00 dB along 
with a 65 ms pulse for the ROESY spin-lock at a power level of 28.30 dB. An acquisition time 
of 0.09353 seconds was used along with a 20 μs power switching delay between low and high 
power pulses. After acquisition and Fourier transform, the data sets were apodized using the 
QSINE multiplication function with a Lorentzian broadening factor of 0.30 and 2.00 Hz in the t1 
and t2 dimensions respectively. A sine bell shift of 2 was applied in both dimensions and a 
Gaussian broadening factor of 0.1 in the t1 and 0.05 in the t2 dimensions. The spectrum was 
referenced to the value obtained from the 1D 
1
H experiment conducted earlier. The spectrum 
was processed using the Bruker XWIN-NMR 3.5 pl6 software.   
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3.3  FK-13 Results 
 3.3.1 Results of Synthesis 
 The results of the solid-phase synthesis of the 13-residue peptide are summarized in 
Table 3.3.1. Coupling of the first amino acid Fmoc-Asp(O-2-PhiPr)-OH (D10) to the HMBA-
AM resin was done using the DCBC method in DMF. The use of this amino acid lends itself 
well for cyclic synthesis as the α-carboxyl group is protected and the γ-carboxyl group is free to 
react with the base-labile resin. Linkage through the side chain allows for the elongation to 
occur on the α-amino group of D10 and eventually cyclizing through the α-carboxyl group once 
all the residues have been added. The initial functionality of the resin was assumed to be 0.88 
mmol/g and after five attempts, the coupling was measured to be 0.5605 mmol/g. This coupling 
was well below the ideal percentage of 80%, and this could be attributed to the use of DCBC in 
the reaction. The acetyl chloride group of 2,6-dicholorbenzoyl chloride acts in the same manner 
as acetic anhydride for the capping process. As the coupling reaction occurs, the unreacted sites 
are simultaneously being capped as well. Any attempts after the first or second try usually won’t 
show a change in the substitution since the sites have either reacted on already or been capped 
by the acetyl chloride. The use of the 4-dimethylaminopyridine (DMAP) or 1-(mesitylene-2-
sulphony)-3-nitro-1H-1,2,4-triazole (MSNT) are better reagents to use for the first coupling as 
they will not cap the unreacted sites as well. The downside to the DMAP method is that 
enantiomerization and dipeptide formation can occur, but this can be limited by using a minimal 
amount of DMAP.
13
 MSNT is favourable when a hydroxyl functionality is being used to anchor 
the first amino acid or when enantiomerization is possible, but this method requires all of the 
equipment being used to be free of moisture for this coupling.
13
 Either of these two methods 
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should be considered in future synthesis of peptides on resin, especially for longer sequences 
such as FK-13.  
Table 3.3.1: The coupling conditions and success of each coupling attempt in the solid-phase 
synthesis of the 13-residue peptide, FK-13. The percentage of total available sites was based off 
the initial molar substitution of 0.88 mmol/g 
Amino 
Acid 
Coupling 
Method 
Solvent # of 
Coupling 
Attempts 
Resin 
Substitution 
(mmol/g) 
% Subs 
of 
Previous 
Available 
Sites 
% Subs 
of Total 
Available 
Sites 
1
st
: Asp 
(O-2-
PhiPr) 
DCBC DMF 5 0.5605 63.9% 63.9% 
2
nd
: Lys 
(Boc) 
HCTU DMF 7 0.4512 80.5% 51.2% 
3
rd
: Ile HCTU DMF 7 0.4368 96.8% 49.6% 
4
th
: Arg 
(Pbf) 
HCTU DMF 9 0.3631 83.1% 41.3% 
5
th
: Gln 
(Trt) 
HCTU DMF 9 0.2917 80.3% 33.1% 
6
th
: Val  HCTU DMF 4 0.2745 94.1% 31.2% 
7
th
: Ile HCTU DMF 3 0.2677 97.5% 30.4% 
8
th
: Arg 
(Pbf) 
HCTU DMF 7 0.2352 87.8% 26.7% 
9
th
: Lys 
(Boc) 
HCTU DMF 5 0.2041 86.7% 23.2% 
10
th
: 
Phe 
HCTU DMF 5 0.1904 93.3% 21.6% 
11
th
: 
Arg 
(Pbf) 
HCTU DMF 8 0.1711 89.9% 19.4% 
12
th
: 
Leu 
HCTU DMF 5 0.1582 92.4% 18.0% 
13
th
: 
Phe 
HCTU DMF 6 0.1471 93.0% 16.7% 
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Table 3.3.1 shows that every step in the synthesis was successful and reached the desired 
80% substitution of the previously available sites. The shorter and simpler amino acids such as 
Ile, Val, Phe, and Leu were all 90% coupling at each of the steps. This could suggest that amino 
acids that do not have protecting groups can couple easier and require fewer attempts to achieve 
a high substitution. On the other hand, while not being lower than the desired 80%, the longer 
amino acids with protecting groups had the lowest substitution percentages. Opposite to what 
the short non-polar amino acids suggest, it is possible that longer polar amino acids could 
somehow interfere with the coupling process due to their flexibility and bulkiness of the 
protecting groups. Overall the chain elongation of FK-13 was successful and the cyclization of 
the peptide was carried out. 
The D10 residue was protected with an O-2-PhiPr group that needed to be removed with 
1% TFA in DCM. Mild acidic conditions were used to ensure that the other protecting groups 
(Pbf, Trt and Boc) would remain and the functionalities they were protecting would not 
interfere with the cyclization process. The resin-bound peptide was treated with the mild acid 
solution 10 times and allowed to shake for 2 minutes each time. After each treatment, the resin 
was washed with DMF 3 times to remove any excess TFA and the cleaved O-2-PhiPr group. A 
substitution check was done after to measure the coupling of the peptide to ensure nothing had 
changed when the cleavage was carried out. This check gave a substitution of 0.1375 mmol/g, 
which is 93.4% of the final substitution and was sufficient to carry on with the cyclization. This 
difference in the substitution could be attributed to the fact that only one check was done as 
opposed to three due to the limited amount of resin-bound peptide available or that a portion of 
the resin that was removed could have had less peptide than other parts of the resin. Removal of 
the Fmoc protecting group from F11 was carried out using 20% piperidine in DMF and was 
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done 3 times to ensure as much of the Fmoc group would be removed. A substitution check was 
done after these attempts and the absorbance reading was negative after the final two attempts 
indicating that no Fmoc remained. The cyclization process was carried out by joining the α 
carboxyl group of D10 to the α amino group of F11 using 5 molar equivalents of HCTU and 10 
molar equivalents of DIPEA and reacted for 2 hours on the shaker. This process was repeated 4 
times and after each attempt, the resin was washed 4 times with DMF. The final step after 
cyclization was to remove all the protecting groups from the peptide with a 95% TFA 5% TIS 
solution. This mixture was added to the Merrifield containing the resin-bound peptide and 
allowed to shake for 1 hour. After the resin was washed 3 times with TFA and the filtrate was 
collected a put aside in case the peptide was accidentally cleaved from the resin. The resin was 
then washed 3 times with DCM, 10% DIPEA in DCM and finally in DCM again. The resin was 
then allowed to dry under suction filtration for 3 hours then placed in the fume hood to dry. This 
synthesis gave a cyclic resin-bound sample of FK-13 that could be analyzed by NMR 
spectroscopy.  
3.3.2 NMR Analysis of FK-13 
 Assignment of all the protons in the 13-residue peptide was done using 1D 
1
H and 2D 
1
H-
1
H experiments and the results are tabulated in Table 3.3.2. The dipsi21D pulse sequence 
was used to obtain the 1D spectrum (Figure 3.3.1) and was a better choice than the regular zg 
pulse sequence that was used for the GSH experiments. This pulse sequence suppresses the 
signal from the resin and the signals from the peptide are not buried under the intense resin 
signals.  
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Figure 3.3.1: 1D spectrum of the resin-bound FK-13 where chemical shift is plotted against 
spectral intensity. The dipsi21D pulse sequence was used to supress the signal from the resin so 
that the peptide frequencies would be easier to visualize.  
Using the COSY and TOCSY spectrum (Figure 3.3.2) 13 different spins systems were 
identified where an amide proton interacts with an α proton.  
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Table 3.3.2: 
1
H chemical shifts of the 13-residue cyclic peptide, FK-13. The chemical shifts of 
these protons were referenced internally to the solvent peaks of DMF-d7 
Amino 
Acid 
NH Hα Hβ Hγ Hδ Other 
D10 8.030 4.322 3.288 - - - 
K9 8.303 4.702 3.114 1.504 1.727 3.387 (ε) 
I8 8.330 4.432 2.326 
1.738 (β’) 
1.614 1.337 - 
R7 8.158 4.378 1.940 1.309 3.285 - 
Q6 8.129 4.525 3.123 1.952 - - 
V5 8.557 4.291 1.906 0.929 - - 
I4 7.754 3.842 2.875 
1.172 (β’) 
2.020 0.937 - 
R3 8.975 4.534 1.712 1.043 3.146 - 
K2 7.851 4.506 1.923 1.445 1.723 3.157 (ε) 
F1 8.022 4.757 2.767 - - - 
R13 8.411 3.831 2.015 1.179 2.863 - 
L12 7.936 4.283 2.141 1.867 0.935 - 
F11 8.022 4.757 2.767 - - - 
 
Identifying the first four residues, (D10, K9, I8 and R7) were simple since a sample of the 
peptide was analyzed after these four residues were coupled to the resin. In these four residues, 
the D10 system was easy to identify as it was the only one that had amide, α and β interactions, 
but no γ or further interactions. The amide proton (8.030 ppm) and the α proton (4.322 ppm) 
showed a strong correlation and the β proton (3.288 ppm) showed a strong correlation to the α 
proton. Differentiating between the K9, I8 and R7 residues was quite challenging since these 
residues are all quite long and have many groups of protons. One residue was observed to have 
an interaction between the α proton and an ε proton and was determined to belong to K9. Four 
interactions that lined up with the α proton (4.702 ppm) in the “α region” belonged to K9 and 
were between the β (3.114 ppm), γ (1.504 ppm), δ (1.727 ppm), and ε (3.387 ppm) protons. 
Differentiating between I8 and R7 came down to the various interactions between the α proton 
132 
 
and the β, γ, and δ protons. One α proton was seen to interact with a set of protons at 2.326, 
1.738, 1.614, and 1.337 ppm. Another α proton was seen to interact with a set of protons at 
1.940, 1.309 and 3.285 ppm. The major difference between these two sets of protons is that the 
second set contains a proton at 3.285 ppm which would not occur in a non-polar aliphatic amino 
acid such as isoleucine. Therefore, the α proton (4.378 ppm) that interacts with protons at 3.285 
ppm, must belong to the R7 residue and in particular the δ protons of this residue. The β protons 
at 1.940 ppm and γ protons at 1.309 ppm also have interactions with this α proton. I8 is a non-
polar aliphatic residue and it is expected that the frequency for all these protons appear less than 
3 ppm. The α proton (4.432 ppm) is interacting with a β proton (2.326 ppm), γ proton (1.614 
ppm) and a δ proton (1.337 ppm). There is also another interaction at 1.738 ppm and this 
belongs to the methyl group coming off the β carbon and will be denoted as β’. Identification of 
the remaining amino acids was also challenging – the spectrum was cluttered with peaks that 
represented the other 9 amino acids with peaks possibly overlapping one another. 
Distinguishing between certain residues was simpler than others. Phenylalanine was the only 
remaining residue that had an amide, α and β protons (along with aromatic protons) and so 
assigning shifts to this residue were simple. An amide proton (8.022 ppm) was seen interacting 
with an α proton (4.757 ppm) in the amide region of the TOCSY spectrum. This α proton was 
also seen interacting with a β proton at 2.767 ppm, but no other residues. This set of shifts was 
assigned to F1 and F11 under the assumption that these residues are close and that the peaks are 
stacked on top of one another. Valine was another residue that was readily assigned as it was a 
short residue with an aliphatic side chain. The α proton (4.291 ppm) was seen to be interacting 
with a β proton (1.906 ppm) and another group far upfield below 1 ppm. This signal was 
determined to belong to the two methyl groups of valine and represents the γ protons (0.929 
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ppm) of the V5 residue. Q6 was another residue that was simple to assign as it only has amide, 
α, β, and γ protons, where one of the proton groups will be shifted downfield more due to the 
proximity of the amide in the R group. The α proton at 4.525 ppm was seen interacting with a 
signal at 3.123 ppm and 1.952 ppm. The fact that these protons were shifted this high suggests 
that these signal do not belong to a residue such as isoleucine or leucine. Therefore, the peak at 
1.952 ppm belongs to the β protons and the peak at 3.123 ppm belongs to the γ protons. Two 
residues that were difficult to identify from one another were I4 and L12, as they are simply 
isomers of one another. The key to separating the two in terms of assignment was understanding 
that L12 would only contain 5 sets of signals (amide, α, β, γ, and δ) while I4 would have 6 sets 
of signals (amide, α, β, β’, γ, and δ).  An α proton (4.283 ppm) that was seen interacting with an 
amide proton (7.936 ppm) was also seen interacting with only 3 other signals, 2.141 ppm, 1.867 
ppm and 0.935 ppm. This set of 5 peaks definitely belongs to L12 and was assigned as such. 
These three signals likely represent the β, γ and the two δ methyl groups in L12. As for I4, an 
amide proton at 7.754 ppm was interacting with an α proton at 3.842 ppm. This α proton is 
interacting with a β proton (2.875 ppm), β’ proton (1.172 ppm), a γ proton (2.020 ppm) and a δ 
proton (0.937 ppm). These four α cross-peaks for I4 helped distinguish it from the L12 residue 
(which only had three α cross-peaks). The remaining residues to be assigned are R3, K2 and 
R13, where K2 will have 6 signals as opposed to R3/R13 having 5. The K2 residue was 
identified after the amide proton at 7.851 ppm was seen interacting with an α proton at 4.506 
ppm. Analysis of the “α region” using the shift for the α proton revealed 4 other interactions to 
this proton. The β proton was seen at 1.923 ppm, the γ proton at 1.445 ppm, the δ proton at 
1.723 ppm and the ε proton at 3.157 ppm. The δ and ε protons appear shifted downfield more 
than the γ proton due to the amino functionality in the K2 side chain. The final two arginine 
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residues, R3 and R13, were identified on the 5 different proton signals for these residues. R3 
had an interaction between an amide proton at 8.975 ppm with an α proton at 4.534 ppm. This α 
proton was then seen to interact with β (1.712 ppm), γ (1.043 ppm) and δ (3.146 ppm) protons. 
These shifts were not very different from the R7 residue that was assigned earlier. The R13 
residue had an amide proton at 8.411 ppm interacting with an α proton at 3.831 ppm. This α 
proton was interacting with a β proton at 2.015 ppm, a γ proton at 1.179 ppm and a δ proton at 
2.863 ppm. These protons seem to be shielded and appear at a lower chemical shift than any of 
the other arginine residues, but this could be due to the nearby F1 residue and the large aromatic 
ring that is next to this residue. The orientation of the aromatic ring could induce a shielding 
effect on the protons of the R13 residue which make it seem to be at a lower shift than expected. 
With all 13 amino acid residues identified, the structure of the peptide on the resin can be 
proposed using the ROESY spectrum. 
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The ROESY spectrum had 14 different cross-peaks, representing 14 different through-
space interactions. These interactions are summarized in Table 3.3.3. Of these interactions, two 
were within the same spin system, five were between sequential amino acids and the remaining 
seven were through-space interactions between different amino acids. The two interactions 
within the same spin system, interactions 6 and 7, are for I8 and R3, respectively. In both cases 
the amide proton and the α proton of these residues are interacting, but do not provide much 
evidence to the structure of the peptide. The five interactions between sequential amino acids 
can provide some insight to the structure of the peptide. Unfortunately only 5 of the possible 13 
interactions were seen, which might be attributed to the very low substitution of the peptide on 
the resin. Regardless, these five interactions (1,2,5,9 and 10) are still useful in the understanding 
of the peptide structure. All of these interactions were between the amide proton and the α 
proton of another residue. Interaction 6 between the K9 amide proton and the I8 α proton 
indicates that these two amino acids that were joined at the beginning of the synthesis was done 
correctly and that up to this point the synthesis was going well. The interaction between the I8 
amide proton and the R7 α proton (interaction 11) was another indication that the synthesis was 
going smoothly. With the continuation of the synthesis the R7 amide proton was seen 
interacting with the α proton of Q6 suggesting that after the four amino acids were analyzed by 
NMR, the synthesis continued successfully. The last sequential interaction was interaction 1 and 
involved the amide proton of Q6 and the α proton of V5, which shows the valine residue was 
successfully coupled to the glutamine residue that came before it. These five interactions 
suggest that the first 5 amino acids were coupled successfully, but no other sequential 
interactions can suggest that the peptide was fully synthesized.  
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Table 3.3.3: The through-space NOE interactions observed in the ROESY spectrum from the 
FK-13 peptide. Interactions listed in bold red are those between different amino acids. The 
ROESY spectrum was referenced internally to the solvent peaks of DMF-d7  
Interaction Chemical Shift 
F1 (ppm) 
Chemical Shift 
F2 (ppm) 
Amino Acid 1 Amino Acid 2 
1 8.115  4.297  Q6 NH V5 Hα 
2 8.156  4.456  R7 NH I8 Hα 
3 8.197  4.572  R7 NH R3 Hα 
4 8.105  4.497  Q6 NH I8 Hα 
5 8.280  4.451  K9 NH I8 Hα 
6 8.325  4.468  I8 NH I8 Hα 
7 9.011  4.614  R3 NH R3 Hα 
8 8.067  4.509  D10 NH K2 Hα 
9 8.153  4.542  R7 NH Q6 Hα 
10 8.219  4.405  I8 NH R7 Hα 
11 8.404  4.477  R13 NH K2 Hα 
12 8.538  4.359  V5 NH R7 Hα 
13 8.495  4.437  R13 NH I8 Hα 
14 8.592  4.494  V5 NH K2 Hα 
 
The interpretation of the through-space interactions can verify if the synthesis was done 
correctly and if the 13-residue peptide has a unique structure. The seven through-space 
interactions can give some insight into the structure of the peptide and whether the synthesis 
was done successfully. Interactions 3, 4, 8, 11, 12, 13, and 14 were between amino acids there 
were not adjacent to one another. Interactions 4 and 12 are between amino acids that are 
separated by two residues. These interactions are between an amide proton of one residue and 
an α proton that is two residues away. Two of the interactions: interaction 4 which was between 
the amide proton of Q6 and the α proton of I8 and interaction 12 between the amide of V5 and 
the α of R7. These interactions are possible if the backbone begins to turn at these residues 
bringing the residues into close contact with one another. Since these 4 amino acids are 
sequential, it could be that this portion of the peptide has an arc conformation or a curve that is 
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part of the whole peptide. Interaction 11 is also between amino acids that are two residues apart 
from one another. The amide proton of R13 and the α proton of K2 were seen interacting with 
one another. These two amino acids were at the end of the synthesis of this peptide and could be 
coupled if the peptide were also turned at this point near the end of the synthesis. The coupling 
of the F11 residue to the D10 residue to form the cyclic peptide could influence the two residues 
to come in closer contact. If this peptide were linear, these interactions would be too far in space 
to be seen in ROESY. An explanation for these couplings appearing would be that the peptide is 
not linear and has some sort of turning conformation, whether that conformation is completely 
cyclic, a simple β turn or an α-helix cannot be determined using just these two interactions. The 
other four interactions (3, 8, 13 and 14) are through-space interactions that are between residues 
that are not very close in space to one another if the peptide had adopted a linear conformation. 
Interaction 3 is between the amide of R7 and R3 α proton, suggesting that this loop must be 
tightly packed in order for these backbone protons to be interacting. Depending on the actual 
conformation of the peptide, this interaction is hypothesized to be one that is bringing one 
portion of the chain in close contact to the other. Interaction 14 is an interaction between the 
amide proton of V5 and the α proton of K2. Knowing that interactions 4 and 12 potentially 
make up a portion of the peptide that is starting to make a turn, it could be that K2 is at the end 
of this turn portion of the peptide as it extends to the D10 residue. If this is the case, then the V5 
and K2 residues would be somewhat close in space and would suggest that the residues I4 and 
R3 would be the last bit of the turn before K2. A very interesting interaction that seems to bring 
opposite regions of the peptide in close contact with one another is interaction 8. The amide 
proton of D10 and the α proton of K2 are seen interacting through-space with one another. This 
interaction may be more useful in hypothesizing a structure for this peptide, since the first 
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amino acid added in the synthesis is seen interacting to one that was added near the end. If these 
two residues are indeed interacting, it suggests that the chain has to be coming back around to 
form the peptide bond between F11 and D10 to form a cyclic peptide. This interaction also rules 
out the possibility of the peptide forming the natural α-helix since this interaction is beyond the 
n+3 limit of ROESY peaks for helices.
67
Interaction 13 is another interesting interaction and also 
suggests that the peptide has adopted a cyclic conformation. This interaction is between the R13 
amide proton and the I8 α proton. The I8 residue was one of the first ones added in the synthesis 
and the R13 was one of the last, so seeing this interaction highly suggests that the peptide has 
come around full loop to form the peptide bond between the D10 residue and the F11 residue. 
Assuming that the peptide was linear, none of these interactions would be possible, especially 
interactions 8 and 13, because the distance between them would be too far for ROESY to detect. 
Also, if the peptide were just an α-helix, some of the interactions violate the n+3 interaction 
restraint that is seen in helices.
67
 There is a possibility that the peptide has formed a β-turn as 
opposed to being cyclic, but this is unlikely. β-turns usually have a stabilizing factor between 
the opposite ends of the chain that bring the two ends closer together and have a repetitive 
sequence that forms the turning point. The FK-13 sequence does not have a repetitive portion 
that would create the turn that a β-turn structure needs. Also the many hydrophobic residues 
would likely be pushed into the core of this peptide, leaving all of the hydrophilic (and polar) 
residues on the outside of the chain. For a β-turn the polar residue side chains facing in towards 
the centre of the peptide would be ideal so that hydrogen bonds could be formed and stabilize 
the β-turn structure. It would be expected that many interactions with the polar side chains be 
observed in the spectrum, but none were observed in the ROESY spectrum. Although the 
ROESY was not sensitive enough to detect interactions between the R groups of the different 
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residues, due to the low substitution of the peptide, the evidence from the backbone interactions 
suggest that the peptide does adopt a cyclic conformation. This cyclic conformation is based on 
interactions 8 and 13 from Table 3.3.3 and these interactions eliminate the possibility of other 
conformers from being formed.  
Further studies into the structure should be considered for examining this peptide. The 
synthesis of the cyclic product could be done with higher efficiency using a different starting 
material to ensure the substitution is higher. A higher substitution should give more signals in 
the ROESY spectrum that could be used to better deduce the structure. More through-space 
interactions in the ROESY could show the desired D10-F11 interaction along with other 
interactions to understand the orientation of the specific R groups and backbone conformation. 
Also the proximity of the side chains within the core of the cyclic peptide could be revealed by 
analyzing the α region of the peptide. No interactions were seen in this ROESY spectrum, 
possibly due to poor sensitivity. These initial studies could be expanded upon to probe the 
success of the synthesis and whether the peptide cyclized or not through different NMR 
techniques and computational studies. 
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Figure 3.3.3: Amide region of the ROESY spectrum for the resin-bound FK-13 peptide. Each 
interaction labelled corresponds to those in Table 3.3.3. In total 14 interactions were observed 
where 2 were within the same spin system and the remaining 12 were between different amino 
acids. Using the 12 interactions, the three-dimensional structure of FK-13 could be 
hypothesized.  
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3.4 Discussion 
 The synthesis of FK-13 was done using a modified solid-phase peptide synthesis 
technique. The use of an HMBA-AM resin allowed for amino acids that contained acid-labile 
protecting groups to be used. Each of the amino acids that had a protecting group, required 
harsh acidic conditions (95% TFA) to be cleaved from the residues (with the exception of the 
D10 residue). Using the HMBA-AM resin avoids the use of protecting groups that require 
different cleavage conditions since the resin requires strong basic conditions to cleave the 
peptide from the resin. The final substitution on the resin was 0.1471 mmol/g (16.7% of the 
total available sites assuming the initial molar substitution was 0.88 mmol/g). Compared to 
other peptides synthesized in the past by the Power group, the substitution is low. Depending on 
the coupling efficiency of each amino acid throughout the synthesis, the overall coupling begins 
to significantly drop after 6-12 residues. Peptides containing more than 6 residues are difficult 
to synthesize manually while trying to achieve a high level of substitution. The reaction sites of 
the resin become less accessible after numerous reaction cycles, especially if β-branched amino 
acids are used (such as Ile and Val).
68  
Even though the overall substitution was low, the 
individual steps were done with great success. The non-polar residues all coupled with over 
90% efficiency, and those that had protecting groups coupled over 80% as well. The primary 
issue with the synthesis came in the first step, where D10 was added to the resin using the 
DCBC method. Future peptide syntheses should not use the DCBC method as it caps the 
reaction sites as it couples. The use of DMAP or MSNT as the coupling reagent should be 
favoured, but both of these methods require more materials and time to achieve a successful 
coupling.
12
 Especially in the case for longer peptides that may contain many polar protected 
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groups, using a coupling reagent that will allow for the highest possible substitution will be 
favoured over DCBC.  
 Analysis of the resin-bound FK-13 peptide was carried out using a variety of 1D and 2D 
1
H NMR experiments. The use of COSY and TOCSY were used to identify the 13 different spin 
systems for the peptide. Identification of the first four residues was based on results obtained 
earlier in the study; the remaining nine were identified based on characteristic shifts of the 
individual amino acids. With the 13 amino acids characterized, ROESY was used to 
hypothesize a three-dimensional structure of the resin-bound peptide. The intent of this study 
was to synthesize a cyclic FK-13 so that comparative studies between the Power (NMR) and 
McMahon (IRMPD) group could be done. In total, 14 through-space interactions were observed 
in the ROESY spectrum allowing for some structure elucidation. There were two key 
interactions in this spectrum: interaction 8 which was between the D10 NH and the K2 α, and 
interaction 13 which was between R13 NH and I8 Hα. These interactions are between amino 
acids at the start of the synthesis (D10 and I8) and one at the end of the synthesis (K2 and R13). 
These interactions suggest that the synthesis did work accordingly, and that the peptide did 
create a head-to-tail peptide bond to form the cyclic peptide. The other interactions in Table 
3.3.3 also eliminate the possibility of the peptide being an α-helix (the natural conformation of 
this sequence), β-sheet or β-turn. Although it is two interactions in the amide region of the 
ROESY spectrum, early indication does suggest that the peptide achieved a cyclic structure. In 
addition to performing the synthesis again with a different starting reagent, other NMR 
experiments should be explored and further elucidate the structure of the resin-bound peptide.  
 The study of the antibacterial peptide FK-13 was done with the aid of solid-phase 
peptide synthesis and HRMAS NMR spectroscopy. Further work should be done to improve the 
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synthesis of the cyclic peptide to achieve higher substitution. With a higher substitution, the 
NMR experiments that were conducted will have better sensitivity, and more cross-peaks in the 
ROESY should be observed. More interactions should give better insight to the structure and 
evidence that the peptide is cyclic. Better NMR results will provide a better model to compare 
to the IRMPD results that were obtained by the McMahon group for this cyclic peptide. 
Computational calculations to determine the most favoured conformation of FK-13 based on the 
spectroscopy results can be performed. All of these methods combined will provide greater 
insight to the structure of the peptide and the results can be compared to one another for greater 
confidence in predicting peptide structure.  
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4.0 Concluding Remarks 
 The analysis of resin-bound GSH and FK-13 was accomplished using a variety of 
techniques. GSH was a small tripeptide that was synthesized with methods used by this group in 
the past. The peptide was analyzed using HRMAS NMR spectroscopy and key through-space 
interactions between the E1 α proton and two C2 β protons suggested that the peptide had 
adopted a semi-folded conformation. The proposed semi-folded structure was confirmed by the 
use of DFT calculations on the resin-bound peptide. Molecular dynamics simulations were 
conducted, but did not agree with the NMR or DFT calculations. The IRMPD results on the 
protonated GSH molecule suggested that the extra proton added gave rise to intramolecular 
hydrogen bonds that causes the peptide to have a folded conformation. A mixture of isomers for 
the protonated species is possible as the lowest energy structure was not the one that possessed 
the best matching spectrum, but the other isomer presented shared many similarities to the 
experimental spectrum and had a low calculated energy. From these studies, it is evident that 
GSH is a very flexible molecule and can adopt different conformations depending on the 
situations it is placed in and how it is analyzed.  
 FK-13 was a 13 residue peptide that was synthesized differently from the GSH peptide. 
It involved more modern techniques that allowed for the synthesis to be completed with 
effectiveness. Replacing the Wang resin with an HMBA-AM resin and HBTU/HOBt with 
HCTU made the synthesis easier and go to completion. Analysis on the resin-bound peptide was 
done using HRMAS NMR spectroscopy. Analysis of the 13 residue peptide was challenging 
since the TOCSY spectrum contained many overlapping peaks in the α region, but the amide 
region had fairly good resolution that assisted in the initial assignment of the peptide. Two key 
interactions in the ROESY spectrum between the residues D10/K2 and R13/I8, suggested that 
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the peptide was synthesized correctly and had adopted a cyclic conformation. The work that was 
presented for this peptide has plenty of room for growth, but all of this work done would be 
useful in future analysis. This work has suggested that manual synthesis of long peptide can be 
accomplished with great effectiveness using the proper procedures and materials. Also, analysis 
of this peptide by NMR spectroscopy shows that even with low sensitivity there are interactions 
that provide insight into the structure of the peptide and should be seen if this cyclic peptide 
were to be examined again. Overall, the study on FK-13 was much more difficult than GSH due 
to the size of the peptide, which affected the synthesis and analysis of the NMR spectra, but it is 
possible to achieve good results if some modifications are made to these methods. 
 Possible future work on both of these peptides can be done to improve the results for 
both systems. Solid-phase peptide synthesis of the two peptides can be improved so that a 
higher substitution can be achieved. The use of the HMBA-AM resin combined with the 
“standard 20” amino acids work well in tandem. The HMBA-AM resin is a base-labile resin, 
meaning that strong basic conditions are required to cleave the synthesized peptide from the 
resin.
21
 The “standard 20” amino acids all have protecting groups that are acid labile, i.e. the 
protecting groups all require strong acidic conditions to be cleaved.
12
 Synthesis of peptides 
should consider the use of these materials throughout the synthesis to minimize the number of 
different cleavage conditions for protecting groups. The use of HCTU as an aminium salt for the 
coupling reactions is an exceptional substitute for HBTU and HOBt. Using just HCTU will 
reduce the reaction time per coupling to 2 hours or less, and is a cleaner method since the 
reagents can be weighed directly into the Merrifield vessel. Also using different starting 
reagents such as MSNT or DMAP will increase the first amino acid coupling since this reagent 
will not cap the reaction sites as it couples and a higher substitution can be achieved.
12
 If a 
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higher starting substitution is achieved, the final substitution can be higher if there are no poor 
couplings throughout the synthesis. Manual synthesis is not necessarily the best approach to 
peptide synthesis; other methods such as automated synthesis
21
, chemical ligation
69
, and 
microwave assistance
70
 are approaches that improve the molecular substitution of the peptide. 
In the case of the FK-13 synthesis, a higher final substitution of the peptide would result in 
better sensitivity in the ROESY spectrum. The sample would be more concentrated and more 
interactions would be seen in the spectrum to provide more support for the proposition of a 
cyclic structure.  
 The continuation of the FK-13 work involves analysis of the peptide using NMR 
spectroscopy and then interpreting at the IRMPD results obtained by Dr. McMahon’s group as 
well. The analysis of the NMR spectra will provide insight into the structure of the resin-bound 
peptide and can be compared to the results obtained in this thesis. Many of the interactions that 
were seen in this thesis should still be observed in future work along with additional 
interactions, namely in the α region, that would be useful in supporting the proposition of the 
cyclic structure. Analysis of the IRMPD structures needs to be done to evaluate the structure of 
the protonated peptide. Generating the protonated structures using DFT calculations would be 
the first step and then comparing the spectra, calculated structure and energies of the species 
would need to be done. The methods and steps for analyzing the IRMPD results for FK-13 can 
be done in the same manner as GSH, i.e. choosing candidate structures, then narrowing down 
the selection based on similarities in spectra, calculated energy and structure. 
Additional work for the structure calculations on GSH and FK-13 can be further 
improved. The GSH results were very good and agreed with the NMR results, but the semi-
folded conformation is not the one that exists for GSH. The exploration of the different 
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structures that exists for GSH can be accomplished using a method known as “basin-hopping”.71 
This technique can be used to explore the potential energy surface of a molecule and determine 
the structures that occupy the different energy minima. This technique uses an unbiased 
algorithm to randomly sample different conformations of the peptide, but also uses lower level 
calculations to complete the analysis.
71
 After obtaining the structures from the low level 
calculations, the structures that occur the most are indicative of the structures that occupy the 
different energy minima of the potential surface and can be further optimized using DFT 
calculations. This will expand upon the analysis of the GSH conformation by not only finding 
the most favourable conformation, but also by looking for other structures that are energetically 
favourable. Analysis of the potential energy surface of the resin-bound GSH and FK-13 peptide 
can be accomplished using this technique to provide more insight into what structures these 
peptides prefer.  
Analysis of the DFT structures for GSH was accomplished using the PCM model of 
solvation. While this technique gives a good interpretation of how the resin-bound peptide 
behaves while in a solution of DMF, it is not the most accurate way to interpret the structure. 
The PCM model of solvation is an implicit model of solvation and puts a “dielectric box” of 
solvent around the molecule to simulate the solvent interactions. This is not entirely accurate 
because it assumes the small scale interactions are the same as the large scale interactions.
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Using the explicit model of solvation would improve the analysis of the resin-bound peptide 
structures because this method introduces actual solvent molecules into the system. This allows 
for the solvent molecules to interact with the peptide being calculated as opposed to simulating 
the effects of the solvent.
72
 Even though the GSH peptide showed a semi-folded conformation 
in the DFT calculation performed, the results could be more accurate by using the explicit 
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model of solvation. For future analysis of the FK-13 peptide, the cyclic structure on its own 
should be calculated first, followed by analysis of the resin-bound peptide. After this the 
introduction of actual solvent molecules into the system can be done to fully analyze the effect 
that solvent molecules would have on the resin-bound cyclic structure of FK-13.  
There are a lot of opportunities to further improve upon the results obtained in the GSH 
work. The sample could be resynthesized if necessary to achieve a higher substitution and 
subsequently could improve upon the NMR results. The main area of improvement for the GSH 
study would be analysis of the different conformations that GSH could adopt with the use of 
basin-hopping. Also, obtaining a more accurate structure for the DFT structure could be 
accomplished using the explicit model of solvation. The work done for FK-13 in this thesis can 
be used a good starting point for future work. The methods outlined to improve the solid-phase 
synthesis of this peptide can be used to achieve a higher final substitution. Having a higher 
substitution on the resin will help improve the sensitivity of the ROESY spectrum, which will 
give rise to interactions in the α region so that more evidence for the cyclic structure can be 
determined. Analysis of the resin-bound FK-13 can also be explored using structure calculations 
to determine the most favourable conformation of this peptide when interacting with DMF 
molecules. Finally, the IRMPD structures of FK-13 can be determined from the experimental 
spectrum obtained by Dr. McMahon’s group using the same procedure as the GSH IRMPD 
analysis. The work presented in this thesis has given a lot of valuable information about the 
structure of GSH and FK-13 and is an excellent starting point for future work in the analysis of 
either of these peptides.  
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Appendix 
Table A: Custom AMBER force field used to generate a wide variety of structures to 
examine the best conformation for the GSH peptide. The ‘Atom Type’ is the AMBER 
atom type needed to run the molecular mechanics calculations. The ‘Partial Charge’ is 
the result from the ChelpG calculation. The X, Y and Z columns are the coordinates of 
the first GSH peptide ran using the AMBER force field.  
Atom Type  Partial Charge          X        Y        Z 
C-C   0.721629        -6.72142441   -0.05211683   -1.95029936 
O-O   -0.622561       -7.38574698   -0.44712557   -1.01027255 
O-OH   -0.704190      -7.26912658    0.50191347   -3.05077773 
H-HO   0.488775       -8.23487438    0.54009544   -2.93047890 
C-CT   0.486977       -5.20042778   -0.06967449   -2.01437781 
H-H1   0.026662       -4.91878404   -0.25417687   -3.05699220 
N-N3   -1.196722      -4.71491297   -1.18957114   -1.20951521 
H-H   0.408767        -4.95537244   -1.05511750   -0.22968409 
H-H   0.451086        -3.70336480   -1.26007140   -1.27066936 
C-CT   0.018362       -4.68883013    1.34200174   -1.61496087 
H-HC   -0.020618      -5.18602589    2.09454306   -2.23447356 
H-HC   0.006749       -4.96802951    1.53696546   -0.57186950 
C-CT   -0.177405      -3.17061949    1.49041312   -1.78457440 
H-HC   0.033001  -2.63267874    0.79909288   -1.12883654 
H-HC   0.036978      -2.88787554    1.24385494   -2.81682479 
C-C   0.798043       -2.70547605    2.91980314   -1.53927134 
O-O   -0.668540       -3.28685575    3.89452775   -2.02554036 
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N-N   -0.789350       -1.59730628    3.05477692   -0.75091548 
H-H   0.412194     -1.12308594    2.21114378   -0.45448301 
C-CT   0.259399  -1.59908380    3.82362692    0.48322304 
H-H1   0.062041       -2.49636298    4.44955873    0.47073007 
C-CT   -0.058171      -0.35072268    4.71793752    0.60130758 
H-H1   0.042927       -0.33466805    5.17579430    1.58993069 
H-H1   0.140433        0.56061401    4.12120124    0.49502615 
S-SH   -0.359477      -0.21831885    6.02989092   -0.68112449 
H-HS   0.220776       -1.24218437    6.79161369   -0.24549221 
C-C   0.659071    -1.72550840    2.96726998    1.76378390 
O-O   -0.670089       -1.80526488    3.51895177    2.86873760 
N-N   -0.592156  -0.68637788    2.19153334    1.40261817 
H-H   0.311719    -0.67601874    1.74575378    0.49282556 
C-CT   0.173864    0.42016720    1.92583534    2.29626698 
H-H1   0.069658   0.08048733    1.44162987    3.21964576 
H-H1   0.060170    0.92376379    2.85301238    2.59350164 
C-C   0.758408     1.42280626    1.02216700    1.61327728 
O-O   -0.602581    1.30394437    0.58342266    0.48462659 
O-OH   -0.671462       2.46726004    0.76094923    2.41239189 
H-HO   0.485632    3.08717956    0.17620172    1.94091820 
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Figure E: Superimposed IRMPD spectra comparing the experimental GSH (red line) to the 
calculated spectrum for isomer 1. The spectra are both reported as frequency versus IRMPD 
efficiency (relative intensity). The three areas of interest in these spectra are the carbonyl region 
(~1900 cm
-1
), amide region (~1600 cm
-1
) and low IR region (~1100 cm
-1
).  
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Figure F: Superimposed IRMPD spectra comparing the experimental GSH (red line) to the 
calculated spectrum for isomer 2. The spectra are both reported as frequency versus IRMPD 
efficiency (relative intensity). The three areas of interest in these spectra are the carbonyl region 
(~1900 cm
-1
), amide region (~1600 cm
-1
) and low IR region (~1100 cm
-1
). 
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Figure G: Superimposed IRMPD spectra comparing the experimental GSH (red line) to the 
calculated spectrum for isomer 3. The spectra are both reported as frequency versus IRMPD 
efficiency (relative intensity). The three areas of interest in these spectra are the carbonyl region 
(~1900 cm
-1
), amide region (~1600 cm
-1
) and low IR region (~1100 cm
-1
). 
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Figure H: Superimposed IRMPD spectra comparing the experimental GSH (red line) to the 
calculated spectrum for isomer 4. The spectra are both reported as frequency versus IRMPD 
efficiency (relative intensity). The three areas of interest in these spectra are the carbonyl region 
(~1900 cm
-1
), amide region (~1600 cm
-1
) and low IR region (~1100 cm
-1
). 
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Figure I: Superimposed IRMPD spectra comparing the experimental GSH (red line) to the 
calculated spectrum for isomer 5. The spectra are both reported as frequency versus IRMPD 
efficiency (relative intensity). The three areas of interest in these spectra are the carbonyl region 
(~1900 cm
-1
), amide region (~1600 cm
-1
) and low IR region (~1100 cm
-1
). 
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